{
  "name": "FDA drug shortage duration tracker",
  "description": "For every package FDA currently lists as in shortage: how long that shortage entry has been open (from openFDA's own `initial_posting_date` to today), what FDA says the package's supply is right now, and any recovery estimate FDA has given. What FDA itself publishes, checked directly on 2026-09-01 rather than assumed: the shortage list page (accessdata.fda.gov/scripts/drugshortages) shows which drugs are short and why and carries no date at all, while each per-drug detail page adds a single 'Date first posted' for the whole drug. Neither prints an elapsed duration, and neither gives the date per manufacturer. openFDA does \u2014 where several manufacturers report a shortage of the same drug, each carries its own posting date, and FDA's page shows only the earliest of them. Cross-checked across 30 drugs against those detail pages: 30 of 30 agreed, and in all 10 multi-manufacturer cases FDA's single date was exactly the earliest of ours. The underlying facts are FDA's own public-domain data; the duration is a computation over them that nobody publishes maintained, because it changes every day and hand-updating it was never worth the effort. A scheduled refetch of the same public API keeps it current for free. Read the duration next to `availability`, and do not read it alone: a shortage entry stays 'Current' until FDA resolves the whole shortage, so 63.8% of listed packages (746 of 1,169, measured 2026-09-01) are marked 'Available' even while their entry has been open for years \u2014 the median entry has been open 1,721 days and 1,118 of 1,169 have been open more than 1,000. Records cite a per-drug, per-manufacturer API query rather than a page offset, because openFDA's result ordering rotates daily and an offset URL stops containing its own record \u2014 see sources.txt. Source: https://api.fda.gov/drug/shortages.json (openFDA, no API key required at this volume). This is a monitored dataset, not a static page \u2014 stale_after_days is short and a build should re-run the fetch on a schedule rather than once.",
  "url": "https://referencesource.org/drug-shortage-duration-tracker/",
  "licence": "openFDA drug shortage data is a U.S. government work and is in the public domain. No source-licence question arises; each record still cites the specific API query and retrieval date it came from.",
  "last_verified": "2026-09-16",
  "stale_after": "2026-09-19",
  "sources": [
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ailex%20Pharmaceuticals%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alembic%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22American%20Regent,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2050%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Anthea%20Pharma%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Desmopressin%20Acetate%20Spray%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Armas%20Pharmaceuticals%20Inc%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aspiro%20Pharma%20Limited%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avet%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avet%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avyxa%20Pharma,%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Azurity%20Pharmaceuticals,%20Inc%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Bristol%20Myers%20Squibb%20Co.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22BTG%20International%20Inc.%22+AND+generic_name%3A%22Hydroxocobalamin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Cheplapharm%20Arzneimittel%20GmbH%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Cumberland%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Conivaptan%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Curium%20US%20LLC%22+AND+generic_name%3A%22Technetium%20TC-99M%20Pyrophosphate%20Kit%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Dr.%20Reddy%27s%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22EDW%20Pharma,%20Inc.%20(formerly%20Italfarmaco%20Pharma,%20Inc.)%22+AND+generic_name%3A%22Riluzole%20Oral%20Suspension%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22ESTEVE%20PHARMACEUTICALS,%20S.A.%22+AND+generic_name%3A%22Streptozocin%20Powder,%20For%20Solution%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Exela%20Pharma%20Sciences,%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fera%20Pharmaceuticals%22+AND+generic_name%3A%22Echothiophate%20Iodide%20Ophthalmic%20Solution%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ferring%22+AND+generic_name%3A%22Desmopressin%20Acetate%20Spray%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Propranolol%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Valproate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Granules%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hainan%20Poly%20Pharm.%20Co.,%20Ltd.%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Oral%20Solution%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Propranolol%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sufentanil%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Valproate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2050%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Pentostatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sufentanil%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22HQ%20Specialty%20Pharma%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Huons%20Co.,%20Ltd%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Huons%20Co.,%20Ltd.%20(South%20Korea)%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Janssen%20Pharmaceuticals%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Jiangsu%20Hengrui%20Pharmaceuticals%20Co.,%20Ltd.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Jiangsu%20Hengrui%20Pharmaceuticals%20Co.%20(US%20Agent%20eVenus%20Pharmaceutical%20Laboratories,%20Inc.)%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Kindos%20Pharmaceuticals%20Co.%20Ltd.%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Laboratorios%20Atral%22+AND+generic_name%3A%22Penicillin%20G%20Benzathine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lifsa%20Drugs%20LLC%22+AND+generic_name%3A%22Isocarboxazid%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Long%20Grove%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medefil,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medefil,%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medexus%22+AND+generic_name%3A%22Triamcinolone%20Hexacetonide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Micro%20Labs%20LTD%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Milla%20Pharmaceuticals%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22MSN%20Laboratories%20Private%20Limited%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mullan%20Pharmaceutical%20Inc.%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Pharmaceuticals%20Inc.,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Specialty,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Nephron%20Pharmaceuticals%20Corporation%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novadoz%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Noven%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Film,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22ONESOURCE%20SPECIALTY%20PTE%20LTD%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Oryza%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Padagis%20US%20LLC%22+AND+generic_name%3A%22Bacitracin%20Ophthalmic%20Ointment%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Par%20Health,%20USA%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Par%20Health,%20USA%20LLC%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Penicillin%20G%20Benzathine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Piramal%20Critical%20Care%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Piramal%20Critical%20Care%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Prinston%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rhodes%20Pharmaceuticals%20L.P.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rising%20Pharma%20Holdings,%20Inc.%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rising%20Pharma%20Holdings,%20Inc.%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sanofi-Aventis%20U.S.%20LLC%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Spectra%20Medical%20Devices,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SteriMax,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SteriMax,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Technetium%20TC-99M%20Pyrophosphate%20Kit%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sunrise%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydroxocobalamin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Streptozocin%20Powder,%20For%20Solution%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teyro%20Labs%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Trigen%20Laboratories,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22WG%20Critical%20Care%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22XGen%20Pharmaceuticals%20DJB,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
    "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22XGen%20Pharmaceuticals%20DJB,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000"
  ],
  "records": [
    {
      "package_ndc": "16729-483-03",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/01/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2435",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "accord-healthcare-inc-atropine-sulfate-injection-16729-483-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-atropine-sulfate-injection-16729-483-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2020\", \"package_ndc\": \"16729-483-03\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-484-45",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/01/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2435",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "accord-healthcare-inc-atropine-sulfate-injection-16729-484-45",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-atropine-sulfate-injection-16729-484-45/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2020\", \"package_ndc\": \"16729-484-45\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-484-90",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/01/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2435",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "accord-healthcare-inc-atropine-sulfate-injection-16729-484-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-atropine-sulfate-injection-16729-484-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2020\", \"package_ndc\": \"16729-484-90\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-512-43",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/17/2026",
      "days_in_shortage": "5357",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "accord-healthcare-inc-atropine-sulfate-injection-16729-512-43",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-atropine-sulfate-injection-16729-512-43/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"16729-512-43\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-525-08",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: September 2026",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/17/2026",
      "days_in_shortage": "5357",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "accord-healthcare-inc-atropine-sulfate-injection-16729-525-08",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-atropine-sulfate-injection-16729-525-08/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"16729-525-08\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: September 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "16729-526-08",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/17/2026",
      "days_in_shortage": "5357",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "accord-healthcare-inc-atropine-sulfate-injection-16729-526-08",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-atropine-sulfate-injection-16729-526-08/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"16729-526-08\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-306-10",
      "generic_name": "Azacitidine Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/21/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2080",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "accord-healthcare-inc-azacitidine-injection-16729-306-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-azacitidine-injection-16729-306-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/21/2020\", \"package_ndc\": \"16729-306-10\", \"generic_name\": \"Azacitidine Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-295-12",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD; NDC is non-exempt",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "accord-healthcare-inc-carboplatin-injection-16729-295-12",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-carboplatin-injection-16729-295-12/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"16729-295-12\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD; NDC is non-exempt\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-295-31",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "accord-healthcare-inc-carboplatin-injection-16729-295-31",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-carboplatin-injection-16729-295-31/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"16729-295-31\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "16729-295-33",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD; NDC is non-exempt",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "accord-healthcare-inc-carboplatin-injection-16729-295-33",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-carboplatin-injection-16729-295-33/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"16729-295-33\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD; NDC is non-exempt\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-295-34",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD; NDC is non-exempt",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "accord-healthcare-inc-carboplatin-injection-16729-295-34",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-carboplatin-injection-16729-295-34/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"16729-295-34\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD; NDC is non-exempt\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-136-00",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "accord-healthcare-inc-clonazepam-tablet-16729-136-00",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-clonazepam-tablet-16729-136-00/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"16729-136-00\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-136-16",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "accord-healthcare-inc-clonazepam-tablet-16729-136-16",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-clonazepam-tablet-16729-136-16/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"16729-136-16\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-137-00",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "accord-healthcare-inc-clonazepam-tablet-16729-137-00",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-clonazepam-tablet-16729-137-00/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"16729-137-00\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-137-16",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "accord-healthcare-inc-clonazepam-tablet-16729-137-16",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-clonazepam-tablet-16729-137-16/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"16729-137-16\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-138-00",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "accord-healthcare-inc-clonazepam-tablet-16729-138-00",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-clonazepam-tablet-16729-138-00/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"16729-138-00\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-138-16",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "accord-healthcare-inc-clonazepam-tablet-16729-138-16",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-clonazepam-tablet-16729-138-16/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"16729-138-16\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-239-93",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2335",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "accord-healthcare-inc-dexmedetomidine-hydrochloride-injection-16729-239-93",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-dexmedetomidine-hydrochloride-injection-16729-239-93/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"16729-239-93\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Dexmedetomidine%20Hydrochloride%20Injection&st=d\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-432-93",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2335",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "accord-healthcare-inc-dexmedetomidine-hydrochloride-injection-16729-432-93",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-dexmedetomidine-hydrochloride-injection-16729-432-93/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"16729-432-93\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-500-08",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD; NDC is non-exempt",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2338",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "accord-healthcare-inc-furosemide-injection-16729-500-08",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-furosemide-injection-16729-500-08/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"16729-500-08\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"866-941-7875\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD; NDC is non-exempt\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-501-43",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD; NDC is non-exempt",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2338",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "accord-healthcare-inc-furosemide-injection-16729-501-43",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-furosemide-injection-16729-501-43/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"16729-501-43\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"866-941-7875\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD; NDC is non-exempt\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-502-43",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD; NDC is non-exempt",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2338",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "accord-healthcare-inc-furosemide-injection-16729-502-43",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-furosemide-injection-16729-502-43/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"16729-502-43\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"866-941-7875\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD; NDC is non-exempt\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16729-277-30",
      "generic_name": "Methotrexate Sodium Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/13/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1268",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "accord-healthcare-inc-methotrexate-sodium-injection-16729-277-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-methotrexate-sodium-injection-16729-277-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"16729-277-30\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "related_info",
          "value": "Fresh batch est avail Sep Week 3; ACC has short dated inventory with expiry of 09/30/27",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"16729-277-30\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"Fresh batch est avail Sep Week 3; ACC has short dated inventory with expiry of 09/30/27\"",
          "as_of": "2026-09-03"
        },
        {
          "field": "shortage_reason",
          "value": "Other",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"16729-277-30\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"Fresh batch est avail Sep Week 3; ACC has short dated inventory with expiry of 09/30/27\"",
          "as_of": "2026-09-03"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "16729-277-35",
      "generic_name": "Methotrexate Sodium Injection",
      "manufacturer_name": "Accord Healthcare Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/13/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1268",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "accord-healthcare-inc-methotrexate-sodium-injection-16729-277-35",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/accord-healthcare-inc-methotrexate-sodium-injection-16729-277-35/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"16729-277-35\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "related_info",
          "value": "ACC has short dated inventory with expiry of 08/31/27; Fresh inventory plan TBD",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"16729-277-35\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"ACC has short dated inventory with expiry of 08/31/27; Fresh inventory plan TBD\"",
          "as_of": "2026-09-03"
        },
        {
          "field": "shortage_reason",
          "value": "Other",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"16729-277-35\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"866-941-7875, option 2\", \"availability\": \"Unavailable\", \"related_info\": \"ACC has short dated inventory with expiry of 08/31/27; Fresh inventory plan TBD\"",
          "as_of": "2026-09-03"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "69784-200-96",
      "generic_name": "Cromolyn Sodium Concentrate",
      "manufacturer_name": "Ailex Pharmaceuticals",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "No longer manufactured, some supplies still available in supply chain. Distributed by Woodward Pharma Services LLC (248) 308-1120 Ext 2",
      "initial_posting_date": "11/03/2023",
      "update_date": "07/17/2026",
      "days_in_shortage": "1033",
      "shortage_reason": "Other",
      "dosage_form": "Concentrate",
      "therapeutic_category": "Pulmonary/Allergy",
      "id": "ailex-pharmaceuticals-cromolyn-sodium-concentrate-69784-200-96",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/ailex-pharmaceuticals-cromolyn-sodium-concentrate-69784-200-96/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ailex%20Pharmaceuticals%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/03/2023\", \"package_ndc\": \"69784-200-96\", \"generic_name\": \"Cromolyn Sodium Concentrate\", \"contact_info\": \"Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195 or customerservice@omniviumpharma.com\", \"availability\": \"Limited Availability\", \"related_info\": \"No longer manufactured, some supplies still available in supply chain. Distributed by Woodward Pharma Services LLC (248) 308-1120 Ext 2\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76204-025-96",
      "generic_name": "Cromolyn Sodium Concentrate",
      "manufacturer_name": "Ailex Pharmaceuticals",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "No longer manufactured, some supplies still available in supply chain. Distributed by Ritedose Pharmaceuticals, LLC (855) 806 3300",
      "initial_posting_date": "11/03/2023",
      "update_date": "07/17/2026",
      "days_in_shortage": "1033",
      "shortage_reason": "Other",
      "dosage_form": "Concentrate",
      "therapeutic_category": "Pulmonary/Allergy",
      "id": "ailex-pharmaceuticals-cromolyn-sodium-concentrate-76204-025-96",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/ailex-pharmaceuticals-cromolyn-sodium-concentrate-76204-025-96/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ailex%20Pharmaceuticals%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/03/2023\", \"package_ndc\": \"76204-025-96\", \"generic_name\": \"Cromolyn Sodium Concentrate\", \"contact_info\": \"Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195 or customerservice@omniviumpharma.com\", \"availability\": \"Limited Availability\", \"related_info\": \"No longer manufactured, some supplies still available in supply chain. Distributed by Ritedose Pharmaceuticals, LLC (855) 806 3300\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "81665-104-96",
      "generic_name": "Cromolyn Sodium Concentrate",
      "manufacturer_name": "Ailex Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195",
      "initial_posting_date": "11/03/2023",
      "update_date": "07/17/2026",
      "days_in_shortage": "1033",
      "dosage_form": "Concentrate",
      "therapeutic_category": "Pulmonary/Allergy",
      "id": "ailex-pharmaceuticals-cromolyn-sodium-concentrate-81665-104-96",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/ailex-pharmaceuticals-cromolyn-sodium-concentrate-81665-104-96/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ailex%20Pharmaceuticals%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/03/2023\", \"package_ndc\": \"81665-104-96\", \"generic_name\": \"Cromolyn Sodium Concentrate\", \"contact_info\": \"Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195 or customerservice@omniviumpharma.com\", \"availability\": \"Available\", \"related_info\": \"Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62332-599-25",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Alembic Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "05/15/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "alembic-pharmaceuticals-ketorolac-tromethamine-injection-62332-599-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alembic-pharmaceuticals-ketorolac-tromethamine-injection-62332-599-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alembic%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"62332-599-25\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"908-393-9604\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62332-600-25",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Alembic Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "05/15/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "alembic-pharmaceuticals-ketorolac-tromethamine-injection-62332-600-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alembic-pharmaceuticals-ketorolac-tromethamine-injection-62332-600-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alembic%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"62332-600-25\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"908-393-9604\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62332-601-25",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Alembic Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "05/15/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "alembic-pharmaceuticals-ketorolac-tromethamine-injection-62332-601-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alembic-pharmaceuticals-ketorolac-tromethamine-injection-62332-601-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alembic%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"62332-601-25\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"908-393-9604\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "47781-174-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Alvogen",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "alvogen-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-47781-174-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alvogen-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-47781-174-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"47781-174-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"844-842-8672 and email: CustomerService-US@alvogen.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "47781-176-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Alvogen",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "alvogen-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-47781-176-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alvogen-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-47781-176-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"47781-176-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"844-842-8672 and email: CustomerService-US@alvogen.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "47781-178-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Alvogen",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "alvogen-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-47781-178-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alvogen-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-47781-178-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"47781-178-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"844-842-8672 and email: CustomerService-US@alvogen.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "47781-179-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Alvogen",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "alvogen-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-47781-179-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alvogen-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-47781-179-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"47781-179-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"844-842-8672 and email: CustomerService-US@alvogen.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "47781-180-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Alvogen",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "alvogen-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-47781-180-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alvogen-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-47781-180-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"47781-180-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"844-842-8672 and email: CustomerService-US@alvogen.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "47781-562-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Alvogen",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "alvogen-lisdexamfetamine-dimesylate-capsule-47781-562-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alvogen-lisdexamfetamine-dimesylate-capsule-47781-562-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"47781-562-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"844-842-8672 and email: CustomerService-US@alvogen.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "47781-563-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Alvogen",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "alvogen-lisdexamfetamine-dimesylate-capsule-47781-563-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alvogen-lisdexamfetamine-dimesylate-capsule-47781-563-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"47781-563-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"844-842-8672 and email: CustomerService-US@alvogen.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "47781-564-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Alvogen",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "alvogen-lisdexamfetamine-dimesylate-capsule-47781-564-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alvogen-lisdexamfetamine-dimesylate-capsule-47781-564-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"47781-564-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"844-842-8672 and email: CustomerService-US@alvogen.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "47781-565-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Alvogen",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "alvogen-lisdexamfetamine-dimesylate-capsule-47781-565-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alvogen-lisdexamfetamine-dimesylate-capsule-47781-565-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"47781-565-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"844-842-8672 and email: CustomerService-US@alvogen.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "47781-566-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Alvogen",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "alvogen-lisdexamfetamine-dimesylate-capsule-47781-566-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alvogen-lisdexamfetamine-dimesylate-capsule-47781-566-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"47781-566-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"844-842-8672 and email: CustomerService-US@alvogen.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "47781-567-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Alvogen",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "alvogen-lisdexamfetamine-dimesylate-capsule-47781-567-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alvogen-lisdexamfetamine-dimesylate-capsule-47781-567-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"47781-567-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"844-842-8672 and email: CustomerService-US@alvogen.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "47781-568-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Alvogen",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "alvogen-lisdexamfetamine-dimesylate-capsule-47781-568-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/alvogen-lisdexamfetamine-dimesylate-capsule-47781-568-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"47781-568-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"844-842-8672 and email: CustomerService-US@alvogen.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0517-1001-25",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "American Regent, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/17/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "american-regent-inc-atropine-sulfate-injection-0517-1001-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/american-regent-inc-atropine-sulfate-injection-0517-1001-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22American%20Regent,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"0517-1001-25\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"800-645-1706\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0517-1004-25",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "American Regent, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/17/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "american-regent-inc-atropine-sulfate-injection-0517-1004-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/american-regent-inc-atropine-sulfate-injection-0517-1004-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22American%20Regent,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"0517-1004-25\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"800-645-1706\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70121-1388-1",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Amneal Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "06/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "amneal-pharmaceuticals-dexmedetomidine-hydrochloride-injection-70121-1388-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amneal-pharmaceuticals-dexmedetomidine-hydrochloride-injection-70121-1388-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"70121-1388-1\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"877-835-5472\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70121-1388-8",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Amneal Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "related_info": "Inventory available 4 to 5 month as per current demand. Next supply: week of 06/29/2026",
      "initial_posting_date": "04/10/2020",
      "update_date": "06/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "amneal-pharmaceuticals-dexmedetomidine-hydrochloride-injection-70121-1388-8",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amneal-pharmaceuticals-dexmedetomidine-hydrochloride-injection-70121-1388-8/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"70121-1388-8\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"866-525-7270\", \"availability\": \"Available\", \"related_info\": \"Inventory available 4 to 5 month as per current demand. Next supply: week of 06/29/2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70121-1389-1",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Amneal Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "06/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "amneal-pharmaceuticals-dexmedetomidine-hydrochloride-injection-70121-1389-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amneal-pharmaceuticals-dexmedetomidine-hydrochloride-injection-70121-1389-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"70121-1389-1\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"866-525-7270\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70121-1389-7",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Amneal Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "06/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "amneal-pharmaceuticals-dexmedetomidine-hydrochloride-injection-70121-1389-7",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amneal-pharmaceuticals-dexmedetomidine-hydrochloride-injection-70121-1389-7/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"70121-1389-7\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"866-525-7270\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65162-023-09",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Amneal Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "amneal-pharmaceuticals-lisdexamfetamine-dimesylate-capsule-65162-023-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amneal-pharmaceuticals-lisdexamfetamine-dimesylate-capsule-65162-023-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"65162-023-09\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"866-525-7270\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65162-024-09",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Amneal Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "amneal-pharmaceuticals-lisdexamfetamine-dimesylate-capsule-65162-024-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amneal-pharmaceuticals-lisdexamfetamine-dimesylate-capsule-65162-024-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"65162-024-09\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"866-525-7270\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65162-025-09",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Amneal Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "amneal-pharmaceuticals-lisdexamfetamine-dimesylate-capsule-65162-025-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amneal-pharmaceuticals-lisdexamfetamine-dimesylate-capsule-65162-025-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"65162-025-09\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"866-525-7270\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65162-026-09",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Amneal Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "amneal-pharmaceuticals-lisdexamfetamine-dimesylate-capsule-65162-026-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amneal-pharmaceuticals-lisdexamfetamine-dimesylate-capsule-65162-026-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"65162-026-09\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"866-525-7270\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65162-027-09",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Amneal Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "amneal-pharmaceuticals-lisdexamfetamine-dimesylate-capsule-65162-027-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amneal-pharmaceuticals-lisdexamfetamine-dimesylate-capsule-65162-027-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"65162-027-09\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"866-525-7270\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65162-028-09",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Amneal Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "amneal-pharmaceuticals-lisdexamfetamine-dimesylate-capsule-65162-028-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amneal-pharmaceuticals-lisdexamfetamine-dimesylate-capsule-65162-028-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"65162-028-09\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"866-525-7270\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70121-1573-1",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Amneal Pharmaceuticals",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "On backorder. Estimated recovery: late July",
      "initial_posting_date": "12/15/2021",
      "update_date": "06/17/2026",
      "days_in_shortage": "1721",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "amneal-pharmaceuticals-methylprednisolone-acetate-injection-70121-1573-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amneal-pharmaceuticals-methylprednisolone-acetate-injection-70121-1573-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"70121-1573-1\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"866-525-7270\", \"availability\": \"Limited Availability\", \"related_info\": \"On backorder. Estimated recovery: late July\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70121-1573-5",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Amneal Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/15/2021",
      "update_date": "06/17/2026",
      "days_in_shortage": "1721",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "amneal-pharmaceuticals-methylprednisolone-acetate-injection-70121-1573-5",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amneal-pharmaceuticals-methylprednisolone-acetate-injection-70121-1573-5/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"70121-1573-5\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"866-525-7270\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70121-1574-1",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Amneal Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/15/2021",
      "update_date": "06/17/2026",
      "days_in_shortage": "1721",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "amneal-pharmaceuticals-methylprednisolone-acetate-injection-70121-1574-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amneal-pharmaceuticals-methylprednisolone-acetate-injection-70121-1574-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"70121-1574-1\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"866-525-7270\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70121-1574-5",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Amneal Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/15/2021",
      "update_date": "06/17/2026",
      "days_in_shortage": "1721",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "amneal-pharmaceuticals-methylprednisolone-acetate-injection-70121-1574-5",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amneal-pharmaceuticals-methylprednisolone-acetate-injection-70121-1574-5/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"70121-1574-5\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"866-525-7270\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76329-3340-1",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Amphastar Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/01/2020",
      "update_date": "08/18/2026",
      "days_in_shortage": "2435",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "amphastar-pharmaceuticals-inc-atropine-sulfate-injection-76329-3340-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amphastar-pharmaceuticals-inc-atropine-sulfate-injection-76329-3340-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2020\", \"package_ndc\": \"76329-3340-1\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"800-423-4136\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76329-3302-1",
      "generic_name": "Dextrose Monohydrate 50% Injection",
      "manufacturer_name": "Amphastar Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/13/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1692",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "amphastar-pharmaceuticals-inc-dextrose-monohydrate-50-injection-76329-3302-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amphastar-pharmaceuticals-inc-dextrose-monohydrate-50-injection-76329-3302-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2050%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/13/2022\", \"package_ndc\": \"76329-3302-1\", \"generic_name\": \"Dextrose Monohydrate 50% Injection\", \"contact_info\": \"800-423-4136\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76329-3390-1",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Amphastar Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Available on allocation",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/18/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "amphastar-pharmaceuticals-inc-lidocaine-hydrochloride-injection-76329-3390-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amphastar-pharmaceuticals-inc-lidocaine-hydrochloride-injection-76329-3390-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"76329-3390-1\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"800-423-4136\", \"availability\": \"Limited Availability\", \"related_info\": \"Available on allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76329-8261-1",
      "generic_name": "Lorazepam Injection",
      "manufacturer_name": "Amphastar Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "05/03/2018",
      "update_date": "08/18/2026",
      "days_in_shortage": "3043",
      "dosage_form": "Injection",
      "therapeutic_category": "Neurology",
      "id": "amphastar-pharmaceuticals-inc-lorazepam-injection-76329-8261-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amphastar-pharmaceuticals-inc-lorazepam-injection-76329-8261-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/03/2018\", \"package_ndc\": \"76329-8261-1\", \"generic_name\": \"Lorazepam Injection\", \"contact_info\": \"800-423-4136\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76329-1912-1",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Amphastar Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/06/2018",
      "update_date": "08/18/2026",
      "days_in_shortage": "2826",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "amphastar-pharmaceuticals-inc-morphine-sulfate-injection-76329-1912-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amphastar-pharmaceuticals-inc-morphine-sulfate-injection-76329-1912-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/06/2018\", \"package_ndc\": \"76329-1912-1\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"800-423-4136\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76329-3352-1",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Amphastar Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Available on allocation",
      "initial_posting_date": "03/01/2017",
      "update_date": "08/18/2026",
      "days_in_shortage": "3471",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "amphastar-pharmaceuticals-inc-sodium-bicarbonate-injection-76329-3352-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/amphastar-pharmaceuticals-inc-sodium-bicarbonate-injection-76329-3352-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2017\", \"package_ndc\": \"76329-3352-1\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"contact_info\": \"800-423-4136\", \"availability\": \"Limited Availability\", \"related_info\": \"Available on allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "83634-651-10",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Anthea Pharma",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Avenacy, LLC",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/04/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "anthea-pharma-lidocaine-hydrochloride-injection-83634-651-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/anthea-pharma-lidocaine-hydrochloride-injection-83634-651-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Anthea%20Pharma%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"83634-651-10\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"Avenacy, LLC: 877-283-6229\", \"availability\": \"Available\", \"related_info\": \"Distributed by Avenacy, LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "83634-651-20",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Anthea Pharma",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Avenacy, LLC",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/04/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "anthea-pharma-lidocaine-hydrochloride-injection-83634-651-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/anthea-pharma-lidocaine-hydrochloride-injection-83634-651-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Anthea%20Pharma%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"83634-651-20\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"Avenacy, LLC: 877-283-6229\", \"availability\": \"Available\", \"related_info\": \"Distributed by Avenacy, LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "83634-651-50",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Anthea Pharma",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Avenacy, LLC",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/04/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "anthea-pharma-lidocaine-hydrochloride-injection-83634-651-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/anthea-pharma-lidocaine-hydrochloride-injection-83634-651-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Anthea%20Pharma%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"83634-651-50\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"Avenacy, LLC: 877-283-6229\", \"availability\": \"Available\", \"related_info\": \"Distributed by Avenacy, LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "83634-653-02",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Anthea Pharma",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Avenacy, LLC",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/04/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "anthea-pharma-lidocaine-hydrochloride-injection-83634-653-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/anthea-pharma-lidocaine-hydrochloride-injection-83634-653-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Anthea%20Pharma%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"83634-653-02\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"Avenacy, LLC: 877-283-6229\", \"availability\": \"Available\", \"related_info\": \"Distributed by Avenacy, LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "83634-653-05",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Anthea Pharma",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Avenacy, LLC",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/04/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "anthea-pharma-lidocaine-hydrochloride-injection-83634-653-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/anthea-pharma-lidocaine-hydrochloride-injection-83634-653-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Anthea%20Pharma%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"83634-653-05\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"Avenacy, LLC: 877-283-6229\", \"availability\": \"Available\", \"related_info\": \"Distributed by Avenacy, LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "83634-653-30",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Anthea Pharma",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Avenacy, LLC",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/04/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "anthea-pharma-lidocaine-hydrochloride-injection-83634-653-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/anthea-pharma-lidocaine-hydrochloride-injection-83634-653-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Anthea%20Pharma%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"83634-653-30\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"Avenacy, LLC: 877-283-6229\", \"availability\": \"Available\", \"related_info\": \"Distributed by Avenacy, LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "60505-0815-0",
      "generic_name": "Desmopressin Acetate Spray",
      "manufacturer_name": "Apotex Corp.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: 9/7/26",
      "initial_posting_date": "03/12/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1999",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Spray",
      "therapeutic_category": "Hematology",
      "id": "apotex-corp-desmopressin-acetate-spray-60505-0815-0",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/apotex-corp-desmopressin-acetate-spray-60505-0815-0/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Desmopressin%20Acetate%20Spray%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/12/2021\", \"package_ndc\": \"60505-0815-0\", \"generic_name\": \"Desmopressin Acetate Spray\", \"contact_info\": \"800-706-5575\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: 9/7/26\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "60505-4739-1",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Apotex Corp.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/01/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1035",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "apotex-corp-lisdexamfetamine-dimesylate-capsule-60505-4739-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/apotex-corp-lisdexamfetamine-dimesylate-capsule-60505-4739-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2023\", \"package_ndc\": \"60505-4739-1\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-706-5575\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "60505-4740-1",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Apotex Corp.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: 10/20/26",
      "initial_posting_date": "11/01/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1035",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "apotex-corp-lisdexamfetamine-dimesylate-capsule-60505-4740-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/apotex-corp-lisdexamfetamine-dimesylate-capsule-60505-4740-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2023\", \"package_ndc\": \"60505-4740-1\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-706-5575\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: 10/20/26\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "60505-4741-1",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Apotex Corp.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/01/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1035",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "apotex-corp-lisdexamfetamine-dimesylate-capsule-60505-4741-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/apotex-corp-lisdexamfetamine-dimesylate-capsule-60505-4741-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2023\", \"package_ndc\": \"60505-4741-1\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-706-5575\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "60505-4742-1",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Apotex Corp.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/01/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1035",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "apotex-corp-lisdexamfetamine-dimesylate-capsule-60505-4742-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/apotex-corp-lisdexamfetamine-dimesylate-capsule-60505-4742-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2023\", \"package_ndc\": \"60505-4742-1\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-706-5575\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "60505-4743-1",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Apotex Corp.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: Week of 8/24/26",
      "initial_posting_date": "11/01/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1035",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "apotex-corp-lisdexamfetamine-dimesylate-capsule-60505-4743-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/apotex-corp-lisdexamfetamine-dimesylate-capsule-60505-4743-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2023\", \"package_ndc\": \"60505-4743-1\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-706-5575\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: Week of 8/24/26\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "60505-4744-1",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Apotex Corp.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/01/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1035",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "apotex-corp-lisdexamfetamine-dimesylate-capsule-60505-4744-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/apotex-corp-lisdexamfetamine-dimesylate-capsule-60505-4744-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2023\", \"package_ndc\": \"60505-4744-1\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-706-5575\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "60505-4745-1",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Apotex Corp.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/01/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1035",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "apotex-corp-lisdexamfetamine-dimesylate-capsule-60505-4745-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/apotex-corp-lisdexamfetamine-dimesylate-capsule-60505-4745-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2023\", \"package_ndc\": \"60505-4745-1\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-706-5575\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72485-201-01",
      "generic_name": "Azacitidine Injection",
      "manufacturer_name": "Armas Pharmaceuticals Inc",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "12/18/2020",
      "update_date": "06/08/2026",
      "days_in_shortage": "2083",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "armas-pharmaceuticals-inc-azacitidine-injection-72485-201-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/armas-pharmaceuticals-inc-azacitidine-injection-72485-201-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Armas%20Pharmaceuticals%20Inc%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/18/2020\", \"package_ndc\": \"72485-201-01\", \"generic_name\": \"Azacitidine Injection\", \"contact_info\": \"732-637-1971\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "31722-275-32",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Aspiro Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "07/17/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "aspiro-pharma-limited-bupivacaine-hydrochloride-injection-31722-275-32",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aspiro-pharma-limited-bupivacaine-hydrochloride-injection-31722-275-32/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aspiro%20Pharma%20Limited%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"31722-275-32\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"732-529-0430, customerservice@camberpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "31722-275-34",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Aspiro Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "07/17/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "aspiro-pharma-limited-bupivacaine-hydrochloride-injection-31722-275-34",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aspiro-pharma-limited-bupivacaine-hydrochloride-injection-31722-275-34/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aspiro%20Pharma%20Limited%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"31722-275-34\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"732-529-0430, customerservice@camberpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "31722-276-32",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Aspiro Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "07/17/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "aspiro-pharma-limited-bupivacaine-hydrochloride-injection-31722-276-32",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aspiro-pharma-limited-bupivacaine-hydrochloride-injection-31722-276-32/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aspiro%20Pharma%20Limited%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"31722-276-32\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"732-529-0430, customerservice@camberpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "31722-276-34",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Aspiro Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "07/17/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "aspiro-pharma-limited-bupivacaine-hydrochloride-injection-31722-276-34",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aspiro-pharma-limited-bupivacaine-hydrochloride-injection-31722-276-34/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aspiro%20Pharma%20Limited%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"31722-276-34\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"732-529-0430, customerservice@camberpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "31722-277-32",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Aspiro Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "07/17/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "aspiro-pharma-limited-bupivacaine-hydrochloride-injection-31722-277-32",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aspiro-pharma-limited-bupivacaine-hydrochloride-injection-31722-277-32/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aspiro%20Pharma%20Limited%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"31722-277-32\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"732-529-0430, customerservice@camberpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "31722-277-34",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Aspiro Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "07/17/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "aspiro-pharma-limited-bupivacaine-hydrochloride-injection-31722-277-34",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aspiro-pharma-limited-bupivacaine-hydrochloride-injection-31722-277-34/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aspiro%20Pharma%20Limited%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"31722-277-34\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"732-529-0430, customerservice@camberpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "13107-068-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated availability: October 2026",
      "initial_posting_date": "10/12/2022",
      "update_date": "07/21/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "aurobindo-pharma-usa-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-13107-068-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-13107-068-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"13107-068-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(866) 850-2876 or CustomerService@AurobindoUSA.com\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated availability: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "13107-069-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated availability: October 2026",
      "initial_posting_date": "10/12/2022",
      "update_date": "07/21/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "aurobindo-pharma-usa-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-13107-069-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-13107-069-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"13107-069-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(866) 850-2876 or CustomerService@AurobindoUSA.com\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated availability: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "13107-070-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated availability: October 2026",
      "initial_posting_date": "10/12/2022",
      "update_date": "07/21/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "aurobindo-pharma-usa-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-13107-070-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-13107-070-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"13107-070-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(866) 850-2876 or CustomerService@AurobindoUSA.com\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated availability: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "13107-072-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated availability: October 2026",
      "initial_posting_date": "10/12/2022",
      "update_date": "07/21/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "aurobindo-pharma-usa-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-13107-072-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-13107-072-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"13107-072-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(866) 850-2876 OR CustomerService@AurobindoUSA.com\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated availability: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "13107-073-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated availability: October 2026",
      "initial_posting_date": "10/12/2022",
      "update_date": "07/21/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "aurobindo-pharma-usa-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-13107-073-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-13107-073-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"13107-073-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(866) 850-2876 or CustomerService@AurobindoUSA.com\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated availability: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "13107-074-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated availability: October 2026",
      "initial_posting_date": "10/12/2022",
      "update_date": "07/21/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "aurobindo-pharma-usa-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-13107-074-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-13107-074-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"13107-074-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(866) 850-2876 OR CustomerService@AurobindoUSA.com\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated availability: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59651-722-01",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/02/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "aurobindo-pharma-usa-clonazepam-tablet-59651-722-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-clonazepam-tablet-59651-722-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"59651-722-01\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"866-850-2876\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59651-722-99",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/02/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "aurobindo-pharma-usa-clonazepam-tablet-59651-722-99",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-clonazepam-tablet-59651-722-99/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"59651-722-99\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"866-850-2876\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59651-723-01",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/02/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "aurobindo-pharma-usa-clonazepam-tablet-59651-723-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-clonazepam-tablet-59651-723-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"59651-723-01\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"866-850-2876\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59651-723-99",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/02/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "aurobindo-pharma-usa-clonazepam-tablet-59651-723-99",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-clonazepam-tablet-59651-723-99/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"59651-723-99\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"866-850-2876\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59651-724-01",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/02/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "aurobindo-pharma-usa-clonazepam-tablet-59651-724-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-clonazepam-tablet-59651-724-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"59651-724-01\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"866-850-2876\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59651-724-05",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/02/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "aurobindo-pharma-usa-clonazepam-tablet-59651-724-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-clonazepam-tablet-59651-724-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"59651-724-05\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"866-850-2876\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65862-617-90",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/19/2023",
      "update_date": "06/02/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "aurobindo-pharma-usa-quinapril-hydrochloride-tablet-65862-617-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-quinapril-hydrochloride-tablet-65862-617-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"65862-617-90\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"866-850-2876\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65862-618-90",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/19/2023",
      "update_date": "06/02/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "aurobindo-pharma-usa-quinapril-hydrochloride-tablet-65862-618-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-quinapril-hydrochloride-tablet-65862-618-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"65862-618-90\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"866-850-2876\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65862-620-90",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/19/2023",
      "update_date": "06/02/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "aurobindo-pharma-usa-quinapril-hydrochloride-tablet-65862-620-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-quinapril-hydrochloride-tablet-65862-620-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"65862-620-90\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"866-850-2876\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65862-161-90",
      "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/19/2023",
      "update_date": "06/02/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "aurobindo-pharma-usa-quinapril-hydrochlorothiazide-tablet-65862-161-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-quinapril-hydrochlorothiazide-tablet-65862-161-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"65862-161-90\", \"generic_name\": \"Quinapril/Hydrochlorothiazide Tablet\", \"contact_info\": \"866-850-2876\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65862-162-90",
      "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/19/2023",
      "update_date": "06/02/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "aurobindo-pharma-usa-quinapril-hydrochlorothiazide-tablet-65862-162-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-quinapril-hydrochlorothiazide-tablet-65862-162-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"65862-162-90\", \"generic_name\": \"Quinapril/Hydrochlorothiazide Tablet\", \"contact_info\": \"866-850-2876\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65862-163-90",
      "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
      "manufacturer_name": "Aurobindo Pharma USA",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/19/2023",
      "update_date": "06/02/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "aurobindo-pharma-usa-quinapril-hydrochlorothiazide-tablet-65862-163-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/aurobindo-pharma-usa-quinapril-hydrochlorothiazide-tablet-65862-163-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"65862-163-90\", \"generic_name\": \"Quinapril/Hydrochlorothiazide Tablet\", \"contact_info\": \"866-850-2876\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "23155-473-41",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Avet Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/18/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "avet-pharmaceuticals-inc-furosemide-injection-23155-473-41",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/avet-pharmaceuticals-inc-furosemide-injection-23155-473-41/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avet%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"23155-473-41\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"855-228-9470\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "23155-473-42",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Avet Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: late October 2026; Manufacturing delay",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/18/2026",
      "days_in_shortage": "2338",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "avet-pharmaceuticals-inc-furosemide-injection-23155-473-42",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/avet-pharmaceuticals-inc-furosemide-injection-23155-473-42/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avet%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"23155-473-42\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"855-228-9470\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: late October 2026; Manufacturing delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "23155-473-44",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Avet Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: late October 2026; Manufacturing delay",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/18/2026",
      "days_in_shortage": "2338",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "avet-pharmaceuticals-inc-furosemide-injection-23155-473-44",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/avet-pharmaceuticals-inc-furosemide-injection-23155-473-44/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avet%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"23155-473-44\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"855-228-9470\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: late October 2026; Manufacturing delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "23155-600-41",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Avet Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: 8/25/2026",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/18/2026",
      "days_in_shortage": "2343",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "avet-pharmaceuticals-inc-midazolam-hydrochloride-injection-23155-600-41",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/avet-pharmaceuticals-inc-midazolam-hydrochloride-injection-23155-600-41/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avet%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"23155-600-41\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"855-228-9470\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: 8/25/2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "23155-601-41",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Avet Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/18/2026",
      "days_in_shortage": "2343",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "avet-pharmaceuticals-inc-midazolam-hydrochloride-injection-23155-601-41",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/avet-pharmaceuticals-inc-midazolam-hydrochloride-injection-23155-601-41/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avet%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"23155-601-41\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"855-228-9470\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "23155-601-42",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Avet Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/18/2026",
      "days_in_shortage": "2343",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "avet-pharmaceuticals-inc-midazolam-hydrochloride-injection-23155-601-42",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/avet-pharmaceuticals-inc-midazolam-hydrochloride-injection-23155-601-42/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avet%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"23155-601-42\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"855-228-9470\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "83831-141-08",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Avyxa Pharma, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/04/2026",
      "days_in_shortage": "1222",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "avyxa-pharma-llc-carboplatin-injection-83831-141-08",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/avyxa-pharma-llc-carboplatin-injection-83831-141-08/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avyxa%20Pharma,%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"83831-141-08\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"877-595-7337; customerservice@avyxa.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "83831-142-50",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Avyxa Pharma, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/04/2026",
      "days_in_shortage": "1222",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "avyxa-pharma-llc-carboplatin-injection-83831-142-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/avyxa-pharma-llc-carboplatin-injection-83831-142-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avyxa%20Pharma,%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"83831-142-50\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"877-595-7337; customerservice@avyxa.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "52536-125-10",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Azurity Pharmaceuticals, Inc",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Wilshire Pharmaceuticals, Inc.",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "azurity-pharmaceuticals-inc-dexmedetomidine-hydrochloride-injection-52536-125-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/azurity-pharmaceuticals-inc-dexmedetomidine-hydrochloride-injection-52536-125-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Azurity%20Pharmaceuticals,%20Inc%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"52536-125-10\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"877-495-6856\", \"availability\": \"Available\", \"related_info\": \"Distributed by Wilshire Pharmaceuticals, Inc.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "52536-126-08",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Azurity Pharmaceuticals, Inc",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Wilshire Pharmaceuticals, Inc.",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "azurity-pharmaceuticals-inc-dexmedetomidine-hydrochloride-injection-52536-126-08",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/azurity-pharmaceuticals-inc-dexmedetomidine-hydrochloride-injection-52536-126-08/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Azurity%20Pharmaceuticals,%20Inc%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"52536-126-08\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"877-495-6856\", \"availability\": \"Available\", \"related_info\": \"Distributed by Wilshire Pharmaceuticals, Inc.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72572-127-10",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Azurity Pharmaceuticals, Inc",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Civica",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "azurity-pharmaceuticals-inc-dexmedetomidine-hydrochloride-injection-72572-127-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/azurity-pharmaceuticals-inc-dexmedetomidine-hydrochloride-injection-72572-127-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Azurity%20Pharmaceuticals,%20Inc%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"72572-127-10\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"877-495-6856\", \"availability\": \"Available\", \"related_info\": \"Distributed by Civica\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72572-128-08",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Azurity Pharmaceuticals, Inc",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Civica",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "azurity-pharmaceuticals-inc-dexmedetomidine-hydrochloride-injection-72572-128-08",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/azurity-pharmaceuticals-inc-dexmedetomidine-hydrochloride-injection-72572-128-08/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Azurity%20Pharmaceuticals,%20Inc%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"72572-128-08\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"877-495-6856\", \"availability\": \"Available\", \"related_info\": \"Distributed by Civica\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-1933-10",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/21/2026",
      "days_in_shortage": "2093",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "b-braun-medical-inc-amino-acid-injection-0264-1933-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-amino-acid-injection-0264-1933-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0264-1933-10\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-4500-00",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/21/2026",
      "days_in_shortage": "2093",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "b-braun-medical-inc-amino-acid-injection-0264-4500-00",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-amino-acid-injection-0264-4500-00/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0264-4500-00\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-4500-05",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/21/2026",
      "days_in_shortage": "2093",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "b-braun-medical-inc-amino-acid-injection-0264-4500-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-amino-acid-injection-0264-4500-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0264-4500-05\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-1510-31",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/21/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-1510-31",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-1510-31/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0264-1510-31\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-1510-32",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/21/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-1510-32",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-1510-32/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0264-1510-32\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-7510-00",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/21/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-00",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-00/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0264-7510-00\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-7510-10",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/21/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0264-7510-10\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-7510-20",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/21/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0264-7510-20\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-7520-00",
      "generic_name": "Dextrose Monohydrate 10% Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/01/2022",
      "update_date": "08/21/2026",
      "days_in_shortage": "1645",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-00",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-00/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"0264-7520-00\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-7520-10",
      "generic_name": "Dextrose Monohydrate 10% Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/01/2022",
      "update_date": "08/21/2026",
      "days_in_shortage": "1645",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"0264-7520-10\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-7520-20",
      "generic_name": "Dextrose Monohydrate 10% Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/01/2022",
      "update_date": "08/21/2026",
      "days_in_shortage": "1645",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"0264-7520-20\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-7387-50",
      "generic_name": "Dextrose Monohydrate 70% Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/11/2024",
      "update_date": "08/21/2026",
      "days_in_shortage": "690",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "b-braun-medical-inc-dextrose-monohydrate-70-injection-0264-7387-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-70-injection-0264-7387-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/11/2024\", \"package_ndc\": \"0264-7387-50\", \"generic_name\": \"Dextrose Monohydrate 70% Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-9872-00",
      "generic_name": "Heparin Sodium Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/14/2017",
      "update_date": "08/21/2026",
      "days_in_shortage": "3213",
      "dosage_form": "Injection",
      "therapeutic_category": "Hematology",
      "id": "b-braun-medical-inc-heparin-sodium-injection-0264-9872-00",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-heparin-sodium-injection-0264-9872-00/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/14/2017\", \"package_ndc\": \"0264-9872-00\", \"generic_name\": \"Heparin Sodium Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "related_info",
          "value": "Estimated recovery: TBD; Manufacturing delays",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"11/14/2017\", \"package_ndc\": \"0264-9872-00\", \"generic_name\": \"Heparin Sodium Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD; Manufacturing delays\"",
          "as_of": "2026-09-15"
        },
        {
          "field": "shortage_reason",
          "value": "Other",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"11/14/2017\", \"package_ndc\": \"0264-9872-00\", \"generic_name\": \"Heparin Sodium Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD; Manufacturing delays\"",
          "as_of": "2026-09-15"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0264-9872-10",
      "generic_name": "Heparin Sodium Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/14/2017",
      "update_date": "08/21/2026",
      "days_in_shortage": "3213",
      "dosage_form": "Injection",
      "therapeutic_category": "Hematology",
      "id": "b-braun-medical-inc-heparin-sodium-injection-0264-9872-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-heparin-sodium-injection-0264-9872-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/14/2017\", \"package_ndc\": \"0264-9872-10\", \"generic_name\": \"Heparin Sodium Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "related_info",
          "value": "Estimated recovery: TBD; Manufacturing delays",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"11/14/2017\", \"package_ndc\": \"0264-9872-10\", \"generic_name\": \"Heparin Sodium Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD; Manufacturing delays\"",
          "as_of": "2026-09-15"
        },
        {
          "field": "shortage_reason",
          "value": "Other",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"11/14/2017\", \"package_ndc\": \"0264-9872-10\", \"generic_name\": \"Heparin Sodium Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD; Manufacturing delays\"",
          "as_of": "2026-09-15"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0264-9594-10",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/25/2017",
      "update_date": "08/21/2026",
      "days_in_shortage": "3233",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9594-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9594-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/25/2017\", \"package_ndc\": \"0264-9594-10\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-9594-20",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/25/2017",
      "update_date": "08/21/2026",
      "days_in_shortage": "3233",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9594-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9594-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/25/2017\", \"package_ndc\": \"0264-9594-20\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-9598-20",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/25/2017",
      "update_date": "08/21/2026",
      "days_in_shortage": "3233",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9598-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9598-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/25/2017\", \"package_ndc\": \"0264-9598-20\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-2101-00",
      "generic_name": "Sterile Water Irrigant",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/21/2026",
      "days_in_shortage": "1222",
      "dosage_form": "Irrigant",
      "therapeutic_category": "Gastroenterology",
      "id": "b-braun-medical-inc-sterile-water-irrigant-0264-2101-00",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-sterile-water-irrigant-0264-2101-00/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"0264-2101-00\", \"generic_name\": \"Sterile Water Irrigant\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0264-2101-10",
      "generic_name": "Sterile Water Irrigant",
      "manufacturer_name": "B. Braun Medical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/21/2026",
      "days_in_shortage": "1222",
      "dosage_form": "Irrigant",
      "therapeutic_category": "Gastroenterology",
      "id": "b-braun-medical-inc-sterile-water-irrigant-0264-2101-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-sterile-water-irrigant-0264-2101-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"0264-2101-10\", \"generic_name\": \"Sterile Water Irrigant\", \"contact_info\": \"800-227-2862\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0499-06",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2093",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "baxter-healthcare-amino-acid-injection-0338-0499-06",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-amino-acid-injection-0338-0499-06/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0338-0499-06\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0502-03",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2093",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "baxter-healthcare-amino-acid-injection-0338-0502-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-amino-acid-injection-0338-0502-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0338-0502-03\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0338-0502-06",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2093",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "baxter-healthcare-amino-acid-injection-0338-0502-06",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-amino-acid-injection-0338-0502-06/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0338-0502-06\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0338-0644-03",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2093",
      "shortage_reason": "Shortage of an inactive ingredient component",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "baxter-healthcare-amino-acid-injection-0338-0644-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-amino-acid-injection-0338-0644-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0338-0644-03\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0338-0644-04",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2093",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "baxter-healthcare-amino-acid-injection-0338-0644-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-amino-acid-injection-0338-0644-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0338-0644-04\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0644-06",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2093",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "baxter-healthcare-amino-acid-injection-0338-0644-06",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-amino-acid-injection-0338-0644-06/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0338-0644-06\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-1130-03",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2093",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "baxter-healthcare-amino-acid-injection-0338-1130-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-amino-acid-injection-0338-1130-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0338-1130-03\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-1130-04",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2093",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "baxter-healthcare-amino-acid-injection-0338-1130-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-amino-acid-injection-0338-1130-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0338-1130-04\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-1130-06",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2093",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "baxter-healthcare-amino-acid-injection-0338-1130-06",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-amino-acid-injection-0338-1130-06/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0338-1130-06\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-3410-50",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1260",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "baxter-healthcare-clindamycin-phosphate-injection-0338-3410-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-clindamycin-phosphate-injection-0338-3410-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0338-3410-50\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-3612-50",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1260",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "baxter-healthcare-clindamycin-phosphate-injection-0338-3612-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-clindamycin-phosphate-injection-0338-3612-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0338-3612-50\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-3814-50",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1260",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "baxter-healthcare-clindamycin-phosphate-injection-0338-3814-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-clindamycin-phosphate-injection-0338-3814-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0338-3814-50\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0338-9545-50",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1260",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "baxter-healthcare-clindamycin-phosphate-injection-0338-9545-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-clindamycin-phosphate-injection-0338-9545-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0338-9545-50\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-9549-50",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1260",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "baxter-healthcare-clindamycin-phosphate-injection-0338-9549-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-clindamycin-phosphate-injection-0338-9549-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0338-9549-50\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-9553-50",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1260",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "baxter-healthcare-clindamycin-phosphate-injection-0338-9553-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-clindamycin-phosphate-injection-0338-9553-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0338-9553-50\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-9555-24",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: September 2026",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2335",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "baxter-healthcare-dexmedetomidine-hydrochloride-injection-0338-9555-24",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dexmedetomidine-hydrochloride-injection-0338-9555-24/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0338-9555-24\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: September 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-9557-12",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "baxter-healthcare-dexmedetomidine-hydrochloride-injection-0338-9557-12",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dexmedetomidine-hydrochloride-injection-0338-9557-12/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0338-9557-12\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43066-555-24",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "baxter-healthcare-dexmedetomidine-hydrochloride-injection-43066-555-24",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dexmedetomidine-hydrochloride-injection-43066-555-24/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"43066-555-24\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43066-557-12",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "baxter-healthcare-dexmedetomidine-hydrochloride-injection-43066-557-12",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dexmedetomidine-hydrochloride-injection-43066-557-12/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"43066-557-12\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0017-02",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-0017-02\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0017-03",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-0017-03\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0017-10",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-0017-10\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0017-11",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-11",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-11/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-0017-11\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0017-18",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-18",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-18/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-0017-18\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0017-31",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-31",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-31/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-0017-31\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0017-38",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-38",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-38/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-0017-38\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0017-41",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-41",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-41/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-0017-41\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0017-48",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-48",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-48/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-0017-48\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0070-10",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-0070-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0070-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-0070-10\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0074-30",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/20/2026",
      "update_date": "08/17/2026",
      "days_in_shortage": "43",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-0074-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0074-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/20/2026\", \"package_ndc\": \"0338-0074-30\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0078-20",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-0078-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0078-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-0078-20\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0551-11",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-0551-11",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0551-11/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-0551-11\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0551-18",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-0551-18",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0551-18/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-0551-18\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-9664-40",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-9664-40",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-9664-40/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-9664-40\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-9666-35",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-5-injection-0338-9666-35",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-9666-35/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0338-9666-35\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0023-02",
      "generic_name": "Dextrose Monohydrate 10% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/01/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1645",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-10-injection-0338-0023-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-10-injection-0338-0023-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"0338-0023-02\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "related_info",
          "value": "Estimated recovery: September 2026",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"0338-0023-02\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: September 2026\"",
          "as_of": "2026-09-10"
        },
        {
          "field": "shortage_reason",
          "value": "Other",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"0338-0023-02\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: September 2026\"",
          "as_of": "2026-09-10"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0338-0023-03",
      "generic_name": "Dextrose Monohydrate 10% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/01/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1645",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-10-injection-0338-0023-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-10-injection-0338-0023-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"0338-0023-03\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0023-04",
      "generic_name": "Dextrose Monohydrate 10% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/01/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1645",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-10-injection-0338-0023-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-10-injection-0338-0023-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"0338-0023-04\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0719-06",
      "generic_name": "Dextrose Monohydrate 70% Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: September 2026",
      "initial_posting_date": "10/11/2024",
      "update_date": "08/17/2026",
      "days_in_shortage": "690",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "baxter-healthcare-dextrose-monohydrate-70-injection-0338-0719-06",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-70-injection-0338-0719-06/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/11/2024\", \"package_ndc\": \"0338-0719-06\", \"generic_name\": \"Dextrose Monohydrate 70% Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: September 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-1073-02",
      "generic_name": "Dobutamine Hydrochloride Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "baxter-healthcare-dobutamine-hydrochloride-injection-0338-1073-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dobutamine-hydrochloride-injection-0338-1073-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0338-1073-02\", \"generic_name\": \"Dobutamine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-1075-02",
      "generic_name": "Dobutamine Hydrochloride Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "baxter-healthcare-dobutamine-hydrochloride-injection-0338-1075-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dobutamine-hydrochloride-injection-0338-1075-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0338-1075-02\", \"generic_name\": \"Dobutamine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-1077-02",
      "generic_name": "Dobutamine Hydrochloride Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "baxter-healthcare-dobutamine-hydrochloride-injection-0338-1077-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dobutamine-hydrochloride-injection-0338-1077-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0338-1077-02\", \"generic_name\": \"Dobutamine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-1005-02",
      "generic_name": "Dopamine Hydrochloride Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "baxter-healthcare-dopamine-hydrochloride-injection-0338-1005-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dopamine-hydrochloride-injection-0338-1005-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0338-1005-02\", \"generic_name\": \"Dopamine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-1005-03",
      "generic_name": "Dopamine Hydrochloride Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "baxter-healthcare-dopamine-hydrochloride-injection-0338-1005-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dopamine-hydrochloride-injection-0338-1005-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0338-1005-03\", \"generic_name\": \"Dopamine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-1007-02",
      "generic_name": "Dopamine Hydrochloride Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "baxter-healthcare-dopamine-hydrochloride-injection-0338-1007-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dopamine-hydrochloride-injection-0338-1007-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0338-1007-02\", \"generic_name\": \"Dopamine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-1007-03",
      "generic_name": "Dopamine Hydrochloride Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "baxter-healthcare-dopamine-hydrochloride-injection-0338-1007-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dopamine-hydrochloride-injection-0338-1007-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0338-1007-03\", \"generic_name\": \"Dopamine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "36000-282-25",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "baxter-healthcare-furosemide-injection-36000-282-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-furosemide-injection-36000-282-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"36000-282-25\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "36000-283-25",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "baxter-healthcare-furosemide-injection-36000-283-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-furosemide-injection-36000-283-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"36000-283-25\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "36000-284-25",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "baxter-healthcare-furosemide-injection-36000-284-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-furosemide-injection-36000-284-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"36000-284-25\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0431-03",
      "generic_name": "Heparin Sodium Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/14/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3213",
      "dosage_form": "Injection",
      "therapeutic_category": "Hematology",
      "id": "baxter-healthcare-heparin-sodium-injection-0338-0431-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-heparin-sodium-injection-0338-0431-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/14/2017\", \"package_ndc\": \"0338-0431-03\", \"generic_name\": \"Heparin Sodium Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0433-04",
      "generic_name": "Heparin Sodium Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/14/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3213",
      "dosage_form": "Injection",
      "therapeutic_category": "Hematology",
      "id": "baxter-healthcare-heparin-sodium-injection-0338-0433-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-heparin-sodium-injection-0338-0433-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/14/2017\", \"package_ndc\": \"0338-0433-04\", \"generic_name\": \"Heparin Sodium Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-3991-01",
      "generic_name": "Ifosfamide Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "06/12/2026",
      "update_date": "08/17/2026",
      "days_in_shortage": "81",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "baxter-healthcare-ifosfamide-injection-0338-3991-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-ifosfamide-injection-0338-3991-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/12/2026\", \"package_ndc\": \"0338-3991-01\", \"generic_name\": \"Ifosfamide Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-3993-01",
      "generic_name": "Ifosfamide Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "06/12/2026",
      "update_date": "08/17/2026",
      "days_in_shortage": "81",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "baxter-healthcare-ifosfamide-injection-0338-3993-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-ifosfamide-injection-0338-3993-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/12/2026\", \"package_ndc\": \"0338-3993-01\", \"generic_name\": \"Ifosfamide Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "10019-925-01",
      "generic_name": "Ifosfamide Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: September 2026",
      "initial_posting_date": "06/12/2026",
      "update_date": "08/17/2026",
      "days_in_shortage": "81",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "baxter-healthcare-ifosfamide-injection-10019-925-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-ifosfamide-injection-10019-925-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/12/2026\", \"package_ndc\": \"10019-925-01\", \"generic_name\": \"Ifosfamide Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: September 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "10019-926-02",
      "generic_name": "Ifosfamide Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: September 2026",
      "initial_posting_date": "06/12/2026",
      "update_date": "08/17/2026",
      "days_in_shortage": "81",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "baxter-healthcare-ifosfamide-injection-10019-926-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-ifosfamide-injection-10019-926-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/12/2026\", \"package_ndc\": \"10019-926-02\", \"generic_name\": \"Ifosfamide Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: September 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0338-0069-10",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: January 2027",
      "initial_posting_date": "06/06/2018",
      "update_date": "08/17/2026",
      "days_in_shortage": "3009",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "baxter-healthcare-ketorolac-tromethamine-injection-0338-0069-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-ketorolac-tromethamine-injection-0338-0069-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/06/2018\", \"package_ndc\": \"0338-0069-10\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: January 2027\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0338-0072-25",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "06/06/2018",
      "update_date": "08/17/2026",
      "days_in_shortage": "3009",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "baxter-healthcare-ketorolac-tromethamine-injection-0338-0072-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-ketorolac-tromethamine-injection-0338-0072-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/06/2018\", \"package_ndc\": \"0338-0072-25\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0338-0409-03",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/25/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3233",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "baxter-healthcare-lidocaine-hydrochloride-injection-0338-0409-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-lidocaine-hydrochloride-injection-0338-0409-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/25/2017\", \"package_ndc\": \"0338-0409-03\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0411-02",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/25/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3233",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "baxter-healthcare-lidocaine-hydrochloride-injection-0338-0411-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-lidocaine-hydrochloride-injection-0338-0411-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/25/2017\", \"package_ndc\": \"0338-0411-02\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-1055-48",
      "generic_name": "Metronidazole Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/13/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1692",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "baxter-healthcare-metronidazole-injection-0338-1055-48",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-metronidazole-injection-0338-1055-48/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/13/2022\", \"package_ndc\": \"0338-1055-48\", \"generic_name\": \"Metronidazole Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43066-007-10",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "baxter-healthcare-rocuronium-bromide-injection-43066-007-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-rocuronium-bromide-injection-43066-007-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"43066-007-10\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43066-013-10",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "baxter-healthcare-rocuronium-bromide-injection-43066-013-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-rocuronium-bromide-injection-43066-013-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"43066-013-10\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0004-02",
      "generic_name": "Sterile Water Irrigant",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "dosage_form": "Irrigant",
      "therapeutic_category": "Gastroenterology",
      "id": "baxter-healthcare-sterile-water-irrigant-0338-0004-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-sterile-water-irrigant-0338-0004-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"0338-0004-02\", \"generic_name\": \"Sterile Water Irrigant\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0338-0004-03",
      "generic_name": "Sterile Water Irrigant",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: August 2026",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Irrigant",
      "therapeutic_category": "Gastroenterology",
      "id": "baxter-healthcare-sterile-water-irrigant-0338-0004-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-sterile-water-irrigant-0338-0004-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"0338-0004-03\", \"generic_name\": \"Sterile Water Irrigant\", \"contact_info\": \"888-229-0001\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: August 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0338-0004-04",
      "generic_name": "Sterile Water Irrigant",
      "manufacturer_name": "Baxter Healthcare",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: September 2026",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Irrigant",
      "therapeutic_category": "Gastroenterology",
      "id": "baxter-healthcare-sterile-water-irrigant-0338-0004-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-sterile-water-irrigant-0338-0004-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"0338-0004-04\", \"generic_name\": \"Sterile Water Irrigant\", \"contact_info\": \"888-229-0001\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: September 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59572-102-01",
      "generic_name": "Azacitidine Injection",
      "manufacturer_name": "Bristol Myers Squibb Co.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/18/2020",
      "update_date": "08/16/2026",
      "days_in_shortage": "2083",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "bristol-myers-squibb-co-azacitidine-injection-59572-102-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/bristol-myers-squibb-co-azacitidine-injection-59572-102-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Bristol%20Myers%20Squibb%20Co.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/18/2020\", \"package_ndc\": \"59572-102-01\", \"generic_name\": \"Azacitidine Injection\", \"contact_info\": \"1-888-423-5436\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "50633-310-11",
      "generic_name": "Hydroxocobalamin Injection",
      "manufacturer_name": "BTG International Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Cyanokit is available to order. To address the drug shortage, BTG International Inc (a SERB Pharmaceuticals company) coordinated with the U.S. Food and Drug Administration (FDA) to make the following impacted batches available to U.S. patients during this period of shortage.",
      "initial_posting_date": "11/04/2024",
      "update_date": "08/17/2026",
      "days_in_shortage": "666",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Other",
      "id": "btg-international-inc-hydroxocobalamin-injection-50633-310-11",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/btg-international-inc-hydroxocobalamin-injection-50633-310-11/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22BTG%20International%20Inc.%22+AND+generic_name%3A%22Hydroxocobalamin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/04/2024\", \"package_ndc\": \"50633-310-11\", \"generic_name\": \"Hydroxocobalamin Injection\", \"related_info_link\": \"https://www.fda.gov/media/185400/download\", \"contact_info\": \"1 877 377 3784\", \"availability\": \"Limited Availability\", \"related_info\": \"Cyanokit is available to order. To address the drug shortage, BTG International Inc (a SERB Pharmaceuticals company) coordinated with the U.S. Food and Drug Administration (FDA) to make the following impacted batches available to U.S. patients during this period of shortage.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65219-445-10",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Caplin Steriles, Ltd.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory; Marketed by Fresenius Kabi",
      "initial_posting_date": "10/05/2022",
      "update_date": "06/16/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "caplin-steriles-ltd-etomidate-injection-65219-445-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/caplin-steriles-ltd-etomidate-injection-65219-445-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"65219-445-10\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"800-551-7176\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory; Marketed by Fresenius Kabi\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65219-447-20",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Caplin Steriles, Ltd.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory; Marketed by Fresenius Kabi",
      "initial_posting_date": "10/05/2022",
      "update_date": "06/16/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "caplin-steriles-ltd-etomidate-injection-65219-447-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/caplin-steriles-ltd-etomidate-injection-65219-447-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"65219-447-20\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"800-551-7176\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory; Marketed by Fresenius Kabi\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72485-508-10",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Caplin Steriles, Ltd.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586",
      "initial_posting_date": "10/05/2022",
      "update_date": "06/16/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "caplin-steriles-ltd-etomidate-injection-72485-508-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/caplin-steriles-ltd-etomidate-injection-72485-508-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"72485-508-10\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"908-803-2586\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72485-509-10",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Caplin Steriles, Ltd.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586",
      "initial_posting_date": "10/05/2022",
      "update_date": "06/16/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "caplin-steriles-ltd-etomidate-injection-72485-509-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/caplin-steriles-ltd-etomidate-injection-72485-509-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"72485-509-10\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"908-803-2586\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43066-015-10",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Caplin Steriles, Ltd.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Check wholesalers for inventory; Marketed by Baxter",
      "initial_posting_date": "12/22/2020",
      "update_date": "06/10/2026",
      "days_in_shortage": "2079",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "caplin-steriles-ltd-ropivacaine-hydrochloride-injection-43066-015-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/caplin-steriles-ltd-ropivacaine-hydrochloride-injection-43066-015-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2020\", \"package_ndc\": \"43066-015-10\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Limited Availability\", \"related_info\": \"Check wholesalers for inventory; Marketed by Baxter\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43066-019-10",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Caplin Steriles, Ltd.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory; Marketed by Baxter",
      "initial_posting_date": "12/22/2020",
      "update_date": "06/10/2026",
      "days_in_shortage": "2079",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "caplin-steriles-ltd-ropivacaine-hydrochloride-injection-43066-019-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/caplin-steriles-ltd-ropivacaine-hydrochloride-injection-43066-019-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2020\", \"package_ndc\": \"43066-019-10\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory; Marketed by Baxter\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43066-023-10",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Caplin Steriles, Ltd.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited supply; Check wholesalers for inventory; Marketed by Baxter",
      "initial_posting_date": "12/22/2020",
      "update_date": "06/10/2026",
      "days_in_shortage": "2079",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "caplin-steriles-ltd-ropivacaine-hydrochloride-injection-43066-023-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/caplin-steriles-ltd-ropivacaine-hydrochloride-injection-43066-023-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2020\", \"package_ndc\": \"43066-023-10\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited supply; Check wholesalers for inventory; Marketed by Baxter\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43066-027-10",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Caplin Steriles, Ltd.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory; Marketed by Baxter",
      "initial_posting_date": "12/22/2020",
      "update_date": "06/10/2026",
      "days_in_shortage": "2079",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "caplin-steriles-ltd-ropivacaine-hydrochloride-injection-43066-027-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/caplin-steriles-ltd-ropivacaine-hydrochloride-injection-43066-027-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2020\", \"package_ndc\": \"43066-027-10\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-229-0001\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory; Marketed by Baxter\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62135-736-30",
      "generic_name": "Flurazepam Hydrochloride Capsule",
      "manufacturer_name": "Chartwell Molecular Holdings LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "08/03/2022",
      "update_date": "08/26/2026",
      "days_in_shortage": "1490",
      "dosage_form": "Capsule",
      "therapeutic_category": "Neurology",
      "id": "chartwell-molecular-holdings-llc-flurazepam-hydrochloride-capsule-62135-736-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/chartwell-molecular-holdings-llc-flurazepam-hydrochloride-capsule-62135-736-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"08/03/2022\", \"package_ndc\": \"62135-736-30\", \"generic_name\": \"Flurazepam Hydrochloride Capsule\", \"contact_info\": \"845-268-5000 Ext. 510\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62135-736-90",
      "generic_name": "Flurazepam Hydrochloride Capsule",
      "manufacturer_name": "Chartwell Molecular Holdings LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "08/03/2022",
      "update_date": "08/26/2026",
      "days_in_shortage": "1490",
      "dosage_form": "Capsule",
      "therapeutic_category": "Oncology",
      "id": "chartwell-molecular-holdings-llc-flurazepam-hydrochloride-capsule-62135-736-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/chartwell-molecular-holdings-llc-flurazepam-hydrochloride-capsule-62135-736-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"08/03/2022\", \"package_ndc\": \"62135-736-90\", \"generic_name\": \"Flurazepam Hydrochloride Capsule\", \"contact_info\": \"845-268-5000 Ext. 510\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62135-737-30",
      "generic_name": "Flurazepam Hydrochloride Capsule",
      "manufacturer_name": "Chartwell Molecular Holdings LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "08/03/2022",
      "update_date": "08/26/2026",
      "days_in_shortage": "1490",
      "dosage_form": "Capsule",
      "therapeutic_category": "Neurology",
      "id": "chartwell-molecular-holdings-llc-flurazepam-hydrochloride-capsule-62135-737-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/chartwell-molecular-holdings-llc-flurazepam-hydrochloride-capsule-62135-737-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"08/03/2022\", \"package_ndc\": \"62135-737-30\", \"generic_name\": \"Flurazepam Hydrochloride Capsule\", \"contact_info\": \"845-268-5000 Ext. 510\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62135-737-90",
      "generic_name": "Flurazepam Hydrochloride Capsule",
      "manufacturer_name": "Chartwell Molecular Holdings LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "08/03/2022",
      "update_date": "08/26/2026",
      "days_in_shortage": "1490",
      "dosage_form": "Capsule",
      "therapeutic_category": "Neurology",
      "id": "chartwell-molecular-holdings-llc-flurazepam-hydrochloride-capsule-62135-737-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/chartwell-molecular-holdings-llc-flurazepam-hydrochloride-capsule-62135-737-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"08/03/2022\", \"package_ndc\": \"62135-737-90\", \"generic_name\": \"Flurazepam Hydrochloride Capsule\", \"contact_info\": \"845-268-5000 Ext. 510\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62135-484-60",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Chartwell Molecular Holdings LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/26/2026",
      "days_in_shortage": "1321",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "chartwell-molecular-holdings-llc-quinapril-hydrochloride-tablet-62135-484-60",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/chartwell-molecular-holdings-llc-quinapril-hydrochloride-tablet-62135-484-60/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"62135-484-60\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62135-485-90",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Chartwell Molecular Holdings LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/26/2026",
      "days_in_shortage": "1321",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "chartwell-molecular-holdings-llc-quinapril-hydrochloride-tablet-62135-485-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/chartwell-molecular-holdings-llc-quinapril-hydrochloride-tablet-62135-485-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"62135-485-90\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62135-486-90",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Chartwell Molecular Holdings LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/26/2026",
      "days_in_shortage": "1321",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "chartwell-molecular-holdings-llc-quinapril-hydrochloride-tablet-62135-486-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/chartwell-molecular-holdings-llc-quinapril-hydrochloride-tablet-62135-486-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"62135-486-90\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62135-487-90",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Chartwell Molecular Holdings LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/26/2026",
      "days_in_shortage": "1321",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "chartwell-molecular-holdings-llc-quinapril-hydrochloride-tablet-62135-487-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/chartwell-molecular-holdings-llc-quinapril-hydrochloride-tablet-62135-487-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"62135-487-90\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62135-667-90",
      "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
      "manufacturer_name": "Chartwell Molecular Holdings LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/26/2026",
      "days_in_shortage": "1321",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "chartwell-molecular-holdings-llc-quinapril-hydrochlorothiazide-tablet-62135-667-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/chartwell-molecular-holdings-llc-quinapril-hydrochlorothiazide-tablet-62135-667-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"62135-667-90\", \"generic_name\": \"Quinapril/Hydrochlorothiazide Tablet\", \"contact_info\": \"845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62135-668-90",
      "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
      "manufacturer_name": "Chartwell Molecular Holdings LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/26/2026",
      "days_in_shortage": "1321",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "chartwell-molecular-holdings-llc-quinapril-hydrochlorothiazide-tablet-62135-668-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/chartwell-molecular-holdings-llc-quinapril-hydrochlorothiazide-tablet-62135-668-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"62135-668-90\", \"generic_name\": \"Quinapril/Hydrochlorothiazide Tablet\", \"contact_info\": \"845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62135-669-90",
      "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
      "manufacturer_name": "Chartwell Molecular Holdings LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/26/2026",
      "days_in_shortage": "1321",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "chartwell-molecular-holdings-llc-quinapril-hydrochlorothiazide-tablet-62135-669-90",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/chartwell-molecular-holdings-llc-quinapril-hydrochlorothiazide-tablet-62135-669-90/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"62135-669-90\", \"generic_name\": \"Quinapril/Hydrochlorothiazide Tablet\", \"contact_info\": \"845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61269-605-10",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Cheplapharm Arzneimittel GmbH",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by H2-Pharma",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "cheplapharm-arzneimittel-gmbh-clonazepam-tablet-61269-605-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/cheplapharm-arzneimittel-gmbh-clonazepam-tablet-61269-605-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Cheplapharm%20Arzneimittel%20GmbH%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"61269-605-10\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"orders@h2-pharma.com\", \"availability\": \"Available\", \"related_info\": \"Marketed by H2-Pharma\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61269-610-10",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Cheplapharm Arzneimittel GmbH",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by H2-Pharma",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "cheplapharm-arzneimittel-gmbh-clonazepam-tablet-61269-610-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/cheplapharm-arzneimittel-gmbh-clonazepam-tablet-61269-610-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Cheplapharm%20Arzneimittel%20GmbH%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"61269-610-10\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"orders@h2-pharma.com\", \"availability\": \"Available\", \"related_info\": \"Marketed by H2-Pharma\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61269-620-10",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Cheplapharm Arzneimittel GmbH",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by H2-Pharma",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "cheplapharm-arzneimittel-gmbh-clonazepam-tablet-61269-620-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/cheplapharm-arzneimittel-gmbh-clonazepam-tablet-61269-620-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Cheplapharm%20Arzneimittel%20GmbH%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"61269-620-10\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"orders@h2-pharma.com\", \"availability\": \"Available\", \"related_info\": \"Marketed by H2-Pharma\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "66220-160-10",
      "generic_name": "Conivaptan Hydrochloride Injection",
      "manufacturer_name": "Cumberland Pharmaceuticals Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/14/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1632",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "cumberland-pharmaceuticals-inc-conivaptan-hydrochloride-injection-66220-160-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/cumberland-pharmaceuticals-inc-conivaptan-hydrochloride-injection-66220-160-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Cumberland%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Conivaptan%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/14/2022\", \"package_ndc\": \"66220-160-10\", \"generic_name\": \"Conivaptan Hydrochloride Injection\", \"contact_info\": \"800-706-5575\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "69945-094-20",
      "generic_name": "Technetium TC-99M Pyrophosphate Kit Injection",
      "manufacturer_name": "Curium US LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Available via allocation",
      "initial_posting_date": "12/27/2023",
      "update_date": "08/19/2026",
      "days_in_shortage": "979",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Injection",
      "therapeutic_category": "Medical Imaging",
      "id": "curium-us-llc-technetium-tc-99m-pyrophosphate-kit-injection-69945-094-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/curium-us-llc-technetium-tc-99m-pyrophosphate-kit-injection-69945-094-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Curium%20US%20LLC%22+AND+generic_name%3A%22Technetium%20TC-99M%20Pyrophosphate%20Kit%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/27/2023\", \"package_ndc\": \"69945-094-20\", \"generic_name\": \"Technetium TC-99M Pyrophosphate Kit Injection\", \"contact_info\": \"888-744-1414\", \"availability\": \"Limited Availability\", \"related_info\": \"Available via allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43598-305-62",
      "generic_name": "Azacitidine Injection",
      "manufacturer_name": "Dr. Reddy's Laboratories, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Available to existing customers",
      "initial_posting_date": "12/18/2020",
      "update_date": "08/05/2026",
      "days_in_shortage": "2083",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "dr-reddy-s-laboratories-inc-azacitidine-injection-43598-305-62",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/dr-reddy-s-laboratories-inc-azacitidine-injection-43598-305-62/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Dr.%20Reddy%27s%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/18/2020\", \"package_ndc\": \"43598-305-62\", \"generic_name\": \"Azacitidine Injection\", \"contact_info\": \"866-732-3952\", \"availability\": \"Available\", \"related_info\": \"Available to existing customers\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70726-0303-1",
      "generic_name": "Riluzole Oral Suspension",
      "manufacturer_name": "EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release not available at this time; Shortage per Manufacturer: Product manufacturing interrupted due to testing",
      "initial_posting_date": "01/26/2024",
      "update_date": "08/17/2026",
      "days_in_shortage": "949",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Oral Suspension",
      "therapeutic_category": "Neurology",
      "id": "edw-pharma-inc-formerly-italfarmaco-pharma-inc-riluzole-oral-suspension-70726-0303-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/edw-pharma-inc-formerly-italfarmaco-pharma-inc-riluzole-oral-suspension-70726-0303-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22EDW%20Pharma,%20Inc.%20(formerly%20Italfarmaco%20Pharma,%20Inc.)%22+AND+generic_name%3A%22Riluzole%20Oral%20Suspension%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/26/2024\", \"package_ndc\": \"70726-0303-1\", \"generic_name\": \"Riluzole Oral Suspension\", \"contact_info\": \"610-937-6172\", \"availability\": \"Unavailable\", \"related_info\": \"Next release not available at this time; Shortage per Manufacturer: Product manufacturing interrupted due to testing\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70726-0304-1",
      "generic_name": "Riluzole Oral Suspension",
      "manufacturer_name": "EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/26/2024",
      "update_date": "08/17/2026",
      "days_in_shortage": "949",
      "dosage_form": "Oral Suspension",
      "therapeutic_category": "Neurology",
      "id": "edw-pharma-inc-formerly-italfarmaco-pharma-inc-riluzole-oral-suspension-70726-0304-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/edw-pharma-inc-formerly-italfarmaco-pharma-inc-riluzole-oral-suspension-70726-0304-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22EDW%20Pharma,%20Inc.%20(formerly%20Italfarmaco%20Pharma,%20Inc.)%22+AND+generic_name%3A%22Riluzole%20Oral%20Suspension%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/26/2024\", \"package_ndc\": \"70726-0304-1\", \"generic_name\": \"Riluzole Oral Suspension\", \"related_info_link\": \"https://www.fda.gov/media/185611/download?attachment\", \"contact_info\": \"610-937-6172\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70726-0305-1",
      "generic_name": "Riluzole Oral Suspension",
      "manufacturer_name": "EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/26/2024",
      "update_date": "08/17/2026",
      "days_in_shortage": "949",
      "dosage_form": "Oral Suspension",
      "therapeutic_category": "Neurology",
      "id": "edw-pharma-inc-formerly-italfarmaco-pharma-inc-riluzole-oral-suspension-70726-0305-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/edw-pharma-inc-formerly-italfarmaco-pharma-inc-riluzole-oral-suspension-70726-0305-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22EDW%20Pharma,%20Inc.%20(formerly%20Italfarmaco%20Pharma,%20Inc.)%22+AND+generic_name%3A%22Riluzole%20Oral%20Suspension%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/26/2024\", \"package_ndc\": \"70726-0305-1\", \"generic_name\": \"Riluzole Oral Suspension\", \"related_info_link\": \"https://www.fda.gov/media/177206/download\", \"contact_info\": \"610-937-6172\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70726-0306-1",
      "generic_name": "Riluzole Oral Suspension",
      "manufacturer_name": "EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/26/2024",
      "update_date": "08/17/2026",
      "days_in_shortage": "949",
      "dosage_form": "Oral Suspension",
      "therapeutic_category": "Neurology",
      "id": "edw-pharma-inc-formerly-italfarmaco-pharma-inc-riluzole-oral-suspension-70726-0306-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/edw-pharma-inc-formerly-italfarmaco-pharma-inc-riluzole-oral-suspension-70726-0306-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22EDW%20Pharma,%20Inc.%20(formerly%20Italfarmaco%20Pharma,%20Inc.)%22+AND+generic_name%3A%22Riluzole%20Oral%20Suspension%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/26/2024\", \"package_ndc\": \"70726-0306-1\", \"generic_name\": \"Riluzole Oral Suspension\", \"related_info_link\": \"https://www.fda.gov/media/185612/download?attachment\", \"contact_info\": \"610-937-6172\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64850-500-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Elite Laboratories, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "elite-laboratories-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-64850-500-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/elite-laboratories-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-64850-500-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"64850-500-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"888-852-6657\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64850-501-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Elite Laboratories, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "elite-laboratories-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-64850-501-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/elite-laboratories-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-64850-501-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"64850-501-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"888-852-6657\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64850-502-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Elite Laboratories, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "elite-laboratories-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-64850-502-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/elite-laboratories-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-64850-502-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"64850-502-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"888-852-6657\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64850-503-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Elite Laboratories, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "elite-laboratories-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-64850-503-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/elite-laboratories-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-64850-503-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"64850-503-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"888-852-6657\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64850-504-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Elite Laboratories, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "elite-laboratories-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-64850-504-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/elite-laboratories-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-64850-504-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"64850-504-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"888-852-6657\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64850-505-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Elite Laboratories, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "elite-laboratories-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-64850-505-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/elite-laboratories-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-64850-505-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"64850-505-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"888-852-6657\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64850-506-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Elite Laboratories, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "08/15/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1113",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "elite-laboratories-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-64850-506-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/elite-laboratories-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-64850-506-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"08/15/2023\", \"package_ndc\": \"64850-506-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"888-852-6657\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64850-550-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Elite Laboratories, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "elite-laboratories-inc-lisdexamfetamine-dimesylate-capsule-64850-550-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/elite-laboratories-inc-lisdexamfetamine-dimesylate-capsule-64850-550-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"64850-550-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"888-852-6657\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64850-551-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Elite Laboratories, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "elite-laboratories-inc-lisdexamfetamine-dimesylate-capsule-64850-551-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/elite-laboratories-inc-lisdexamfetamine-dimesylate-capsule-64850-551-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"64850-551-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"888-852-6657\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64850-552-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Elite Laboratories, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "elite-laboratories-inc-lisdexamfetamine-dimesylate-capsule-64850-552-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/elite-laboratories-inc-lisdexamfetamine-dimesylate-capsule-64850-552-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"64850-552-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"888-852-6657\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64850-553-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Elite Laboratories, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "elite-laboratories-inc-lisdexamfetamine-dimesylate-capsule-64850-553-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/elite-laboratories-inc-lisdexamfetamine-dimesylate-capsule-64850-553-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"64850-553-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"888-852-6657\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64850-554-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Elite Laboratories, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "elite-laboratories-inc-lisdexamfetamine-dimesylate-capsule-64850-554-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/elite-laboratories-inc-lisdexamfetamine-dimesylate-capsule-64850-554-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"64850-554-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"888-852-6657\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64850-555-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Elite Laboratories, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "elite-laboratories-inc-lisdexamfetamine-dimesylate-capsule-64850-555-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/elite-laboratories-inc-lisdexamfetamine-dimesylate-capsule-64850-555-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"64850-555-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"888-852-6657\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64850-556-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Elite Laboratories, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "elite-laboratories-inc-lisdexamfetamine-dimesylate-capsule-64850-556-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/elite-laboratories-inc-lisdexamfetamine-dimesylate-capsule-64850-556-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"64850-556-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"888-852-6657\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42806-339-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Epic Pharma, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "epic-pharma-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-42806-339-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/epic-pharma-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-42806-339-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"42806-339-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "42806-341-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Epic Pharma, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "epic-pharma-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-42806-341-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/epic-pharma-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-42806-341-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"42806-341-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "related_info",
          "value": "Estimated recovery: TBD",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"42806-341-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
          "as_of": "2026-09-07"
        },
        {
          "field": "shortage_reason",
          "value": "Shortage of an active ingredient",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"42806-341-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
          "as_of": "2026-09-07"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "42806-343-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Epic Pharma, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "epic-pharma-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-42806-343-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/epic-pharma-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-42806-343-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"42806-343-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "related_info",
          "value": "Estimated recovery: TBD",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"42806-343-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
          "as_of": "2026-09-07"
        },
        {
          "field": "shortage_reason",
          "value": "Shortage of an active ingredient",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"42806-343-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
          "as_of": "2026-09-07"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "42806-344-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Epic Pharma, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "epic-pharma-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-42806-344-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/epic-pharma-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-42806-344-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"42806-344-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42806-345-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Epic Pharma, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "epic-pharma-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-42806-345-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/epic-pharma-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-42806-345-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"42806-345-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "related_info",
          "value": "Estimated recovery: TBD",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"42806-345-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
          "as_of": "2026-09-07"
        },
        {
          "field": "shortage_reason",
          "value": "Shortage of an active ingredient",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"42806-345-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
          "as_of": "2026-09-07"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "42806-799-01",
      "generic_name": "Rifampin Capsule",
      "manufacturer_name": "Epic Pharma, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "12/22/2021",
      "update_date": "08/17/2026",
      "days_in_shortage": "1714",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Capsule",
      "therapeutic_category": "Anti-Infective",
      "id": "epic-pharma-llc-rifampin-capsule-42806-799-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/epic-pharma-llc-rifampin-capsule-42806-799-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2021\", \"package_ndc\": \"42806-799-01\", \"generic_name\": \"Rifampin Capsule\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42806-799-05",
      "generic_name": "Rifampin Capsule",
      "manufacturer_name": "Epic Pharma, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "12/22/2021",
      "update_date": "08/17/2026",
      "days_in_shortage": "1714",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Capsule",
      "therapeutic_category": "Anti-Infective",
      "id": "epic-pharma-llc-rifampin-capsule-42806-799-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/epic-pharma-llc-rifampin-capsule-42806-799-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2021\", \"package_ndc\": \"42806-799-05\", \"generic_name\": \"Rifampin Capsule\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42806-799-30",
      "generic_name": "Rifampin Capsule",
      "manufacturer_name": "Epic Pharma, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "12/22/2021",
      "update_date": "08/17/2026",
      "days_in_shortage": "1714",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Capsule",
      "therapeutic_category": "Anti-Infective",
      "id": "epic-pharma-llc-rifampin-capsule-42806-799-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/epic-pharma-llc-rifampin-capsule-42806-799-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2021\", \"package_ndc\": \"42806-799-30\", \"generic_name\": \"Rifampin Capsule\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42806-799-60",
      "generic_name": "Rifampin Capsule",
      "manufacturer_name": "Epic Pharma, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/22/2021",
      "update_date": "08/17/2026",
      "days_in_shortage": "1714",
      "dosage_form": "Capsule",
      "therapeutic_category": "Anti-Infective",
      "id": "epic-pharma-llc-rifampin-capsule-42806-799-60",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/epic-pharma-llc-rifampin-capsule-42806-799-60/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2021\", \"package_ndc\": \"42806-799-60\", \"generic_name\": \"Rifampin Capsule\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42806-801-01",
      "generic_name": "Rifampin Capsule",
      "manufacturer_name": "Epic Pharma, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "12/22/2021",
      "update_date": "08/17/2026",
      "days_in_shortage": "1714",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Capsule",
      "therapeutic_category": "Anti-Infective",
      "id": "epic-pharma-llc-rifampin-capsule-42806-801-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/epic-pharma-llc-rifampin-capsule-42806-801-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2021\", \"package_ndc\": \"42806-801-01\", \"generic_name\": \"Rifampin Capsule\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42806-801-30",
      "generic_name": "Rifampin Capsule",
      "manufacturer_name": "Epic Pharma, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/22/2021",
      "update_date": "08/17/2026",
      "days_in_shortage": "1714",
      "dosage_form": "Capsule",
      "therapeutic_category": "Anti-Infective",
      "id": "epic-pharma-llc-rifampin-capsule-42806-801-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/epic-pharma-llc-rifampin-capsule-42806-801-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2021\", \"package_ndc\": \"42806-801-30\", \"generic_name\": \"Rifampin Capsule\", \"contact_info\": \"(718) 276-8600 ext. 3\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68118-100-01",
      "generic_name": "Streptozocin Powder, For Solution",
      "manufacturer_name": "ESTEVE PHARMACEUTICALS, S.A.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/12/2022",
      "update_date": "05/06/2026",
      "days_in_shortage": "1512",
      "dosage_form": "Powder, For Solution",
      "therapeutic_category": "Oncology",
      "id": "esteve-pharmaceuticals-s-a-streptozocin-powder-for-solution-68118-100-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/esteve-pharmaceuticals-s-a-streptozocin-powder-for-solution-68118-100-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22ESTEVE%20PHARMACEUTICALS,%20S.A.%22+AND+generic_name%3A%22Streptozocin%20Powder,%20For%20Solution%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/12/2022\", \"package_ndc\": \"68118-100-01\", \"generic_name\": \"Streptozocin Powder, For Solution\", \"related_info_link\": \"https://www.fda.gov/media/187353/download?attachment\", \"contact_info\": \"USSZTOrders@esteve.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-393-01",
      "generic_name": "Azacitidine Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: TBD. Check wholesalers for inventory",
      "initial_posting_date": "12/22/2020",
      "update_date": "08/06/2026",
      "days_in_shortage": "2079",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "eugia-us-llc-azacitidine-injection-55150-393-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-azacitidine-injection-55150-393-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2020\", \"package_ndc\": \"55150-393-01\", \"generic_name\": \"Azacitidine Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: TBD. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-167-10",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-bupivacaine-hydrochloride-injection-55150-167-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-bupivacaine-hydrochloride-injection-55150-167-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-167-10\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-168-30",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-bupivacaine-hydrochloride-injection-55150-168-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-bupivacaine-hydrochloride-injection-55150-168-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-168-30\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-169-10",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-bupivacaine-hydrochloride-injection-55150-169-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-bupivacaine-hydrochloride-injection-55150-169-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-169-10\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-170-30",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-bupivacaine-hydrochloride-injection-55150-170-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-bupivacaine-hydrochloride-injection-55150-170-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-170-30\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-171-10",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-bupivacaine-hydrochloride-injection-55150-171-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-bupivacaine-hydrochloride-injection-55150-171-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-171-10\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-172-30",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-bupivacaine-hydrochloride-injection-55150-172-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-bupivacaine-hydrochloride-injection-55150-172-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-172-30\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-249-50",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-bupivacaine-hydrochloride-injection-55150-249-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-bupivacaine-hydrochloride-injection-55150-249-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-249-50\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-250-50",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-bupivacaine-hydrochloride-injection-55150-250-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-bupivacaine-hydrochloride-injection-55150-250-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-250-50\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-335-01",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: TBD. Check wholesalers for inventory",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/06/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "eugia-us-llc-carboplatin-injection-55150-335-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-carboplatin-injection-55150-335-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"55150-335-01\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: TBD. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "55150-386-01",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/06/2026",
      "days_in_shortage": "1222",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "eugia-us-llc-carboplatin-injection-55150-386-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-carboplatin-injection-55150-386-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"55150-386-01\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-304-25",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/06/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "eugia-us-llc-dexamethasone-sodium-phosphate-injection-55150-304-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-dexamethasone-sodium-phosphate-injection-55150-304-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"55150-304-25\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-209-02",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/06/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-dexmedetomidine-hydrochloride-injection-55150-209-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-dexmedetomidine-hydrochloride-injection-55150-209-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"55150-209-02\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-296-10",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/06/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-dexmedetomidine-hydrochloride-injection-55150-296-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-dexmedetomidine-hydrochloride-injection-55150-296-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"55150-296-10\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-297-10",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/06/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-dexmedetomidine-hydrochloride-injection-55150-297-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-dexmedetomidine-hydrochloride-injection-55150-297-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"55150-297-10\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-221-10",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: TBD. Check wholesalers for inventory",
      "initial_posting_date": "10/05/2022",
      "update_date": "08/06/2026",
      "days_in_shortage": "1427",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-etomidate-injection-55150-221-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-etomidate-injection-55150-221-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"55150-221-10\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: TBD. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-222-20",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: TBD. Check wholesalers for inventory",
      "initial_posting_date": "10/05/2022",
      "update_date": "08/06/2026",
      "days_in_shortage": "1427",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-etomidate-injection-55150-222-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-etomidate-injection-55150-222-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"55150-222-20\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: TBD. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-322-25",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: TBD. Check wholesalers for inventory",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/06/2026",
      "days_in_shortage": "2338",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "eugia-us-llc-furosemide-injection-55150-322-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-furosemide-injection-55150-322-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"55150-322-25\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: TBD. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-323-25",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/06/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "eugia-us-llc-furosemide-injection-55150-323-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-furosemide-injection-55150-323-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"55150-323-25\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-324-25",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/06/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "eugia-us-llc-furosemide-injection-55150-324-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-furosemide-injection-55150-324-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"55150-324-25\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-159-74",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: TBD. Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-lidocaine-hydrochloride-injection-55150-159-74",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-lidocaine-hydrochloride-injection-55150-159-74/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-159-74\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: TBD. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-161-02",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-lidocaine-hydrochloride-injection-55150-161-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-lidocaine-hydrochloride-injection-55150-161-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-161-02\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "shortage_reason",
          "value": "Demand increase for the drug",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-161-02\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: late September 2026. Check wholesalers for inventory\"",
          "as_of": "2026-09-07"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "55150-162-05",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-lidocaine-hydrochloride-injection-55150-162-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-lidocaine-hydrochloride-injection-55150-162-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-162-05\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-163-30",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-lidocaine-hydrochloride-injection-55150-163-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-lidocaine-hydrochloride-injection-55150-163-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-163-30\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-164-02",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-lidocaine-hydrochloride-injection-55150-164-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-lidocaine-hydrochloride-injection-55150-164-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-164-02\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-165-05",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-lidocaine-hydrochloride-injection-55150-165-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-lidocaine-hydrochloride-injection-55150-165-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-165-05\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "shortage_reason",
          "value": "Demand increase for the drug",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"55150-165-05\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: October 2026. Check wholesalers for inventory\"",
          "as_of": "2026-09-07"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "55150-251-10",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: end-August 2026. Check wholesalers for inventory",
      "initial_posting_date": "06/13/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3002",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-lidocaine-hydrochloride-injection-55150-251-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-lidocaine-hydrochloride-injection-55150-251-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/13/2018\", \"package_ndc\": \"55150-251-10\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: end-August 2026. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "55150-252-20",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "06/13/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3002",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-lidocaine-hydrochloride-injection-55150-252-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-lidocaine-hydrochloride-injection-55150-252-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/13/2018\", \"package_ndc\": \"55150-252-20\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "shortage_reason",
          "value": "Demand increase for the drug",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"06/13/2018\", \"package_ndc\": \"55150-252-20\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: TBD. Check wholesalers for inventory\"",
          "as_of": "2026-09-07"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "55150-254-10",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: TBD. Check wholesalers for inventory",
      "initial_posting_date": "06/13/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3002",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-lidocaine-hydrochloride-injection-55150-254-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-lidocaine-hydrochloride-injection-55150-254-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/13/2018\", \"package_ndc\": \"55150-254-10\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: TBD. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-255-20",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: mid-August 2026. Check wholesalers for inventory",
      "initial_posting_date": "06/13/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3002",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-lidocaine-hydrochloride-injection-55150-255-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-lidocaine-hydrochloride-injection-55150-255-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/13/2018\", \"package_ndc\": \"55150-255-20\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: mid-August 2026. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "55150-256-50",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: TBD. Check wholesalers for inventory",
      "initial_posting_date": "06/13/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3002",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-lidocaine-hydrochloride-injection-55150-256-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-lidocaine-hydrochloride-injection-55150-256-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/13/2018\", \"package_ndc\": \"55150-256-50\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: TBD. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-313-01",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: TBD. Check wholesalers for inventory",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/06/2026",
      "days_in_shortage": "1721",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "eugia-us-llc-methylprednisolone-acetate-injection-55150-313-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-methylprednisolone-acetate-injection-55150-313-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"55150-313-01\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: TBD. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-314-01",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: TBD. Check wholesalers for inventory",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/06/2026",
      "days_in_shortage": "1721",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "eugia-us-llc-methylprednisolone-acetate-injection-55150-314-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-methylprednisolone-acetate-injection-55150-314-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"55150-314-01\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: TBD. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-225-05",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/06/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-rocuronium-bromide-injection-55150-225-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-rocuronium-bromide-injection-55150-225-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"55150-225-05\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-226-10",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/06/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-rocuronium-bromide-injection-55150-226-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-rocuronium-bromide-injection-55150-226-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"55150-226-10\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-195-20",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: TBD. Check wholesalers for inventory",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-ropivacaine-hydrochloride-injection-55150-195-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-ropivacaine-hydrochloride-injection-55150-195-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"55150-195-20\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: TBD. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-196-99",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-ropivacaine-hydrochloride-injection-55150-196-99",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-ropivacaine-hydrochloride-injection-55150-196-99/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"55150-196-99\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-197-20",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-ropivacaine-hydrochloride-injection-55150-197-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-ropivacaine-hydrochloride-injection-55150-197-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"55150-197-20\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-198-30",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-ropivacaine-hydrochloride-injection-55150-198-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-ropivacaine-hydrochloride-injection-55150-198-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"55150-198-30\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55150-199-20",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: end-August 2026. Check wholesalers for inventory",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-ropivacaine-hydrochloride-injection-55150-199-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-ropivacaine-hydrochloride-injection-55150-199-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"55150-199-20\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: end-August 2026. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "55150-200-10",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "On backorder. Recovery: end-August 2026. Check wholesalers for inventory",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-ropivacaine-hydrochloride-injection-55150-200-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-ropivacaine-hydrochloride-injection-55150-200-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"55150-200-10\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Unavailable\", \"related_info\": \"On backorder. Recovery: end-August 2026. Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "55150-201-20",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Eugia US LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/06/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "eugia-us-llc-ropivacaine-hydrochloride-injection-55150-201-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/eugia-us-llc-ropivacaine-hydrochloride-injection-55150-201-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"55150-201-20\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-238-7880\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "51754-5001-5",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Exela Pharma Sciences, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/24/2017",
      "update_date": "07/22/2026",
      "days_in_shortage": "3326",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "exela-pharma-sciences-llc-sodium-bicarbonate-injection-51754-5001-5",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/exela-pharma-sciences-llc-sodium-bicarbonate-injection-51754-5001-5/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Exela%20Pharma%20Sciences,%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/24/2017\", \"package_ndc\": \"51754-5001-5\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"contact_info\": \"828-758-5474 ext. 154\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "51754-5011-4",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Exela Pharma Sciences, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/24/2017",
      "update_date": "07/22/2026",
      "days_in_shortage": "3326",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "exela-pharma-sciences-llc-sodium-bicarbonate-injection-51754-5011-4",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/exela-pharma-sciences-llc-sodium-bicarbonate-injection-51754-5011-4/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Exela%20Pharma%20Sciences,%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/24/2017\", \"package_ndc\": \"51754-5011-4\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"contact_info\": \"828-758-5474 ext. 154\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "51754-5012-4",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Exela Pharma Sciences, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/24/2017",
      "update_date": "07/22/2026",
      "days_in_shortage": "3326",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "exela-pharma-sciences-llc-sodium-bicarbonate-injection-51754-5012-4",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/exela-pharma-sciences-llc-sodium-bicarbonate-injection-51754-5012-4/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Exela%20Pharma%20Sciences,%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/24/2017\", \"package_ndc\": \"51754-5012-4\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"contact_info\": \"828-758-5474 ext. 154\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "48102-053-05",
      "generic_name": "Echothiophate Iodide Ophthalmic Solution",
      "manufacturer_name": "Fera Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "related_info": "Available through limited distribution by Walgreens Specialty Pharmacy.",
      "initial_posting_date": "09/24/2019",
      "update_date": "08/10/2026",
      "days_in_shortage": "2534",
      "shortage_reason": "Other",
      "dosage_form": "Ophthalmic Solution",
      "therapeutic_category": "Ophthalmology",
      "id": "fera-pharmaceuticals-echothiophate-iodide-ophthalmic-solution-48102-053-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fera-pharmaceuticals-echothiophate-iodide-ophthalmic-solution-48102-053-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fera%20Pharmaceuticals%22+AND+generic_name%3A%22Echothiophate%20Iodide%20Ophthalmic%20Solution%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"09/24/2019\", \"package_ndc\": \"48102-053-05\", \"generic_name\": \"Echothiophate Iodide Ophthalmic Solution\", \"contact_info\": \"516-277-1449\", \"availability\": \"Available\", \"related_info\": \"Available through limited distribution by Walgreens Specialty Pharmacy.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0053-6871-00",
      "generic_name": "Desmopressin Acetate Spray",
      "manufacturer_name": "Ferring",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/12/2021",
      "update_date": "05/01/2026",
      "days_in_shortage": "1999",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Spray",
      "therapeutic_category": "Hematology",
      "id": "ferring-desmopressin-acetate-spray-0053-6871-00",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/ferring-desmopressin-acetate-spray-0053-6871-00/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ferring%22+AND+generic_name%3A%22Desmopressin%20Acetate%20Spray%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/12/2021\", \"package_ndc\": \"0053-6871-00\", \"generic_name\": \"Desmopressin Acetate Spray\", \"contact_info\": \"888-337-7464\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "55566-2500-0",
      "generic_name": "Desmopressin Acetate Spray",
      "manufacturer_name": "Ferring",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/12/2021",
      "update_date": "05/01/2026",
      "days_in_shortage": "1999",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Spray",
      "therapeutic_category": "Hematology",
      "id": "ferring-desmopressin-acetate-spray-55566-2500-0",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/ferring-desmopressin-acetate-spray-55566-2500-0/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ferring%22+AND+generic_name%3A%22Desmopressin%20Acetate%20Spray%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/12/2021\", \"package_ndc\": \"55566-2500-0\", \"generic_name\": \"Desmopressin Acetate Spray\", \"contact_info\": \"888-337-7464\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "69918-501-05",
      "generic_name": "Desmopressin Acetate Spray",
      "manufacturer_name": "Ferring",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/12/2021",
      "update_date": "05/01/2026",
      "days_in_shortage": "1999",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Spray",
      "therapeutic_category": "Hematology",
      "id": "ferring-desmopressin-acetate-spray-69918-501-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/ferring-desmopressin-acetate-spray-69918-501-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ferring%22+AND+generic_name%3A%22Desmopressin%20Acetate%20Spray%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/12/2021\", \"package_ndc\": \"69918-501-05\", \"generic_name\": \"Desmopressin Acetate Spray\", \"contact_info\": \"888-337-7464\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-580-20",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-atropine-sulfate-injection-63323-580-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-atropine-sulfate-injection-63323-580-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"63323-580-20\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-771-39",
      "generic_name": "Azacitidine Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "12/18/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2083",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "fresenius-kabi-usa-llc-azacitidine-injection-63323-771-39",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-azacitidine-injection-63323-771-39/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/18/2020\", \"package_ndc\": \"63323-771-39\", \"generic_name\": \"Azacitidine Injection\", \"contact_info\": \"1-888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "65219-570-04",
      "generic_name": "Bumetanide Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "01/31/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3135",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "fresenius-kabi-usa-llc-bumetanide-injection-65219-570-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bumetanide-injection-65219-570-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/31/2018\", \"package_ndc\": \"65219-570-04\", \"generic_name\": \"Bumetanide Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65219-572-10",
      "generic_name": "Bumetanide Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "01/31/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3135",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "fresenius-kabi-usa-llc-bumetanide-injection-65219-572-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bumetanide-injection-65219-572-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/31/2018\", \"package_ndc\": \"65219-572-10\", \"generic_name\": \"Bumetanide Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-460-37",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesaler for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-460-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-460-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-460-37\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesaler for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-461-57",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesaler for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-461-57",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-461-57/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-461-57\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesaler for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-462-17",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "7 month dating available on request. Check wholesalers for inventory.",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-462-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-462-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-462-17\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"7 month dating available on request. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "63323-462-31",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-462-31",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-462-31/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-462-31\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-462-37",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-462-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-462-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-462-37\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-463-57",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesaler for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-463-57",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-463-57/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-463-57\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesaler for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-468-17",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-468-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-468-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-468-17\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-468-37",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesaler for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-468-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-63323-468-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-468-37\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesaler for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-464-17",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-464-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-464-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-464-17\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-464-31",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-464-31",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-464-31/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-464-31\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-464-37",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-464-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-464-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-464-37\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-465-57",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-465-57",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-465-57/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-465-57\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-466-17",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-466-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-466-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-466-17\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-466-31",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-466-31",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-466-31/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-466-31\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-466-37",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-466-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-466-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-466-37\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-467-57",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-467-57",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-467-57/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-467-57\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-472-17",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-472-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-472-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-472-17\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-472-37",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-472-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-bupivacaine-hydrochloride-injection-63323-472-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"63323-472-37\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-172-60",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release November 2026. Check wholesalers for inventory.",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/25/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "fresenius-kabi-usa-llc-carboplatin-injection-63323-172-60",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-carboplatin-injection-63323-172-60/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"63323-172-60\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release November 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-165-01",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/25/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-63323-165-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-63323-165-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"63323-165-01\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-165-05",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/25/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-63323-165-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-63323-165-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"63323-165-05\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-165-30",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/25/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-63323-165-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-63323-165-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"63323-165-30\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-506-01",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/25/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-63323-506-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-63323-506-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"63323-506-01\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-516-10",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/25/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-63323-516-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-63323-516-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"63323-516-10\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76045-0210-10",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Checkwholesalers for inventory",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/25/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-76045-0210-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-76045-0210-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"76045-0210-10\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Checkwholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76045-210-10",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/25/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-76045-210-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-76045-210-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"76045-210-10\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76045-0212-10",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "4 month expiry available on request. Next release not available at this time.",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/25/2026",
      "days_in_shortage": "2762",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-76045-0212-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-76045-0212-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"76045-0212-10\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Limited Availability\", \"related_info\": \"4 month expiry available on request. Next release not available at this time.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76045-212-10",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "4 month expiry available on request. Next release not available at this time.",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/25/2026",
      "days_in_shortage": "2762",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-76045-212-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dexamethasone-sodium-phosphate-injection-76045-212-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"76045-212-10\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Limited Availability\", \"related_info\": \"4 month expiry available on request. Next release not available at this time.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-421-02",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2335",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-dexmedetomidine-hydrochloride-injection-63323-421-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dexmedetomidine-hydrochloride-injection-63323-421-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"63323-421-02\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-671-00",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Expected recovery: TBD",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2335",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-dexmedetomidine-hydrochloride-injection-63323-671-00",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dexmedetomidine-hydrochloride-injection-63323-671-00/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"63323-671-00\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Expected recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-671-20",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Expected recovery: TBD",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2335",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-dexmedetomidine-hydrochloride-injection-63323-671-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dexmedetomidine-hydrochloride-injection-63323-671-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"63323-671-20\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Expected recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-671-50",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2335",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-dexmedetomidine-hydrochloride-injection-63323-671-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dexmedetomidine-hydrochloride-injection-63323-671-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"63323-671-50\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65219-456-60",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholealers for inventory",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/25/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "fresenius-kabi-usa-llc-dextrose-monohydrate-5-injection-65219-456-60",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dextrose-monohydrate-5-injection-65219-456-60/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"65219-456-60\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholealers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65219-458-30",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/25/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "fresenius-kabi-usa-llc-dextrose-monohydrate-5-injection-65219-458-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dextrose-monohydrate-5-injection-65219-458-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"65219-458-30\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65219-460-20",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/25/2026",
      "days_in_shortage": "1660",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "fresenius-kabi-usa-llc-dextrose-monohydrate-5-injection-65219-460-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dextrose-monohydrate-5-injection-65219-460-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"65219-460-20\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65219-462-10",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/25/2026",
      "days_in_shortage": "1660",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "fresenius-kabi-usa-llc-dextrose-monohydrate-5-injection-65219-462-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dextrose-monohydrate-5-injection-65219-462-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"65219-462-10\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65219-464-50",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/25/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "fresenius-kabi-usa-llc-dextrose-monohydrate-5-injection-65219-464-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dextrose-monohydrate-5-injection-65219-464-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"65219-464-50\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-824-74",
      "generic_name": "Dextrose Monohydrate 10% Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "03/01/2022",
      "update_date": "08/25/2026",
      "days_in_shortage": "1645",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "fresenius-kabi-usa-llc-dextrose-monohydrate-10-injection-63323-824-74",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dextrose-monohydrate-10-injection-63323-824-74/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"63323-824-74\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-824-75",
      "generic_name": "Dextrose Monohydrate 10% Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "03/01/2022",
      "update_date": "08/25/2026",
      "days_in_shortage": "1645",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "fresenius-kabi-usa-llc-dextrose-monohydrate-10-injection-63323-824-75",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dextrose-monohydrate-10-injection-63323-824-75/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"63323-824-75\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-824-76",
      "generic_name": "Dextrose Monohydrate 10% Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "03/01/2022",
      "update_date": "08/25/2026",
      "days_in_shortage": "1645",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "fresenius-kabi-usa-llc-dextrose-monohydrate-10-injection-63323-824-76",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-dextrose-monohydrate-10-injection-63323-824-76/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"63323-824-76\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-481-57",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "10/14/2016",
      "update_date": "08/25/2026",
      "days_in_shortage": "3609",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-481-57",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-481-57/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/14/2016\", \"package_ndc\": \"63323-481-57\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-482-17",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "10/14/2016",
      "update_date": "08/25/2026",
      "days_in_shortage": "3609",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-482-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-482-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/14/2016\", \"package_ndc\": \"63323-482-17\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-482-27",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "10/14/2016",
      "update_date": "08/25/2026",
      "days_in_shortage": "3609",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-482-27",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-482-27/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/14/2016\", \"package_ndc\": \"63323-482-27\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-482-57",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release August 2026. Check wholesalers for inventory.",
      "initial_posting_date": "10/14/2016",
      "update_date": "08/25/2026",
      "days_in_shortage": "3609",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-482-57",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-482-57/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/14/2016\", \"package_ndc\": \"63323-482-57\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release August 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "63323-483-27",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "10/14/2016",
      "update_date": "08/25/2026",
      "days_in_shortage": "3609",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-483-27",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-483-27/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/14/2016\", \"package_ndc\": \"63323-483-27\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-483-57",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "10/14/2016",
      "update_date": "08/25/2026",
      "days_in_shortage": "3609",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-483-57",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-483-57/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/14/2016\", \"package_ndc\": \"63323-483-57\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-487-17",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "10/14/2016",
      "update_date": "08/25/2026",
      "days_in_shortage": "3609",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-487-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-487-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/14/2016\", \"package_ndc\": \"63323-487-17\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-487-37",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "10/14/2016",
      "update_date": "08/25/2026",
      "days_in_shortage": "3609",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-487-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-487-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/14/2016\", \"package_ndc\": \"63323-487-37\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-488-17",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "10/14/2016",
      "update_date": "08/25/2026",
      "days_in_shortage": "3609",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-488-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-488-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/14/2016\", \"package_ndc\": \"63323-488-17\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-488-37",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "10/14/2016",
      "update_date": "08/25/2026",
      "days_in_shortage": "3609",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-488-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-488-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/14/2016\", \"package_ndc\": \"63323-488-37\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-489-17",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "10/14/2016",
      "update_date": "08/25/2026",
      "days_in_shortage": "3609",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-489-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-489-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/14/2016\", \"package_ndc\": \"63323-489-17\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-489-27",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "10/14/2016",
      "update_date": "08/25/2026",
      "days_in_shortage": "3609",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-489-27",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-epinephrine-bitartrate-lidocaine-hydrochloride-injection-63323-489-27/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/14/2016\", \"package_ndc\": \"63323-489-27\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-806-01",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-fentanyl-citrate-injection-63323-806-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-fentanyl-citrate-injection-63323-806-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"63323-806-01\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-806-02",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-fentanyl-citrate-injection-63323-806-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-fentanyl-citrate-injection-63323-806-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"63323-806-02\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-806-05",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-fentanyl-citrate-injection-63323-806-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-fentanyl-citrate-injection-63323-806-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"63323-806-05\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-806-20",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-fentanyl-citrate-injection-63323-806-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-fentanyl-citrate-injection-63323-806-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"63323-806-20\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-806-50",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5357",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-fentanyl-citrate-injection-63323-806-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-fentanyl-citrate-injection-63323-806-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"63323-806-50\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "63323-808-11",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-fentanyl-citrate-injection-63323-808-11",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-fentanyl-citrate-injection-63323-808-11/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"63323-808-11\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-280-02",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "fresenius-kabi-usa-llc-furosemide-injection-63323-280-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-furosemide-injection-63323-280-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"63323-280-02\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-280-04",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "fresenius-kabi-usa-llc-furosemide-injection-63323-280-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-furosemide-injection-63323-280-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"63323-280-04\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-280-10",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "fresenius-kabi-usa-llc-furosemide-injection-63323-280-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-furosemide-injection-63323-280-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"63323-280-10\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-519-10",
      "generic_name": "Heparin Sodium Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "11/14/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3213",
      "dosage_form": "Injection",
      "therapeutic_category": "Hematology",
      "id": "fresenius-kabi-usa-llc-heparin-sodium-injection-63323-519-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-heparin-sodium-injection-63323-519-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/14/2017\", \"package_ndc\": \"63323-519-10\", \"generic_name\": \"Heparin Sodium Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-519-77",
      "generic_name": "Heparin Sodium Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "11/14/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3213",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Hematology",
      "id": "fresenius-kabi-usa-llc-heparin-sodium-injection-63323-519-77",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-heparin-sodium-injection-63323-519-77/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/14/2017\", \"package_ndc\": \"63323-519-77\", \"generic_name\": \"Heparin Sodium Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-851-10",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-63323-851-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-63323-851-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"63323-851-10\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-851-15",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesaler for inventory",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-63323-851-15",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-63323-851-15/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"63323-851-15\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesaler for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-851-50",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-63323-851-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-63323-851-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"63323-851-50\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-852-25",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-63323-852-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-63323-852-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"63323-852-25\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-853-25",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release October 2026. Check wholesalers for inventory.",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-63323-853-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-63323-853-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"63323-853-25\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release October 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "63323-854-10",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "11/01/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3226",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-63323-854-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-63323-854-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2017\", \"package_ndc\": \"63323-854-10\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76045-009-06",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release August 2026. Check wholesalers for inventory.",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-76045-009-06",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-76045-009-06/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"76045-009-06\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release August 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "76045-009-11",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release October 2026. Check wholesalers for inventory.",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-76045-009-11",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-76045-009-11/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"76045-009-11\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release October 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76045-010-11",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release not available at this time. Check wholesalers for inventory.",
      "initial_posting_date": "11/01/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3226",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-76045-010-11",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-76045-010-11/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2017\", \"package_ndc\": \"76045-010-11\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release not available at this time. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76045-121-11",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "11/01/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3226",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-76045-121-11",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-hydromorphone-hydrochloride-injection-76045-121-11/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2017\", \"package_ndc\": \"76045-121-11\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "shortage_reason",
          "value": "Other",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"11/01/2017\", \"package_ndc\": \"76045-121-11\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD; Check wholesalers for inventory.\"",
          "as_of": "2026-09-03"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "63323-142-10",
      "generic_name": "Ifosfamide Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release August 2026",
      "initial_posting_date": "06/12/2026",
      "update_date": "08/25/2026",
      "days_in_shortage": "81",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "fresenius-kabi-usa-llc-ifosfamide-injection-63323-142-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ifosfamide-injection-63323-142-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/12/2026\", \"package_ndc\": \"63323-142-10\", \"generic_name\": \"Ifosfamide Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release August 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "63323-161-01",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-ketorolac-tromethamine-injection-63323-161-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ketorolac-tromethamine-injection-63323-161-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-161-01\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-162-01",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-ketorolac-tromethamine-injection-63323-162-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ketorolac-tromethamine-injection-63323-162-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-162-01\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-162-02",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-ketorolac-tromethamine-injection-63323-162-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ketorolac-tromethamine-injection-63323-162-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-162-02\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76045-104-10",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-ketorolac-tromethamine-injection-76045-104-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ketorolac-tromethamine-injection-76045-104-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"76045-104-10\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76045-105-20",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-ketorolac-tromethamine-injection-76045-105-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ketorolac-tromethamine-injection-76045-105-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"76045-105-20\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76045-107-10",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/23/2018",
      "update_date": "09/01/2026",
      "days_in_shortage": "3086",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-ketorolac-tromethamine-injection-76045-107-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ketorolac-tromethamine-injection-76045-107-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"76045-107-10\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-201-02",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-201-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-201-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-201-02\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-201-10",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release October 2026. Check wholesalers for inventory.",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-201-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-201-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-201-10\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release October 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-202-02",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-202-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-202-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-202-02\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-208-05",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-208-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-208-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-208-05\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "63323-484-57",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-484-57",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-484-57/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-484-57\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-485-27",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-485-27",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-485-27/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-485-27\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-485-57",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-485-57",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-485-57/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-485-57\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-486-17",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-486-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-486-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-486-17\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-486-27",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-486-27",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-486-27/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-486-27\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-486-57",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-486-57",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-486-57/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-486-57\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-491-57",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-491-57",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-491-57/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-491-57\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-492-27",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-492-27",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-492-27/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-492-27\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-492-31",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-492-31",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-492-31/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-492-31\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-492-37",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-492-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-492-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-492-37\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-492-57",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-492-57",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-492-57/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-492-57\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-493-91",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-493-91",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-493-91/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-493-91\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-493-97",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-493-97",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-493-97/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-493-97\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-495-07",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-495-07",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-495-07/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-495-07\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-495-27",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-495-27",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-495-27/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-495-27\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-496-97",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/25/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-496-97",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lidocaine-hydrochloride-injection-63323-496-97/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"63323-496-97\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65219-368-02",
      "generic_name": "Lorazepam Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "05/03/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3043",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Neurology",
      "id": "fresenius-kabi-usa-llc-lorazepam-injection-65219-368-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-lorazepam-injection-65219-368-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/03/2018\", \"package_ndc\": \"65219-368-02\", \"generic_name\": \"Lorazepam Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-122-50",
      "generic_name": "Methotrexate Sodium Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesaler for inventory",
      "initial_posting_date": "03/13/2023",
      "update_date": "08/25/2026",
      "days_in_shortage": "1268",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "fresenius-kabi-usa-llc-methotrexate-sodium-injection-63323-122-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-methotrexate-sodium-injection-63323-122-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"63323-122-50\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesaler for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-123-10",
      "generic_name": "Methotrexate Sodium Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesaler for inventory",
      "initial_posting_date": "03/13/2023",
      "update_date": "08/25/2026",
      "days_in_shortage": "1268",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "fresenius-kabi-usa-llc-methotrexate-sodium-injection-63323-123-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-methotrexate-sodium-injection-63323-123-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"63323-123-10\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesaler for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-411-10",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2343",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-midazolam-hydrochloride-injection-63323-411-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-midazolam-hydrochloride-injection-63323-411-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"63323-411-10\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-411-12",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2343",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-midazolam-hydrochloride-injection-63323-411-12",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-midazolam-hydrochloride-injection-63323-411-12/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"63323-411-12\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-411-25",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2343",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-midazolam-hydrochloride-injection-63323-411-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-midazolam-hydrochloride-injection-63323-411-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"63323-411-25\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "63323-412-02",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2343",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-midazolam-hydrochloride-injection-63323-412-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-midazolam-hydrochloride-injection-63323-412-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"63323-412-02\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-412-10",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2343",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-midazolam-hydrochloride-injection-63323-412-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-midazolam-hydrochloride-injection-63323-412-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"63323-412-10\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-412-25",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2343",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-midazolam-hydrochloride-injection-63323-412-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-midazolam-hydrochloride-injection-63323-412-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"63323-412-25\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76045-211-20",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release October 2026. Check wholesalers for inventory.",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2343",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-midazolam-hydrochloride-injection-76045-211-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-midazolam-hydrochloride-injection-76045-211-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"76045-211-20\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release October 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-451-01",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-morphine-sulfate-injection-63323-451-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-morphine-sulfate-injection-63323-451-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"63323-451-01\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-452-01",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-morphine-sulfate-injection-63323-452-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-morphine-sulfate-injection-63323-452-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"63323-452-01\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-454-01",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release October 2026. Check wholesalers for inventory.",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-morphine-sulfate-injection-63323-454-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-morphine-sulfate-injection-63323-454-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"63323-454-01\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release October 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-455-01",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-morphine-sulfate-injection-63323-455-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-morphine-sulfate-injection-63323-455-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"63323-455-01\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76045-004-11",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-morphine-sulfate-injection-76045-004-11",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-morphine-sulfate-injection-76045-004-11/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"76045-004-11\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "76045-005-11",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-morphine-sulfate-injection-76045-005-11",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-morphine-sulfate-injection-76045-005-11/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"76045-005-11\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-604-01",
      "generic_name": "Propranolol Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "10/31/2023",
      "update_date": "08/25/2026",
      "days_in_shortage": "1036",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "fresenius-kabi-usa-llc-propranolol-hydrochloride-injection-63323-604-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-propranolol-hydrochloride-injection-63323-604-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Propranolol%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2023\", \"package_ndc\": \"63323-604-01\", \"generic_name\": \"Propranolol Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-723-03",
      "generic_name": "Remifentanil Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "06/28/2022",
      "update_date": "08/25/2026",
      "days_in_shortage": "1526",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-remifentanil-hydrochloride-injection-63323-723-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-remifentanil-hydrochloride-injection-63323-723-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/28/2022\", \"package_ndc\": \"63323-723-03\", \"generic_name\": \"Remifentanil Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-724-05",
      "generic_name": "Remifentanil Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "06/28/2022",
      "update_date": "08/25/2026",
      "days_in_shortage": "1526",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-remifentanil-hydrochloride-injection-63323-724-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-remifentanil-hydrochloride-injection-63323-724-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/28/2022\", \"package_ndc\": \"63323-724-05\", \"generic_name\": \"Remifentanil Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-725-10",
      "generic_name": "Remifentanil Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "06/28/2022",
      "update_date": "08/25/2026",
      "days_in_shortage": "1526",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "fresenius-kabi-usa-llc-remifentanil-hydrochloride-injection-63323-725-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-remifentanil-hydrochloride-injection-63323-725-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/28/2022\", \"package_ndc\": \"63323-725-10\", \"generic_name\": \"Remifentanil Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-351-20",
      "generic_name": "Rifampin Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/17/2021",
      "update_date": "08/25/2026",
      "days_in_shortage": "2022",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "fresenius-kabi-usa-llc-rifampin-injection-63323-351-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-rifampin-injection-63323-351-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/17/2021\", \"package_ndc\": \"63323-351-20\", \"generic_name\": \"Rifampin Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "shortage_reason",
          "value": "Other",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"02/17/2021\", \"package_ndc\": \"63323-351-20\", \"generic_name\": \"Rifampin Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Limited Availability\", \"related_info\": \"Check wholesalers for inventory\"",
          "as_of": "2026-09-10"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "63323-426-05",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/25/2026",
      "days_in_shortage": "1294",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-rocuronium-bromide-injection-63323-426-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-rocuronium-bromide-injection-63323-426-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"63323-426-05\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "63323-426-10",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/25/2026",
      "days_in_shortage": "1294",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-rocuronium-bromide-injection-63323-426-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-rocuronium-bromide-injection-63323-426-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"63323-426-10\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "65219-065-05",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/25/2026",
      "days_in_shortage": "1294",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-rocuronium-bromide-injection-65219-065-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-rocuronium-bromide-injection-65219-065-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"65219-065-05\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65219-442-05",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release August 2026. Check wholesalers for inventory.",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/25/2026",
      "days_in_shortage": "1294",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-rocuronium-bromide-injection-65219-442-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-rocuronium-bromide-injection-65219-442-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"65219-442-05\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release August 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "65219-444-10",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/25/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-rocuronium-bromide-injection-65219-444-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-rocuronium-bromide-injection-65219-444-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"65219-444-10\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-285-10",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-285-10\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-285-13",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesaler for inventory",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-13",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-13/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-285-13\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesaler for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-285-20",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-285-20\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-285-23",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-23",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-23/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-285-23\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-285-61",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-61",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-61/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-285-61\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-285-63",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-63",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-63/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-285-63\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-285-64",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-64",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-64/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-285-64\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-285-65",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-65",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-285-65/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-285-65\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-286-00",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-286-00",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-286-00/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-286-00\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-286-20",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-286-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-286-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-286-20\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-286-23",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-286-23",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-286-23/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-286-23\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-286-31",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-286-31",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-286-31/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-286-31\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-286-35",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-286-35",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-286-35/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-286-35\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-286-63",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-286-63",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-286-63/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-286-63\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-287-20",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-287-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-287-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-287-20\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-287-21",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-287-21",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-287-21/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-287-21\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-288-10",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-288-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-288-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-288-10\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-288-11",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-288-11",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-288-11/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-288-11\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-288-20",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-288-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-288-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-288-20\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-288-21",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-288-21",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-63323-288-21/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"63323-288-21\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65219-632-10",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-65219-632-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-65219-632-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"65219-632-10\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65219-632-20",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "08/25/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-65219-632-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-ropivacaine-hydrochloride-injection-65219-632-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"65219-632-20\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-032-00",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "03/23/2016",
      "update_date": "08/25/2026",
      "days_in_shortage": "3814",
      "dosage_form": "Injection",
      "therapeutic_category": "Total Parenteral Nutrition",
      "id": "fresenius-kabi-usa-llc-sodium-acetate-injection-63323-032-00",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-sodium-acetate-injection-63323-032-00/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2016\", \"package_ndc\": \"63323-032-00\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-083-05",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory.",
      "initial_posting_date": "07/24/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3326",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "fresenius-kabi-usa-llc-sodium-bicarbonate-injection-63323-083-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-sodium-bicarbonate-injection-63323-083-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/24/2017\", \"package_ndc\": \"63323-083-05\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-089-50",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "07/24/2017",
      "update_date": "08/25/2026",
      "days_in_shortage": "3326",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "fresenius-kabi-usa-llc-sodium-bicarbonate-injection-63323-089-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-sodium-bicarbonate-injection-63323-089-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/24/2017\", \"package_ndc\": \"63323-089-50\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-178-76",
      "generic_name": "Sterile Water Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "11/23/2021",
      "update_date": "08/25/2026",
      "days_in_shortage": "1743",
      "dosage_form": "Injection",
      "therapeutic_category": "Other",
      "id": "fresenius-kabi-usa-llc-sterile-water-injection-63323-178-76",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-sterile-water-injection-63323-178-76/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/23/2021\", \"package_ndc\": \"63323-178-76\", \"generic_name\": \"Sterile Water Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-185-10",
      "generic_name": "Sterile Water Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "initial_posting_date": "11/23/2021",
      "update_date": "08/25/2026",
      "days_in_shortage": "1743",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Other",
      "id": "fresenius-kabi-usa-llc-sterile-water-injection-63323-185-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-sterile-water-injection-63323-185-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/23/2021\", \"package_ndc\": \"63323-185-10\", \"generic_name\": \"Sterile Water Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Unavailable\", \"related_info\": \"Next release September 2026. Check wholesalers for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-185-20",
      "generic_name": "Sterile Water Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "11/23/2021",
      "update_date": "08/25/2026",
      "days_in_shortage": "1743",
      "dosage_form": "Injection",
      "therapeutic_category": "Other",
      "id": "fresenius-kabi-usa-llc-sterile-water-injection-63323-185-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-sterile-water-injection-63323-185-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/23/2021\", \"package_ndc\": \"63323-185-20\", \"generic_name\": \"Sterile Water Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-185-50",
      "generic_name": "Sterile Water Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "11/23/2021",
      "update_date": "08/25/2026",
      "days_in_shortage": "1743",
      "dosage_form": "Injection",
      "therapeutic_category": "Other",
      "id": "fresenius-kabi-usa-llc-sterile-water-injection-63323-185-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-sterile-water-injection-63323-185-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/23/2021\", \"package_ndc\": \"63323-185-50\", \"generic_name\": \"Sterile Water Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "63323-494-05",
      "generic_name": "Valproate Sodium Injection",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Checkwholesalers for inventory",
      "initial_posting_date": "12/30/2020",
      "update_date": "08/25/2026",
      "days_in_shortage": "2071",
      "dosage_form": "Injection",
      "therapeutic_category": "Neurology",
      "id": "fresenius-kabi-usa-llc-valproate-sodium-injection-63323-494-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/fresenius-kabi-usa-llc-valproate-sodium-injection-63323-494-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Valproate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/30/2020\", \"package_ndc\": \"63323-494-05\", \"generic_name\": \"Valproate Sodium Injection\", \"contact_info\": \"888-386-1300\", \"availability\": \"Available\", \"related_info\": \"Checkwholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "54288-164-01",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinued; Distributed by BPI Labs, LLC",
      "initial_posting_date": "04/28/2023",
      "update_date": "07/22/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "gland-pharma-limited-carboplatin-injection-54288-164-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-carboplatin-injection-54288-164-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"54288-164-01\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinued; Distributed by BPI Labs, LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "54288-165-01",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: end of August 2026; Distributed by BPI Labs, LLC",
      "initial_posting_date": "04/28/2023",
      "update_date": "07/22/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "gland-pharma-limited-carboplatin-injection-54288-165-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-carboplatin-injection-54288-165-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"54288-165-01\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: end of August 2026; Distributed by BPI Labs, LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "54288-166-01",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: end of June 2026; Distributed by BPI Labs, LLC",
      "initial_posting_date": "04/28/2023",
      "update_date": "07/22/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "gland-pharma-limited-carboplatin-injection-54288-166-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-carboplatin-injection-54288-166-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"54288-166-01\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: end of June 2026; Distributed by BPI Labs, LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "54288-167-01",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Distributed by BPI Labs, LLC",
      "initial_posting_date": "04/28/2023",
      "update_date": "07/22/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "gland-pharma-limited-carboplatin-injection-54288-167-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-carboplatin-injection-54288-167-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"54288-167-01\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270\", \"availability\": \"Limited Availability\", \"related_info\": \"Distributed by BPI Labs, LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "43598-975-58",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by DRL",
      "initial_posting_date": "04/10/2020",
      "update_date": "07/22/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "gland-pharma-limited-dexmedetomidine-hydrochloride-injection-43598-975-58",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-dexmedetomidine-hydrochloride-injection-43598-975-58/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"43598-975-58\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"Distributed by DRL\", \"availability\": \"Available\", \"related_info\": \"Distributed by DRL\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43598-976-58",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by DRL",
      "initial_posting_date": "04/10/2020",
      "update_date": "07/22/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "gland-pharma-limited-dexmedetomidine-hydrochloride-injection-43598-976-58",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-dexmedetomidine-hydrochloride-injection-43598-976-58/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"43598-976-58\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"Distributed by DRL\", \"availability\": \"Available\", \"related_info\": \"Distributed by DRL\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "66794-230-42",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Piramal Critical Care Inc.: 800-414-1901",
      "initial_posting_date": "04/10/2020",
      "update_date": "07/22/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "gland-pharma-limited-dexmedetomidine-hydrochloride-injection-66794-230-42",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-dexmedetomidine-hydrochloride-injection-66794-230-42/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"66794-230-42\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"855-273-0154\", \"availability\": \"Available\", \"related_info\": \"Marketed by Piramal Critical Care Inc.: 800-414-1901\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72266-146-10",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.",
      "initial_posting_date": "10/05/2022",
      "update_date": "07/22/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "gland-pharma-limited-etomidate-injection-72266-146-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-etomidate-injection-72266-146-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"72266-146-10\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"833-291-9645\", \"availability\": \"Available\", \"related_info\": \"Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72266-147-10",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.",
      "initial_posting_date": "10/05/2022",
      "update_date": "07/22/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "gland-pharma-limited-etomidate-injection-72266-147-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-etomidate-injection-72266-147-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"72266-147-10\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"833-291-9645\", \"availability\": \"Available\", \"related_info\": \"Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-311-02",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product",
      "initial_posting_date": "04/07/2020",
      "update_date": "07/22/2026",
      "days_in_shortage": "2338",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "gland-pharma-limited-furosemide-injection-25021-311-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-furosemide-injection-25021-311-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"25021-311-02\", \"generic_name\": \"Furosemide Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Furosemide%20Injection&st=d\", \"contact_info\": \"866-625-1618\", \"availability\": \"Unavailable\", \"related_info\": \"Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-311-04",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product",
      "initial_posting_date": "04/07/2020",
      "update_date": "07/22/2026",
      "days_in_shortage": "2338",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "gland-pharma-limited-furosemide-injection-25021-311-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-furosemide-injection-25021-311-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"25021-311-04\", \"generic_name\": \"Furosemide Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Furosemide%20Injection&st=d\", \"contact_info\": \"866-625-1618\", \"availability\": \"Unavailable\", \"related_info\": \"Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-311-10",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product",
      "initial_posting_date": "04/07/2020",
      "update_date": "07/22/2026",
      "days_in_shortage": "2338",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "gland-pharma-limited-furosemide-injection-25021-311-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-furosemide-injection-25021-311-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"25021-311-10\", \"generic_name\": \"Furosemide Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Furosemide%20Injection&st=d\", \"contact_info\": \"866-625-1918\", \"availability\": \"Unavailable\", \"related_info\": \"Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-700-01",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "07/22/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "gland-pharma-limited-ketorolac-tromethamine-injection-25021-700-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-ketorolac-tromethamine-injection-25021-700-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"25021-700-01\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"833-291-9645\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-701-01",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "07/22/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "gland-pharma-limited-ketorolac-tromethamine-injection-25021-701-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-ketorolac-tromethamine-injection-25021-701-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"25021-701-01\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"833-291-9645\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-701-02",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "07/22/2026",
      "days_in_shortage": "3084",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "gland-pharma-limited-ketorolac-tromethamine-injection-25021-701-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-ketorolac-tromethamine-injection-25021-701-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"25021-701-02\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"833-291-9645\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72266-118-25",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.",
      "initial_posting_date": "06/06/2018",
      "update_date": "07/22/2026",
      "days_in_shortage": "3009",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "gland-pharma-limited-ketorolac-tromethamine-injection-72266-118-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-ketorolac-tromethamine-injection-72266-118-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/06/2018\", \"package_ndc\": \"72266-118-25\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"833-291-9645\", \"availability\": \"Available\", \"related_info\": \"Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72266-119-25",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.",
      "initial_posting_date": "06/06/2018",
      "update_date": "07/22/2026",
      "days_in_shortage": "3009",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "gland-pharma-limited-ketorolac-tromethamine-injection-72266-119-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-ketorolac-tromethamine-injection-72266-119-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/06/2018\", \"package_ndc\": \"72266-119-25\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"833-291-9645\", \"availability\": \"Available\", \"related_info\": \"Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "47335-993-01",
      "generic_name": "Metronidazole Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/13/2022",
      "update_date": "07/22/2026",
      "days_in_shortage": "1692",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "gland-pharma-limited-metronidazole-injection-47335-993-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-metronidazole-injection-47335-993-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/13/2022\", \"package_ndc\": \"47335-993-01\", \"generic_name\": \"Metronidazole Injection\", \"contact_info\": \"Distributed by Sun Pharma\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-655-02",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals",
      "initial_posting_date": "04/02/2020",
      "update_date": "07/22/2026",
      "days_in_shortage": "2343",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "gland-pharma-limited-midazolam-hydrochloride-injection-25021-655-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-midazolam-hydrochloride-injection-25021-655-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"25021-655-02\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"Avet Pharmaceuticals, Inc.: 855-228-9470; Sagent Pharmaceuticals: 866-625-1618\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-661-10",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Gland Pharma Limited",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals",
      "initial_posting_date": "04/02/2020",
      "update_date": "07/22/2026",
      "days_in_shortage": "2343",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "gland-pharma-limited-midazolam-hydrochloride-injection-25021-661-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/gland-pharma-limited-midazolam-hydrochloride-injection-25021-661-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"25021-661-10\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"Avet Pharmaceuticals, Inc.: 855-228-9470; Sagent Pharmaceuticals: 866-625-1618\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70010-111-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Granules Pharmaceuticals Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "granules-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-70010-111-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/granules-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-70010-111-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Granules%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"70010-111-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"877-770-3183\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70010-112-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Granules Pharmaceuticals Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "granules-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-70010-112-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/granules-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-70010-112-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Granules%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"70010-112-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"877-770-3183\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70010-113-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Granules Pharmaceuticals Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "granules-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-70010-113-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/granules-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-70010-113-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Granules%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"70010-113-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"877-770-3183\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70010-114-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Granules Pharmaceuticals Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "granules-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-70010-114-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/granules-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-70010-114-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Granules%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"70010-114-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"877-770-3183\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70010-115-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Granules Pharmaceuticals Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "granules-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-70010-115-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/granules-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-70010-115-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Granules%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"70010-115-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"877-770-3183\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70010-116-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Granules Pharmaceuticals Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "granules-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-70010-116-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/granules-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-70010-116-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Granules%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"70010-116-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"877-770-3183\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70010-117-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Granules Pharmaceuticals Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "granules-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-70010-117-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/granules-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-70010-117-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Granules%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"70010-117-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"877-770-3183\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70436-203-80",
      "generic_name": "Dobutamine Hydrochloride Injection",
      "manufacturer_name": "Hainan Poly Pharm. Co., Ltd.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988",
      "initial_posting_date": "11/06/2017",
      "update_date": "05/08/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hainan-poly-pharm-co-ltd-dobutamine-hydrochloride-injection-70436-203-80",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hainan-poly-pharm-co-ltd-dobutamine-hydrochloride-injection-70436-203-80/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hainan%20Poly%20Pharm.%20Co.,%20Ltd.%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"70436-203-80\", \"generic_name\": \"Dobutamine Hydrochloride Injection\", \"contact_info\": \"Slate Run Pharmaceuticals, LLC: 844-529-8988\", \"availability\": \"Available\", \"related_info\": \"Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6251-10",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/20/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "986",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-atropine-sulfate-injection-0641-6251-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-atropine-sulfate-injection-0641-6251-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/20/2023\", \"package_ndc\": \"0641-6251-10\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9606-01",
      "generic_name": "Azacitidine Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.",
      "initial_posting_date": "12/18/2020",
      "update_date": "08/13/2026",
      "days_in_shortage": "2083",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "hikma-pharmaceuticals-usa-inc-azacitidine-injection-0143-9606-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-azacitidine-injection-0143-9606-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/18/2020\", \"package_ndc\": \"0143-9606-01\", \"generic_name\": \"Azacitidine Injection\", \"contact_info\": \"1-800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6007-10",
      "generic_name": "Bumetanide Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.",
      "initial_posting_date": "01/31/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "3135",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hikma-pharmaceuticals-usa-inc-bumetanide-injection-0641-6007-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-bumetanide-injection-0641-6007-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/31/2018\", \"package_ndc\": \"0641-6007-10\", \"generic_name\": \"Bumetanide Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6008-10",
      "generic_name": "Bumetanide Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.",
      "initial_posting_date": "01/31/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "3135",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hikma-pharmaceuticals-usa-inc-bumetanide-injection-0641-6008-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-bumetanide-injection-0641-6008-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/31/2018\", \"package_ndc\": \"0641-6008-10\", \"generic_name\": \"Bumetanide Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9930-10",
      "generic_name": "Cefotaxime Sodium Powder, for Solution",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/17/2015",
      "update_date": "08/13/2026",
      "days_in_shortage": "4214",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Powder, For Solution",
      "therapeutic_category": "Anti-Infective",
      "id": "hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9930-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9930-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/17/2015\", \"package_ndc\": \"0143-9930-10\", \"generic_name\": \"Cefotaxime Sodium Powder, for Solution\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9931-25",
      "generic_name": "Cefotaxime Sodium Powder, for Solution",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/17/2015",
      "update_date": "08/13/2026",
      "days_in_shortage": "4214",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Powder, For Solution",
      "therapeutic_category": "Anti-Infective",
      "id": "hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9931-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9931-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/17/2015\", \"package_ndc\": \"0143-9931-25\", \"generic_name\": \"Cefotaxime Sodium Powder, for Solution\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9933-25",
      "generic_name": "Cefotaxime Sodium Powder, for Solution",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/17/2015",
      "update_date": "08/13/2026",
      "days_in_shortage": "4214",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Powder, For Solution",
      "therapeutic_category": "Anti-Infective",
      "id": "hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9933-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9933-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/17/2015\", \"package_ndc\": \"0143-9933-25\", \"generic_name\": \"Cefotaxime Sodium Powder, for Solution\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9935-01",
      "generic_name": "Cefotaxime Sodium Powder, for Solution",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/17/2015",
      "update_date": "08/13/2026",
      "days_in_shortage": "4214",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Powder, For Solution",
      "therapeutic_category": "Anti-Infective",
      "id": "hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9935-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9935-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/17/2015\", \"package_ndc\": \"0143-9935-01\", \"generic_name\": \"Cefotaxime Sodium Powder, for Solution\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-0367-25",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Product will be made available as it is released.",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/13/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "hikma-pharmaceuticals-usa-inc-dexamethasone-sodium-phosphate-injection-0641-0367-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-dexamethasone-sodium-phosphate-injection-0641-0367-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"0641-0367-25\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6145-25",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional product will be made available as it is released.",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/13/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "hikma-pharmaceuticals-usa-inc-dexamethasone-sodium-phosphate-injection-0641-6145-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-dexamethasone-sodium-phosphate-injection-0641-6145-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"0641-6145-25\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6146-25",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional product will be made available as it is released.",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/13/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "hikma-pharmaceuticals-usa-inc-dexamethasone-sodium-phosphate-injection-0641-6146-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-dexamethasone-sodium-phosphate-injection-0641-6146-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"0641-6146-25\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9532-25",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Product temporarily on backorder. Additional lots will be available in the September 2026 timeframe.",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/13/2026",
      "days_in_shortage": "2335",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-dexmedetomidine-hydrochloride-injection-0143-9532-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-dexmedetomidine-hydrochloride-injection-0143-9532-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0143-9532-25\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Product temporarily on backorder. Additional lots will be available in the September 2026 timeframe.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9252-25",
      "generic_name": "Dopamine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Product temporarily on backorder. Additional lots will be available in the February 2027 timeframe.",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/13/2026",
      "days_in_shortage": "3221",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hikma-pharmaceuticals-usa-inc-dopamine-hydrochloride-injection-0143-9252-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-dopamine-hydrochloride-injection-0143-9252-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0143-9252-25\", \"generic_name\": \"Dopamine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Product temporarily on backorder. Additional lots will be available in the February 2027 timeframe.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9254-25",
      "generic_name": "Dopamine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/13/2026",
      "days_in_shortage": "3221",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hikma-pharmaceuticals-usa-inc-dopamine-hydrochloride-injection-0143-9254-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-dopamine-hydrochloride-injection-0143-9254-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0143-9254-25\", \"generic_name\": \"Dopamine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0143-9310-10",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Novaplus label",
      "initial_posting_date": "10/05/2022",
      "update_date": "08/13/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9310-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9310-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"0143-9310-10\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Novaplus label\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9311-10",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Novaplus label",
      "initial_posting_date": "10/05/2022",
      "update_date": "08/13/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9311-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9311-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"0143-9311-10\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Novaplus label\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9506-10",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional product will be made available as it is released.",
      "initial_posting_date": "10/05/2022",
      "update_date": "08/13/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9506-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9506-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"0143-9506-10\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9507-10",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional product will be made available as it is released.",
      "initial_posting_date": "10/05/2022",
      "update_date": "08/13/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9507-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9507-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"0143-9507-10\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72572-160-10",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Civica",
      "initial_posting_date": "10/05/2022",
      "update_date": "08/13/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-etomidate-injection-72572-160-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-etomidate-injection-72572-160-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"72572-160-10\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Distributed by Civica\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72572-161-10",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Civica",
      "initial_posting_date": "10/05/2022",
      "update_date": "08/13/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-etomidate-injection-72572-161-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-etomidate-injection-72572-161-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"72572-161-10\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Distributed by Civica\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6024-10",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Inventory available in vial presentations.",
      "initial_posting_date": "12/20/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "986",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6024-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6024-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/20/2023\", \"package_ndc\": \"0641-6024-10\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Inventory available in vial presentations.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6025-10",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Inventory available in vial presentations.",
      "initial_posting_date": "12/20/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "986",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6025-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6025-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/20/2023\", \"package_ndc\": \"0641-6025-10\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Inventory available in vial presentations.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6026-05",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Inventory available in vial presentations.",
      "initial_posting_date": "12/20/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "986",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6026-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6026-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/20/2023\", \"package_ndc\": \"0641-6026-05\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Inventory available in vial presentations.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6027-25",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Additional lots will be available August 2026 timeframe. Product will be made available as it is released.",
      "initial_posting_date": "12/20/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "986",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6027-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6027-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/20/2023\", \"package_ndc\": \"0641-6027-25\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Additional lots will be available August 2026 timeframe. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0641-6028-25",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.",
      "initial_posting_date": "12/20/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "986",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6028-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6028-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/20/2023\", \"package_ndc\": \"0641-6028-25\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6029-25",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.",
      "initial_posting_date": "12/20/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "986",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6029-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6029-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/20/2023\", \"package_ndc\": \"0641-6029-25\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6030-01",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Additional lots will be available September 2026 timeframe. Product will be made available as it is released.",
      "initial_posting_date": "12/20/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "986",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6030-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6030-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/20/2023\", \"package_ndc\": \"0641-6030-01\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Additional lots will be available September 2026 timeframe. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0641-6247-25",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.",
      "initial_posting_date": "12/20/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "986",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6247-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-fentanyl-citrate-injection-0641-6247-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/20/2023\", \"package_ndc\": \"0641-6247-25\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0054-3294-46",
      "generic_name": "Furosemide Oral Solution",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Available on allocation",
      "initial_posting_date": "03/31/2026",
      "update_date": "08/13/2026",
      "days_in_shortage": "154",
      "shortage_reason": "Shortage of an inactive ingredient component",
      "dosage_form": "Oral Solution",
      "therapeutic_category": "Cardiovascular",
      "id": "hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3294-46",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3294-46/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Oral%20Solution%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/31/2026\", \"package_ndc\": \"0054-3294-46\", \"generic_name\": \"Furosemide Oral Solution\", \"contact_info\": \"800-631-2174\", \"availability\": \"Limited Availability\", \"related_info\": \"Available on allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0054-3294-50",
      "generic_name": "Furosemide Oral Solution",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Available on allocation",
      "initial_posting_date": "03/31/2026",
      "update_date": "08/13/2026",
      "days_in_shortage": "154",
      "shortage_reason": "Shortage of an inactive ingredient component",
      "dosage_form": "Oral Solution",
      "therapeutic_category": "Cardiovascular",
      "id": "hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3294-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3294-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Oral%20Solution%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/31/2026\", \"package_ndc\": \"0054-3294-50\", \"generic_name\": \"Furosemide Oral Solution\", \"contact_info\": \"800-631-2174\", \"availability\": \"Limited Availability\", \"related_info\": \"Available on allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0054-3298-63",
      "generic_name": "Furosemide Oral Solution",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Available on allocation",
      "initial_posting_date": "03/31/2026",
      "update_date": "08/13/2026",
      "days_in_shortage": "154",
      "shortage_reason": "Shortage of an inactive ingredient component",
      "dosage_form": "Oral Solution",
      "therapeutic_category": "Cardiovascular",
      "id": "hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3298-63",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3298-63/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Oral%20Solution%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/31/2026\", \"package_ndc\": \"0054-3298-63\", \"generic_name\": \"Furosemide Oral Solution\", \"contact_info\": \"800-631-2174\", \"availability\": \"Limited Availability\", \"related_info\": \"Available on allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-0121-25",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.",
      "initial_posting_date": "11/03/2017",
      "update_date": "08/13/2026",
      "days_in_shortage": "3224",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-hydromorphone-hydrochloride-injection-0641-0121-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-hydromorphone-hydrochloride-injection-0641-0121-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/03/2017\", \"change_date\": \"01/03/2025\", \"package_ndc\": \"0641-0121-25\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6254-01",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Product temporarily on backorder. Additional lots will be available in the August 2026 timeframe.",
      "initial_posting_date": "11/01/2017",
      "update_date": "08/13/2026",
      "days_in_shortage": "3226",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-hydromorphone-hydrochloride-injection-0641-6254-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-hydromorphone-hydrochloride-injection-0641-6254-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2017\", \"package_ndc\": \"0641-6254-01\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Product temporarily on backorder. Additional lots will be available in the August 2026 timeframe.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0143-9530-01",
      "generic_name": "Ifosfamide Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.",
      "initial_posting_date": "06/12/2026",
      "update_date": "08/13/2026",
      "days_in_shortage": "81",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "hikma-pharmaceuticals-usa-inc-ifosfamide-injection-0143-9530-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-ifosfamide-injection-0143-9530-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/12/2026\", \"package_ndc\": \"0143-9530-01\", \"generic_name\": \"Ifosfamide Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9531-01",
      "generic_name": "Ifosfamide Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.",
      "initial_posting_date": "06/12/2026",
      "update_date": "08/13/2026",
      "days_in_shortage": "81",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "hikma-pharmaceuticals-usa-inc-ifosfamide-injection-0143-9531-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-ifosfamide-injection-0143-9531-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/12/2026\", \"package_ndc\": \"0143-9531-01\", \"generic_name\": \"Ifosfamide Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6041-25",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "06/06/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "3009",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-ketorolac-tromethamine-injection-0641-6041-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-ketorolac-tromethamine-injection-0641-6041-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/06/2018\", \"package_ndc\": \"0641-6041-25\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6042-25",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "06/06/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "3009",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-ketorolac-tromethamine-injection-0641-6042-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-ketorolac-tromethamine-injection-0641-6042-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/06/2018\", \"package_ndc\": \"0641-6042-25\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6043-25",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "06/06/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "3009",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-ketorolac-tromethamine-injection-0641-6043-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-ketorolac-tromethamine-injection-0641-6043-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/06/2018\", \"package_ndc\": \"0641-6043-25\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9575-10",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.",
      "initial_posting_date": "06/13/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "3002",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9575-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9575-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/13/2018\", \"package_ndc\": \"0143-9575-10\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9577-10",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.",
      "initial_posting_date": "06/13/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "3002",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9577-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9577-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/13/2018\", \"package_ndc\": \"0143-9577-10\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9594-25",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "06/13/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "3002",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9594-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9594-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/13/2018\", \"package_ndc\": \"0143-9594-25\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9595-25",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.",
      "initial_posting_date": "06/13/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "3002",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9595-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9595-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/13/2018\", \"package_ndc\": \"0143-9595-25\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9144-02",
      "generic_name": "Liraglutide Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/18/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1141",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hikma-pharmaceuticals-usa-inc-liraglutide-injection-0143-9144-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-liraglutide-injection-0143-9144-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/18/2023\", \"package_ndc\": \"0143-9144-02\", \"generic_name\": \"Liraglutide Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9144-03",
      "generic_name": "Liraglutide Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/18/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1141",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hikma-pharmaceuticals-usa-inc-liraglutide-injection-0143-9144-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-liraglutide-injection-0143-9144-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/18/2023\", \"package_ndc\": \"0143-9144-03\", \"generic_name\": \"Liraglutide Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0054-0370-25",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Available on allocation",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0370-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0370-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0054-0370-25\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-631-2174\", \"availability\": \"Limited Availability\", \"related_info\": \"Available on allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0054-0371-25",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Available on allocation",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0371-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0371-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0054-0371-25\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-631-2174\", \"availability\": \"Limited Availability\", \"related_info\": \"Available on allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0054-0372-25",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Available on allocation",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0372-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0372-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0054-0372-25\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-631-2174\", \"availability\": \"Limited Availability\", \"related_info\": \"Available on allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0054-0373-25",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Available on allocation",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0373-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0373-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0054-0373-25\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-631-2174\", \"availability\": \"Limited Availability\", \"related_info\": \"Available on allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0054-0374-25",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Available on allocation",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0374-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0374-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0054-0374-25\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-631-2174\", \"availability\": \"Limited Availability\", \"related_info\": \"Available on allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0054-0375-25",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Available on allocation",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0375-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0375-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0054-0375-25\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-631-2174\", \"availability\": \"Limited Availability\", \"related_info\": \"Available on allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0054-0660-25",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Available on allocation",
      "initial_posting_date": "07/14/2023",
      "update_date": "05/12/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0660-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0660-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0054-0660-25\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-631-2174\", \"availability\": \"Limited Availability\", \"related_info\": \"Available on allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6000-10",
      "generic_name": "Lorazepam Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "09/05/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "2918",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Neurology",
      "id": "hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6000-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6000-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"09/05/2018\", \"package_ndc\": \"0641-6000-10\", \"generic_name\": \"Lorazepam Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6001-25",
      "generic_name": "Lorazepam Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Lots are being manufactured to meet demand",
      "initial_posting_date": "09/05/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "2918",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Neurology",
      "id": "hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6001-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6001-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"09/05/2018\", \"package_ndc\": \"0641-6001-25\", \"generic_name\": \"Lorazepam Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Limited Availability\", \"related_info\": \"Lots are being manufactured to meet demand\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0641-6002-10",
      "generic_name": "Lorazepam Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "09/05/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "2918",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Neurology",
      "id": "hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6002-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6002-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"09/05/2018\", \"package_ndc\": \"0641-6002-10\", \"generic_name\": \"Lorazepam Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6003-25",
      "generic_name": "Lorazepam Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "09/05/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "2918",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Neurology",
      "id": "hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6003-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6003-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"09/05/2018\", \"package_ndc\": \"0641-6003-25\", \"generic_name\": \"Lorazepam Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6044-25",
      "generic_name": "Lorazepam Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Lots are being manufactured to meet demand",
      "initial_posting_date": "09/05/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "2918",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Neurology",
      "id": "hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6044-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6044-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"09/05/2018\", \"package_ndc\": \"0641-6044-25\", \"generic_name\": \"Lorazepam Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Limited Availability\", \"related_info\": \"Lots are being manufactured to meet demand\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0641-6045-25",
      "generic_name": "Lorazepam Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "09/05/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "2918",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Neurology",
      "id": "hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6045-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6045-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"09/05/2018\", \"package_ndc\": \"0641-6045-25\", \"generic_name\": \"Lorazepam Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6046-10",
      "generic_name": "Lorazepam Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "09/05/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "2918",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Neurology",
      "id": "hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6046-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6046-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"09/05/2018\", \"package_ndc\": \"0641-6046-10\", \"generic_name\": \"Lorazepam Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6047-10",
      "generic_name": "Lorazepam Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "05/03/2018",
      "update_date": "08/13/2026",
      "days_in_shortage": "3043",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Neurology",
      "id": "hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6047-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lorazepam-injection-0641-6047-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/03/2018\", \"package_ndc\": \"0641-6047-10\", \"generic_name\": \"Lorazepam Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6052-25",
      "generic_name": "Meperidine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "05/30/2025",
      "update_date": "08/13/2026",
      "days_in_shortage": "459",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-meperidine-hydrochloride-injection-0641-6052-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-meperidine-hydrochloride-injection-0641-6052-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/30/2025\", \"package_ndc\": \"0641-6052-25\", \"generic_name\": \"Meperidine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6053-25",
      "generic_name": "Meperidine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "05/30/2025",
      "update_date": "08/13/2026",
      "days_in_shortage": "459",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-meperidine-hydrochloride-injection-0641-6053-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-meperidine-hydrochloride-injection-0641-6053-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/30/2025\", \"package_ndc\": \"0641-6053-25\", \"generic_name\": \"Meperidine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6054-25",
      "generic_name": "Meperidine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "05/30/2025",
      "update_date": "08/13/2026",
      "days_in_shortage": "459",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-meperidine-hydrochloride-injection-0641-6054-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-meperidine-hydrochloride-injection-0641-6054-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/30/2025\", \"package_ndc\": \"0641-6054-25\", \"generic_name\": \"Meperidine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9519-10",
      "generic_name": "Methotrexate Sodium Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "03/13/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1268",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "hikma-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0143-9519-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0143-9519-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"0143-9519-10\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "shortage_reason",
          "value": "Demand increase for the drug",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"0143-9519-10\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.\"",
          "as_of": "2026-09-07"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0143-9830-01",
      "generic_name": "Methotrexate Sodium Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.",
      "initial_posting_date": "03/13/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1268",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "hikma-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0143-9830-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0143-9830-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"0143-9830-01\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6056-10",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/13/2026",
      "days_in_shortage": "2343",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-midazolam-hydrochloride-injection-0641-6056-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-midazolam-hydrochloride-injection-0641-6056-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0641-6056-10\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6057-25",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/13/2026",
      "days_in_shortage": "2343",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-midazolam-hydrochloride-injection-0641-6057-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-midazolam-hydrochloride-injection-0641-6057-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0641-6057-25\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6059-01",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/13/2026",
      "days_in_shortage": "2343",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-midazolam-hydrochloride-injection-0641-6059-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-midazolam-hydrochloride-injection-0641-6059-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0641-6059-01\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0641-6060-10",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/13/2026",
      "days_in_shortage": "2343",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-midazolam-hydrochloride-injection-0641-6060-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-midazolam-hydrochloride-injection-0641-6060-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0641-6060-10\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6061-25",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/13/2026",
      "days_in_shortage": "2343",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-midazolam-hydrochloride-injection-0641-6061-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-midazolam-hydrochloride-injection-0641-6061-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0641-6061-25\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6019-10",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "11/03/2017",
      "update_date": "08/13/2026",
      "days_in_shortage": "3224",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-morphine-sulfate-injection-0641-6019-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-morphine-sulfate-injection-0641-6019-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/03/2017\", \"package_ndc\": \"0641-6019-10\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6020-10",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "11/03/2017",
      "update_date": "08/13/2026",
      "days_in_shortage": "3224",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-morphine-sulfate-injection-0641-6020-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-morphine-sulfate-injection-0641-6020-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/03/2017\", \"package_ndc\": \"0641-6020-10\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6039-01",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "11/03/2017",
      "update_date": "08/13/2026",
      "days_in_shortage": "3224",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-morphine-sulfate-injection-0641-6039-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-morphine-sulfate-injection-0641-6039-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/03/2017\", \"package_ndc\": \"0641-6039-01\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6040-01",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "11/03/2017",
      "update_date": "08/13/2026",
      "days_in_shortage": "3224",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-morphine-sulfate-injection-0641-6040-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-morphine-sulfate-injection-0641-6040-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/03/2017\", \"package_ndc\": \"0641-6040-01\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6125-25",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "11/03/2017",
      "update_date": "08/13/2026",
      "days_in_shortage": "3224",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-morphine-sulfate-injection-0641-6125-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-morphine-sulfate-injection-0641-6125-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/03/2017\", \"package_ndc\": \"0641-6125-25\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6126-25",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "11/03/2017",
      "update_date": "08/13/2026",
      "days_in_shortage": "3224",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-morphine-sulfate-injection-0641-6126-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-morphine-sulfate-injection-0641-6126-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/03/2017\", \"package_ndc\": \"0641-6126-25\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6127-25",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "11/03/2017",
      "update_date": "08/13/2026",
      "days_in_shortage": "3224",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-morphine-sulfate-injection-0641-6127-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-morphine-sulfate-injection-0641-6127-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/03/2017\", \"package_ndc\": \"0641-6127-25\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "shortage_reason",
          "value": "Demand increase for the drug",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"11/03/2017\", \"package_ndc\": \"0641-6127-25\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released.\"",
          "as_of": "2026-09-07"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0641-0928-25",
      "generic_name": "Promethazine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "11/21/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1015",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-0928-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-0928-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/21/2023\", \"package_ndc\": \"0641-0928-25\", \"generic_name\": \"Promethazine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-0929-25",
      "generic_name": "Promethazine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "11/21/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1015",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-0929-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-0929-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/21/2023\", \"package_ndc\": \"0641-0929-25\", \"generic_name\": \"Promethazine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "shortage_reason",
          "value": "Other",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"11/21/2023\", \"package_ndc\": \"0641-0929-25\", \"generic_name\": \"Promethazine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
          "as_of": "2026-09-10"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0641-1495-35",
      "generic_name": "Promethazine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "11/21/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1015",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-1495-35",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-1495-35/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/21/2023\", \"package_ndc\": \"0641-1495-35\", \"generic_name\": \"Promethazine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "shortage_reason",
          "value": "Other",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"11/21/2023\", \"package_ndc\": \"0641-1495-35\", \"generic_name\": \"Promethazine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released.\"",
          "as_of": "2026-09-10"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0641-1496-35",
      "generic_name": "Promethazine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "11/21/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1015",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-1496-35",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-1496-35/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/21/2023\", \"package_ndc\": \"0641-1496-35\", \"generic_name\": \"Promethazine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0641-6082-25",
      "generic_name": "Promethazine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "11/21/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1015",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-6082-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-6082-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/21/2023\", \"package_ndc\": \"0641-6082-25\", \"generic_name\": \"Promethazine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "shortage_reason",
          "value": "Other",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"11/21/2023\", \"package_ndc\": \"0641-6082-25\", \"generic_name\": \"Promethazine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
          "as_of": "2026-09-10"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0641-6083-25",
      "generic_name": "Promethazine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "This presentation is temporarily on backorder. Expected in October 2026 timeframe",
      "initial_posting_date": "11/21/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1015",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-6083-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-6083-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/21/2023\", \"package_ndc\": \"0641-6083-25\", \"generic_name\": \"Promethazine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"This presentation is temporarily on backorder. Expected in October 2026 timeframe\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6084-25",
      "generic_name": "Promethazine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "11/21/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1015",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-6084-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-6084-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/21/2023\", \"package_ndc\": \"0641-6084-25\", \"generic_name\": \"Promethazine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6085-25",
      "generic_name": "Promethazine Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
      "initial_posting_date": "11/21/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1015",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-6085-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-promethazine-hydrochloride-injection-0641-6085-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/21/2023\", \"package_ndc\": \"0641-6085-25\", \"generic_name\": \"Promethazine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots are scheduled to be manufactured. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "shortage_reason",
          "value": "Other",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"11/21/2023\", \"package_ndc\": \"0641-6085-25\", \"generic_name\": \"Promethazine Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
          "as_of": "2026-09-10"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0143-9872-10",
      "generic_name": "Propranolol Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "10/31/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1036",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hikma-pharmaceuticals-usa-inc-propranolol-hydrochloride-injection-0143-9872-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-propranolol-hydrochloride-injection-0143-9872-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Propranolol%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2023\", \"package_ndc\": \"0143-9872-10\", \"generic_name\": \"Propranolol Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9391-10",
      "generic_name": "Remifentanil Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "06/28/2022",
      "update_date": "08/13/2026",
      "days_in_shortage": "1526",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9391-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9391-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/28/2022\", \"package_ndc\": \"0143-9391-10\", \"generic_name\": \"Remifentanil Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9392-10",
      "generic_name": "Remifentanil Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "06/28/2022",
      "update_date": "08/13/2026",
      "days_in_shortage": "1526",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9392-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9392-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/28/2022\", \"package_ndc\": \"0143-9392-10\", \"generic_name\": \"Remifentanil Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9393-10",
      "generic_name": "Remifentanil Hydrochloride Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots will be available. Product will be made available as it is released.",
      "initial_posting_date": "06/28/2022",
      "update_date": "08/13/2026",
      "days_in_shortage": "1526",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9393-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9393-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/28/2022\", \"package_ndc\": \"0143-9393-10\", \"generic_name\": \"Remifentanil Hydrochloride Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots will be available. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9250-10",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots will be available. Product will be made available as it is released.",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-rocuronium-bromide-injection-0143-9250-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-rocuronium-bromide-injection-0143-9250-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"0143-9250-10\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots will be available. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9251-10",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots will be available. Product will be made available as it is released.",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/13/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hikma-pharmaceuticals-usa-inc-rocuronium-bromide-injection-0143-9251-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-rocuronium-bromide-injection-0143-9251-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"0143-9251-10\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots will be available. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6261-01",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots will be available. Product will be made available as it is released.",
      "initial_posting_date": "02/03/2016",
      "update_date": "08/13/2026",
      "days_in_shortage": "3863",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hikma-pharmaceuticals-usa-inc-sodium-acetate-injection-0641-6261-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-sodium-acetate-injection-0641-6261-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/03/2016\", \"package_ndc\": \"0641-6261-01\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots will be available. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6262-01",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots will be available. Product will be made available as it is released.",
      "initial_posting_date": "02/03/2016",
      "update_date": "08/13/2026",
      "days_in_shortage": "3863",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hikma-pharmaceuticals-usa-inc-sodium-acetate-injection-0641-6262-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-sodium-acetate-injection-0641-6262-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/03/2016\", \"package_ndc\": \"0641-6262-01\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots will be available. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0641-6147-10",
      "generic_name": "Sterile Water Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots will be scheduled for manufacturing. Product will be made available as it is released.",
      "initial_posting_date": "11/23/2021",
      "update_date": "08/13/2026",
      "days_in_shortage": "1743",
      "dosage_form": "Injection",
      "therapeutic_category": "Other",
      "id": "hikma-pharmaceuticals-usa-inc-sterile-water-injection-0641-6147-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-sterile-water-injection-0641-6147-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/23/2021\", \"package_ndc\": \"0641-6147-10\", \"generic_name\": \"Sterile Water Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots will be scheduled for manufacturing. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "17478-050-01",
      "generic_name": "Sufentanil Citrate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Not currently manufactured",
      "initial_posting_date": "05/03/2022",
      "update_date": "08/13/2026",
      "days_in_shortage": "1582",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-sufentanil-citrate-injection-17478-050-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-sufentanil-citrate-injection-17478-050-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sufentanil%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/03/2022\", \"package_ndc\": \"17478-050-01\", \"generic_name\": \"Sufentanil Citrate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Not currently manufactured\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "17478-050-02",
      "generic_name": "Sufentanil Citrate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Not currently manufactured",
      "initial_posting_date": "05/03/2022",
      "update_date": "08/13/2026",
      "days_in_shortage": "1582",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-sufentanil-citrate-injection-17478-050-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-sufentanil-citrate-injection-17478-050-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sufentanil%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/03/2022\", \"package_ndc\": \"17478-050-02\", \"generic_name\": \"Sufentanil Citrate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Not currently manufactured\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "17478-050-05",
      "generic_name": "Sufentanil Citrate Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Not currently manufactured",
      "initial_posting_date": "05/03/2022",
      "update_date": "08/13/2026",
      "days_in_shortage": "1582",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hikma-pharmaceuticals-usa-inc-sufentanil-citrate-injection-17478-050-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-sufentanil-citrate-injection-17478-050-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sufentanil%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/03/2022\", \"package_ndc\": \"17478-050-05\", \"generic_name\": \"Sufentanil Citrate Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Unavailable\", \"related_info\": \"Not currently manufactured\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0143-9785-10",
      "generic_name": "Valproate Sodium Injection",
      "manufacturer_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Additional lots will be available. Product will be made available as it is released.",
      "initial_posting_date": "12/30/2020",
      "update_date": "08/13/2026",
      "days_in_shortage": "2071",
      "dosage_form": "Injection",
      "therapeutic_category": "Neurology",
      "id": "hikma-pharmaceuticals-usa-inc-valproate-sodium-injection-0143-9785-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-valproate-sodium-injection-0143-9785-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Valproate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/30/2020\", \"package_ndc\": \"0143-9785-10\", \"generic_name\": \"Valproate Sodium Injection\", \"contact_info\": \"800-631-2174\", \"availability\": \"Available\", \"related_info\": \"Additional lots will be available. Product will be made available as it is released.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1630-10",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5357",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-atropine-sulfate-injection-0409-1630-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-atropine-sulfate-injection-0409-1630-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"0409-1630-10\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4910-34",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5357",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-atropine-sulfate-injection-0409-4910-34",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-atropine-sulfate-injection-0409-4910-34/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"0409-4910-34\", \"generic_name\": \"Atropine Sulfate Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Atropine+Sulfate+Injection&st=d&tab=tabs-2\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4911-34",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5357",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-atropine-sulfate-injection-0409-4911-34",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-atropine-sulfate-injection-0409-4911-34/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"0409-4911-34\", \"generic_name\": \"Atropine Sulfate Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Atropine+Sulfate+Injection&st=d&tab=tabs-2\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-9630-05",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-atropine-sulfate-injection-0409-9630-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-atropine-sulfate-injection-0409-9630-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"0409-9630-05\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1746-10",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-1746-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-1746-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1746-10\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1746-30",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-1746-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-1746-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1746-30\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1749-10",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-1749-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-1749-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1749-10\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1749-29",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-1749-29",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-1749-29/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1749-29\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1752-50",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-1752-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-1752-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1752-50\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1755-50",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-1755-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-1755-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1755-50\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-9042-01",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-9042-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-9042-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-9042-01\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-9042-17",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-9042-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-9042-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-9042-17\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-9043-01",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-9043-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-9043-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-9043-01\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-9045-01",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-9045-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-9045-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-9045-01\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-9045-17",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-9045-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-9045-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-9045-17\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-9046-01",
      "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-9046-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-epinephrine-bitartrate-injection-0409-9046-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-9046-01\", \"generic_name\": \"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-0525-25",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "related_info": "Historical NDC: 0409-1610-50",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/31/2026",
      "days_in_shortage": "3117",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-0525-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-0525-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-0525-25\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\", \"related_info\": \"Historical NDC: 0409-1610-50\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1159-01",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1159-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1159-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1159-01\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1159-02",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1159-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1159-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1159-02\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1159-10",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1159-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1159-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1159-10\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1160-01",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1160-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1160-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1160-01\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1162-01",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1162-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1162-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1162-01\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1162-02",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1162-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1162-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1162-02\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1163-01",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1163-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1163-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1163-01\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1165-01",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1165-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1165-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1165-01\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1165-02",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1165-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1165-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1165-02\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1530-01",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "09/11/2026",
      "days_in_shortage": "3129",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1530-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1530-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1530-01\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1559-10",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1559-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1559-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1559-10\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"company_name\": \"Hospira, Inc., a Pfizer Company\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1559-30",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1559-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1559-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1559-30\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"company_name\": \"Hospira, Inc., a Pfizer Company\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1560-10",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1560-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1560-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1560-10\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"company_name\": \"Hospira, Inc., a Pfizer Company\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1560-29",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1560-29",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1560-29/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1560-29\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"company_name\": \"Hospira, Inc., a Pfizer Company\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1761-10",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: October 2026; Estimated Recovery: December 2026",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1761-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1761-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1761-10\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: October 2026; Estimated Recovery: December 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-1761-62",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1761-62",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-1761-62/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-1761-62\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2253-01",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "related_info": "Historical NDC: 0409-1582-29",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-2253-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-2253-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-2253-01\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\", \"related_info\": \"Historical NDC: 0409-1582-29\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2253-25",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "related_info": "Historical NDC: 0409-1582-29",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/31/2026",
      "days_in_shortage": "3117",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-2253-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-2253-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-2253-25\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\", \"related_info\": \"Historical NDC: 0409-1582-29\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2510-01",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "09/11/2026",
      "days_in_shortage": "3129",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-2510-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-2510-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-2510-01\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3613-01",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-3613-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-3613-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-3613-01\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-5010-01",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "09/11/2026",
      "days_in_shortage": "3129",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-5010-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-5010-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-5010-01\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-7535-01",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "09/11/2026",
      "days_in_shortage": "3129",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-7535-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-bupivacaine-hydrochloride-injection-0409-7535-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"0409-7535-01\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61703-150-05",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "hospira-inc-a-pfizer-company-carboplatin-injection-61703-150-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-carboplatin-injection-61703-150-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"61703-150-05\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61703-262-05",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "hospira-inc-a-pfizer-company-carboplatin-injection-61703-262-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-carboplatin-injection-61703-262-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"61703-262-05\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61703-339-18",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "hospira-inc-a-pfizer-company-carboplatin-injection-61703-339-18",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-carboplatin-injection-61703-339-18/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"61703-339-18\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61703-339-22",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "hospira-inc-a-pfizer-company-carboplatin-injection-61703-339-22",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-carboplatin-injection-61703-339-22/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"61703-339-22\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "61703-339-50",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "hospira-inc-a-pfizer-company-carboplatin-injection-61703-339-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-carboplatin-injection-61703-339-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"61703-339-50\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61703-339-56",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "hospira-inc-a-pfizer-company-carboplatin-injection-61703-339-56",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-carboplatin-injection-61703-339-56/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"61703-339-56\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61703-360-18",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "hospira-inc-a-pfizer-company-carboplatin-injection-61703-360-18",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-carboplatin-injection-61703-360-18/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"61703-360-18\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61703-600-05",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "hospira-inc-a-pfizer-company-carboplatin-injection-61703-600-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-carboplatin-injection-61703-600-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"61703-600-05\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4902-34",
      "generic_name": "Dextrose Monohydrate 50% Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/13/2022",
      "update_date": "08/24/2026",
      "days_in_shortage": "1692",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-dextrose-monohydrate-50-injection-0409-4902-34",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dextrose-monohydrate-50-injection-0409-4902-34/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2050%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/13/2022\", \"package_ndc\": \"0409-4902-34\", \"generic_name\": \"Dextrose Monohydrate 50% Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Dextrose%20Monohydrate%2050per%20Injection&st=d\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-6648-02",
      "generic_name": "Dextrose Monohydrate 50% Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Next Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "01/13/2022",
      "update_date": "08/24/2026",
      "days_in_shortage": "1692",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-dextrose-monohydrate-50-injection-0409-6648-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dextrose-monohydrate-50-injection-0409-6648-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2050%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/13/2022\", \"package_ndc\": \"0409-6648-02\", \"generic_name\": \"Dextrose Monohydrate 50% Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Next Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-7517-16",
      "generic_name": "Dextrose Monohydrate 50% Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/13/2022",
      "update_date": "08/24/2026",
      "days_in_shortage": "1692",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-dextrose-monohydrate-50-injection-0409-7517-16",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dextrose-monohydrate-50-injection-0409-7517-16/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2050%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/13/2022\", \"package_ndc\": \"0409-7517-16\", \"generic_name\": \"Dextrose Monohydrate 50% Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-0025-10",
      "generic_name": "Dobutamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "09/11/2026",
      "days_in_shortage": "3235",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-0025-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-0025-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-0025-10\", \"generic_name\": \"Dobutamine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-0151-10",
      "generic_name": "Dobutamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "09/11/2026",
      "days_in_shortage": "3235",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-0151-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-0151-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-0151-10\", \"generic_name\": \"Dobutamine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1100-10",
      "generic_name": "Dobutamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "09/11/2026",
      "days_in_shortage": "3235",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-1100-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-1100-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-1100-10\", \"generic_name\": \"Dobutamine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2344-01",
      "generic_name": "Dobutamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-2344-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-2344-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-2344-01\", \"generic_name\": \"Dobutamine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2344-02",
      "generic_name": "Dobutamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-2344-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-2344-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-2344-02\", \"generic_name\": \"Dobutamine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2344-88",
      "generic_name": "Dobutamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3221",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-2344-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-2344-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-2344-88\", \"generic_name\": \"Dobutamine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2346-32",
      "generic_name": "Dobutamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-2346-32",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-2346-32/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-2346-32\", \"generic_name\": \"Dobutamine Hydrochloride Injection\", \"company_name\": \"Hospira, Inc., a Pfizer Company\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2347-32",
      "generic_name": "Dobutamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-2347-32",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-2347-32/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-2347-32\", \"generic_name\": \"Dobutamine Hydrochloride Injection\", \"company_name\": \"Hospira, Inc., a Pfizer Company\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3724-32",
      "generic_name": "Dobutamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-3724-32",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dobutamine-hydrochloride-injection-0409-3724-32/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-3724-32\", \"generic_name\": \"Dobutamine Hydrochloride Injection\", \"company_name\": \"Hospira, Inc., a Pfizer Company\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-0042-12",
      "generic_name": "Dopamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "09/11/2026",
      "days_in_shortage": "3235",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dopamine-hydrochloride-injection-0409-0042-12",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dopamine-hydrochloride-injection-0409-0042-12/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-0042-12\", \"generic_name\": \"Dopamine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1858-12",
      "generic_name": "Dopamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "09/11/2026",
      "days_in_shortage": "3235",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dopamine-hydrochloride-injection-0409-1858-12",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dopamine-hydrochloride-injection-0409-1858-12/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-1858-12\", \"generic_name\": \"Dopamine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-5820-01",
      "generic_name": "Dopamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3221",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dopamine-hydrochloride-injection-0409-5820-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dopamine-hydrochloride-injection-0409-5820-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-5820-01\", \"generic_name\": \"Dopamine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-7809-22",
      "generic_name": "Dopamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dopamine-hydrochloride-injection-0409-7809-22",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dopamine-hydrochloride-injection-0409-7809-22/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-7809-22\", \"generic_name\": \"Dopamine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-7809-24",
      "generic_name": "Dopamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3221",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dopamine-hydrochloride-injection-0409-7809-24",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dopamine-hydrochloride-injection-0409-7809-24/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-7809-24\", \"generic_name\": \"Dopamine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-7810-22",
      "generic_name": "Dopamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dopamine-hydrochloride-injection-0409-7810-22",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dopamine-hydrochloride-injection-0409-7810-22/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-7810-22\", \"generic_name\": \"Dopamine Hydrochloride Injection\", \"company_name\": \"Hospira, Inc., a Pfizer Company\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-9104-20",
      "generic_name": "Dopamine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/06/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3221",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-dopamine-hydrochloride-injection-0409-9104-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-dopamine-hydrochloride-injection-0409-9104-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/06/2017\", \"package_ndc\": \"0409-9104-20\", \"generic_name\": \"Dopamine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1209-01",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-1209-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-1209-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-1209-01\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3177-01",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3177-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3177-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-3177-01\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3178-01",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3178-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3178-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-3178-01\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3178-02",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: November 2026; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3178-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3178-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-3178-02\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: November 2026; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-3178-03",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3178-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3178-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-3178-03\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3181-01",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3181-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3181-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-3181-01\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3182-01",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3182-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3182-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-3182-01\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3182-02",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery: May 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3182-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3182-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-3182-02\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery: May 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3182-03",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery: April 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3182-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3182-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-3182-03\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery: April 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-3183-01",
      "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3183-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-epinephrine-bitartrate-lidocaine-hydrochloride-injection-0409-3183-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-3183-01\", \"generic_name\": \"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-6695-01",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/05/2022",
      "update_date": "08/24/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-etomidate-injection-0409-6695-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-etomidate-injection-0409-6695-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"0409-6695-01\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-6695-02",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "10/05/2022",
      "update_date": "08/24/2026",
      "days_in_shortage": "1427",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-etomidate-injection-0409-6695-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-etomidate-injection-0409-6695-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"0409-6695-02\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-9094-22",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-fentanyl-citrate-injection-0409-9094-22",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-fentanyl-citrate-injection-0409-9094-22/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"0409-9094-22\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-9094-25",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-fentanyl-citrate-injection-0409-9094-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-fentanyl-citrate-injection-0409-9094-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"0409-9094-25\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-9094-28",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-fentanyl-citrate-injection-0409-9094-28",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-fentanyl-citrate-injection-0409-9094-28/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"0409-9094-28\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-9094-31",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5357",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-fentanyl-citrate-injection-0409-9094-31",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-fentanyl-citrate-injection-0409-9094-31/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"0409-9094-31\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-9094-61",
      "generic_name": "Fentanyl Citrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-fentanyl-citrate-injection-0409-9094-61",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-fentanyl-citrate-injection-0409-9094-61/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"0409-9094-61\", \"generic_name\": \"Fentanyl Citrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-6102-02",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-furosemide-injection-0409-6102-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-furosemide-injection-0409-6102-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"0409-6102-02\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-6102-04",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-furosemide-injection-0409-6102-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-furosemide-injection-0409-6102-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"0409-6102-04\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-6102-10",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-furosemide-injection-0409-6102-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-furosemide-injection-0409-6102-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"0409-6102-10\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-6102-25",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2338",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-furosemide-injection-0409-6102-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-furosemide-injection-0409-6102-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"0409-6102-25\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-6102-26",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2338",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-furosemide-injection-0409-6102-26",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-furosemide-injection-0409-6102-26/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"0409-6102-26\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-6102-27",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2338",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "hospira-inc-a-pfizer-company-furosemide-injection-0409-6102-27",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-furosemide-injection-0409-6102-27/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"0409-6102-27\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1005-20",
      "generic_name": "Heparin Sodium Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/14/2017",
      "update_date": "09/11/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Hematology",
      "id": "hospira-inc-a-pfizer-company-heparin-sodium-injection-0409-1005-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-heparin-sodium-injection-0409-1005-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/14/2017\", \"package_ndc\": \"0409-1005-20\", \"generic_name\": \"Heparin Sodium Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2222-12",
      "generic_name": "Heparin Sodium Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/14/2017",
      "update_date": "09/11/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Hematology",
      "id": "hospira-inc-a-pfizer-company-heparin-sodium-injection-0409-2222-12",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-heparin-sodium-injection-0409-2222-12/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/14/2017\", \"package_ndc\": \"0409-2222-12\", \"generic_name\": \"Heparin Sodium Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-7620-03",
      "generic_name": "Heparin Sodium Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/14/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3213",
      "dosage_form": "Injection",
      "therapeutic_category": "Hematology",
      "id": "hospira-inc-a-pfizer-company-heparin-sodium-injection-0409-7620-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-heparin-sodium-injection-0409-7620-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/14/2017\", \"package_ndc\": \"0409-7620-03\", \"generic_name\": \"Heparin Sodium Injection\", \"company_name\": \"Hospira, Inc., a Pfizer Company\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-7620-59",
      "generic_name": "Heparin Sodium Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/14/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3213",
      "dosage_form": "Injection",
      "therapeutic_category": "Hematology",
      "id": "hospira-inc-a-pfizer-company-heparin-sodium-injection-0409-7620-59",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-heparin-sodium-injection-0409-7620-59/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/14/2017\", \"package_ndc\": \"0409-7620-59\", \"generic_name\": \"Heparin Sodium Injection\", \"company_name\": \"Hospira, Inc., a Pfizer Company\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1283-31",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-1283-31",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-1283-31/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-1283-31\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1283-37",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-1283-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-1283-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-1283-37\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-1304-31",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-1304-31",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-1304-31/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-1304-31\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1312-30",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-1312-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-1312-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-1312-30\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1312-36",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-1312-36",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-1312-36/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-1312-36\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1805-01",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "11/01/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3226",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-1805-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-1805-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2017\", \"package_ndc\": \"0409-1805-01\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-2634-01",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-2634-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-2634-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-2634-01\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2634-05",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-2634-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-2634-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-2634-05\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2634-50",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-2634-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-2634-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-2634-50\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3365-10",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-3365-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-3365-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-3365-10\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4264-01",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "11/01/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3226",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-4264-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-hydromorphone-hydrochloride-injection-0409-4264-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2017\", \"package_ndc\": \"0409-4264-01\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-3793-01",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "03/26/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3081",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-ketorolac-tromethamine-injection-0409-3793-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-ketorolac-tromethamine-injection-0409-3793-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/26/2018\", \"package_ndc\": \"0409-3793-01\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3795-01",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "03/26/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3081",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-ketorolac-tromethamine-injection-0409-3795-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-ketorolac-tromethamine-injection-0409-3795-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/26/2018\", \"package_ndc\": \"0409-3795-01\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3796-01",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "03/26/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3081",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-ketorolac-tromethamine-injection-0409-3796-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-ketorolac-tromethamine-injection-0409-3796-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/26/2018\", \"package_ndc\": \"0409-3796-01\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-1323-05",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-1323-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-1323-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-1323-05\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2066-05",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-2066-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-2066-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-2066-05\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4275-01",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4275-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4275-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4275-01\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4276-01",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4276-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4276-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4276-01\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4276-02",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4276-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4276-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4276-02\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4277-01",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4277-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4277-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4277-01\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4277-02",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4277-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4277-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4277-02\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4278-01",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4278-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4278-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4278-01\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4279-02",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4279-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4279-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4279-02\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4282-01",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4282-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4282-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4282-01\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4282-02",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4282-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4282-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4282-02\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4283-01",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4283-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4283-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4283-01\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4713-02",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4713-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4713-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4713-02\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4713-32",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4713-32",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4713-32/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4713-32\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4776-01",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4776-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4776-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4776-01\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4903-34",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4903-34",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4903-34/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4903-34\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lidocaine%20Hydrochloride%20Injection&st=d\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4904-34",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4904-34",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-4904-34/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-4904-34\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lidocaine%20Hydrochloride%20Injection&st=d\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-9137-05",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/22/2012",
      "update_date": "08/24/2026",
      "days_in_shortage": "5305",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-9137-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lidocaine-hydrochloride-injection-0409-9137-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/22/2012\", \"package_ndc\": \"0409-9137-05\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1985-30",
      "generic_name": "Lorazepam Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "05/03/2018",
      "update_date": "08/24/2026",
      "days_in_shortage": "3043",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Neurology",
      "id": "hospira-inc-a-pfizer-company-lorazepam-injection-0409-1985-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-lorazepam-injection-0409-1985-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/03/2018\", \"package_ndc\": \"0409-1985-30\", \"generic_name\": \"Lorazepam Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-1176-30",
      "generic_name": "Meperidine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "05/30/2025",
      "update_date": "08/24/2026",
      "days_in_shortage": "459",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-meperidine-hydrochloride-injection-0409-1176-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-meperidine-hydrochloride-injection-0409-1176-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/30/2025\", \"package_ndc\": \"0409-1176-30\", \"generic_name\": \"Meperidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-1178-30",
      "generic_name": "Meperidine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "05/30/2025",
      "update_date": "08/24/2026",
      "days_in_shortage": "459",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-meperidine-hydrochloride-injection-0409-1178-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-meperidine-hydrochloride-injection-0409-1178-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/30/2025\", \"package_ndc\": \"0409-1178-30\", \"generic_name\": \"Meperidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1179-30",
      "generic_name": "Meperidine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "05/30/2025",
      "update_date": "08/24/2026",
      "days_in_shortage": "459",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-meperidine-hydrochloride-injection-0409-1179-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-meperidine-hydrochloride-injection-0409-1179-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/30/2025\", \"package_ndc\": \"0409-1179-30\", \"generic_name\": \"Meperidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1180-69",
      "generic_name": "Meperidine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "05/30/2025",
      "update_date": "08/24/2026",
      "days_in_shortage": "459",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-meperidine-hydrochloride-injection-0409-1180-69",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-meperidine-hydrochloride-injection-0409-1180-69/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/30/2025\", \"package_ndc\": \"0409-1180-69\", \"generic_name\": \"Meperidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1181-30",
      "generic_name": "Meperidine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "05/30/2025",
      "update_date": "08/24/2026",
      "days_in_shortage": "459",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-meperidine-hydrochloride-injection-0409-1181-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-meperidine-hydrochloride-injection-0409-1181-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/30/2025\", \"package_ndc\": \"0409-1181-30\", \"generic_name\": \"Meperidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1362-01",
      "generic_name": "Meperidine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "05/30/2025",
      "update_date": "08/24/2026",
      "days_in_shortage": "459",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-meperidine-hydrochloride-injection-0409-1362-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-meperidine-hydrochloride-injection-0409-1362-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/30/2025\", \"package_ndc\": \"0409-1362-01\", \"generic_name\": \"Meperidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1418-01",
      "generic_name": "Meperidine Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "05/30/2025",
      "update_date": "08/24/2026",
      "days_in_shortage": "459",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-meperidine-hydrochloride-injection-0409-1418-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-meperidine-hydrochloride-injection-0409-1418-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/30/2025\", \"package_ndc\": \"0409-1418-01\", \"generic_name\": \"Meperidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61703-124-40",
      "generic_name": "Methotrexate Sodium Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/13/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1268",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "hospira-inc-a-pfizer-company-methotrexate-sodium-injection-61703-124-40",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-methotrexate-sodium-injection-61703-124-40/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"61703-124-40\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61703-350-10",
      "generic_name": "Methotrexate Sodium Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/13/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1268",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "hospira-inc-a-pfizer-company-methotrexate-sodium-injection-61703-350-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-methotrexate-sodium-injection-61703-350-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"61703-350-10\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61703-350-38",
      "generic_name": "Methotrexate Sodium Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/13/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1268",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "hospira-inc-a-pfizer-company-methotrexate-sodium-injection-61703-350-38",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-methotrexate-sodium-injection-61703-350-38/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"61703-350-38\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61703-408-25",
      "generic_name": "Methotrexate Sodium Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/13/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1268",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "hospira-inc-a-pfizer-company-methotrexate-sodium-injection-61703-408-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-methotrexate-sodium-injection-61703-408-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"61703-408-25\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "61703-408-41",
      "generic_name": "Methotrexate Sodium Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/13/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1268",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "hospira-inc-a-pfizer-company-methotrexate-sodium-injection-61703-408-41",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-methotrexate-sodium-injection-61703-408-41/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"61703-408-41\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-0001-25",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Next Delivery and Estimated Recovery: December 2026",
      "initial_posting_date": "04/02/2020",
      "update_date": "09/11/2026",
      "days_in_shortage": "2357",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-0001-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-0001-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0409-0001-25\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2305-05",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: October 2026; Estimated Recovery: December 2026",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2343",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-2305-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-2305-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0409-2305-05\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: October 2026; Estimated Recovery: December 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2305-17",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Next Delivery and Estimated Recovery: December 2026",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2343",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-2305-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-2305-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0409-2305-17\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-2308-01",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2026",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2343",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-2308-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-2308-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0409-2308-01\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2308-02",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: September 2026",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2343",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-2308-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-2308-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0409-2308-02\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: September 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2587-05",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2026",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2343",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-2587-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-2587-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0409-2587-05\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2596-03",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2343",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-2596-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-2596-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0409-2596-03\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "related_info",
          "value": "Next Delivery and Estimated Recovery: September 2026",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0409-2596-03\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: September 2026\"",
          "as_of": "2026-09-15"
        },
        {
          "field": "shortage_reason",
          "value": "Demand increase for the drug",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0409-2596-03\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: September 2026\"",
          "as_of": "2026-09-15"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-2596-05",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2343",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-2596-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-midazolam-hydrochloride-injection-0409-2596-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"0409-2596-05\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1134-05",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-1134-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-1134-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-1134-05\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1890-01",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-1890-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-1890-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-1890-01\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1890-23",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Next Delivery November 2026; Estimated Recovery in December 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/31/2026",
      "days_in_shortage": "3229",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-1890-23",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-1890-23/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-1890-23\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Next Delivery November 2026; Estimated Recovery in December 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-1891-01",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-1891-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-1891-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-1891-01\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1892-01",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-1892-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-1892-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-1892-01\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1893-01",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-1893-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-1893-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-1893-01\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1896-20",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-1896-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-1896-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-1896-20\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-2022-01",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/31/2017",
      "update_date": "09/11/2026",
      "days_in_shortage": "3241",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-2022-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-2022-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-2022-01\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3814-12",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-3814-12",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-3814-12/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-3814-12\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3815-12",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-3815-12",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-morphine-sulfate-injection-0409-3815-12/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"0409-3815-12\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-0801-01",
      "generic_name": "Pentostatin Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next delivery: Q2 2027; Estimated recovery: Q3 2027; Shortage per manufacturer: manufacturing delays",
      "initial_posting_date": "08/27/2026",
      "update_date": "08/27/2026",
      "days_in_shortage": "5",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "hospira-inc-a-pfizer-company-pentostatin-injection-0409-0801-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-pentostatin-injection-0409-0801-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Pentostatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"08/27/2026\", \"package_ndc\": \"0409-0801-01\", \"generic_name\": \"Pentostatin Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next delivery: Q2 2027; Estimated recovery: Q3 2027; Shortage per manufacturer: manufacturing delays\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1403-10",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-rocuronium-bromide-injection-0409-1403-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-rocuronium-bromide-injection-0409-1403-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"0409-1403-10\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3189-10",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-rocuronium-bromide-injection-0409-3189-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-rocuronium-bromide-injection-0409-3189-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"0409-3189-10\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-5160-10",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-rocuronium-bromide-injection-0409-5160-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-rocuronium-bromide-injection-0409-5160-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"0409-5160-10\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-7037-10",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hospira-inc-a-pfizer-company-rocuronium-bromide-injection-0409-7037-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-rocuronium-bromide-injection-0409-7037-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"0409-7037-10\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3299-05",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/03/2016",
      "update_date": "08/24/2026",
      "days_in_shortage": "3863",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-sodium-acetate-injection-0409-3299-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sodium-acetate-injection-0409-3299-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/03/2016\", \"package_ndc\": \"0409-3299-05\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3299-06",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Next Delivery and Estimated Recovery: September 2026. Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "02/03/2016",
      "update_date": "08/24/2026",
      "days_in_shortage": "3863",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-sodium-acetate-injection-0409-3299-06",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sodium-acetate-injection-0409-3299-06/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/03/2016\", \"package_ndc\": \"0409-3299-06\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Next Delivery and Estimated Recovery: September 2026. Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3299-25",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/03/2016",
      "update_date": "08/24/2026",
      "days_in_shortage": "3863",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-sodium-acetate-injection-0409-3299-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sodium-acetate-injection-0409-3299-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/03/2016\", \"package_ndc\": \"0409-3299-25\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3299-26",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/03/2016",
      "update_date": "08/24/2026",
      "days_in_shortage": "3863",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-sodium-acetate-injection-0409-3299-26",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sodium-acetate-injection-0409-3299-26/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/03/2016\", \"package_ndc\": \"0409-3299-26\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-7299-25",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/03/2016",
      "update_date": "08/24/2026",
      "days_in_shortage": "3863",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-sodium-acetate-injection-0409-7299-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sodium-acetate-injection-0409-7299-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/03/2016\", \"package_ndc\": \"0409-7299-25\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-7299-73",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/03/2016",
      "update_date": "08/24/2026",
      "days_in_shortage": "3863",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-sodium-acetate-injection-0409-7299-73",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sodium-acetate-injection-0409-7299-73/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/03/2016\", \"package_ndc\": \"0409-7299-73\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4900-14",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "03/01/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3471",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-4900-14",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-4900-14/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2017\", \"package_ndc\": \"0409-4900-14\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Sodium%20Bicarbonate%20Injection&st=d\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4916-14",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "03/01/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3471",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-4916-14",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-4916-14/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2017\", \"package_ndc\": \"0409-4916-14\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Sodium%20Bicarbonate%20Injection&st=d\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-5534-14",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "03/01/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3471",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-5534-14",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-5534-14/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2017\", \"package_ndc\": \"0409-5534-14\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Sodium%20Bicarbonate%20Injection&st=d\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-5555-01",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: April 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "03/01/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3471",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-5555-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-5555-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2017\", \"package_ndc\": \"0409-5555-01\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: April 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-5555-02",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "03/01/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3471",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-5555-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-5555-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2017\", \"package_ndc\": \"0409-5555-02\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-6625-14",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/01/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3471",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-6625-14",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-6625-14/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2017\", \"package_ndc\": \"0409-6625-14\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-6625-35",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "03/01/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3471",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-6625-35",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-6625-35/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2017\", \"package_ndc\": \"0409-6625-35\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-6637-14",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "03/01/2017",
      "update_date": "08/24/2026",
      "days_in_shortage": "3471",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-6637-14",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sodium-bicarbonate-injection-0409-6637-14/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2017\", \"package_ndc\": \"0409-6637-14\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Sodium%20Bicarbonate%20Injection&st=d\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3977-03",
      "generic_name": "Sterile Water Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "12/03/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1733",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Other",
      "id": "hospira-inc-a-pfizer-company-sterile-water-injection-0409-3977-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sterile-water-injection-0409-3977-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/03/2021\", \"package_ndc\": \"0409-3977-03\", \"generic_name\": \"Sterile Water Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0409-4887-10",
      "generic_name": "Sterile Water Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/23/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1743",
      "dosage_form": "Injection",
      "therapeutic_category": "Other",
      "id": "hospira-inc-a-pfizer-company-sterile-water-injection-0409-4887-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sterile-water-injection-0409-4887-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/23/2021\", \"package_ndc\": \"0409-4887-10\", \"generic_name\": \"Sterile Water Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4887-20",
      "generic_name": "Sterile Water Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/23/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1743",
      "dosage_form": "Injection",
      "therapeutic_category": "Other",
      "id": "hospira-inc-a-pfizer-company-sterile-water-injection-0409-4887-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sterile-water-injection-0409-4887-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/23/2021\", \"package_ndc\": \"0409-4887-20\", \"generic_name\": \"Sterile Water Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4887-50",
      "generic_name": "Sterile Water Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/23/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1743",
      "dosage_form": "Injection",
      "therapeutic_category": "Other",
      "id": "hospira-inc-a-pfizer-company-sterile-water-injection-0409-4887-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sterile-water-injection-0409-4887-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/23/2021\", \"package_ndc\": \"0409-4887-50\", \"generic_name\": \"Sterile Water Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4887-99",
      "generic_name": "Sterile Water Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/23/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1743",
      "dosage_form": "Injection",
      "therapeutic_category": "Other",
      "id": "hospira-inc-a-pfizer-company-sterile-water-injection-0409-4887-99",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sterile-water-injection-0409-4887-99/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/23/2021\", \"package_ndc\": \"0409-4887-99\", \"generic_name\": \"Sterile Water Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3382-21",
      "generic_name": "Sufentanil Citrate Injection",
      "manufacturer_name": "Hospira, Inc., a Pfizer Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "05/03/2022",
      "update_date": "08/24/2026",
      "days_in_shortage": "1582",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "hospira-inc-a-pfizer-company-sufentanil-citrate-injection-0409-3382-21",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hospira-inc-a-pfizer-company-sufentanil-citrate-injection-0409-3382-21/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sufentanil%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/03/2022\", \"package_ndc\": \"0409-3382-21\", \"generic_name\": \"Sufentanil Citrate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "44567-600-04",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "HQ Specialty Pharma",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by WG Critical Care",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hq-specialty-pharma-dexmedetomidine-hydrochloride-injection-44567-600-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hq-specialty-pharma-dexmedetomidine-hydrochloride-injection-44567-600-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22HQ%20Specialty%20Pharma%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"44567-600-04\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"WG Critical Care 888-493-0861\", \"availability\": \"Available\", \"related_info\": \"Marketed by WG Critical Care\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "44567-601-04",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "HQ Specialty Pharma",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by WG Critical Care",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hq-specialty-pharma-dexmedetomidine-hydrochloride-injection-44567-601-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hq-specialty-pharma-dexmedetomidine-hydrochloride-injection-44567-601-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22HQ%20Specialty%20Pharma%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"44567-601-04\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"WG Critical Care 888-493-0861\", \"availability\": \"Available\", \"related_info\": \"Marketed by WG Critical Care\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "44567-602-24",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "HQ Specialty Pharma",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by WG Critical Care",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hq-specialty-pharma-dexmedetomidine-hydrochloride-injection-44567-602-24",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hq-specialty-pharma-dexmedetomidine-hydrochloride-injection-44567-602-24/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22HQ%20Specialty%20Pharma%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"44567-602-24\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"WG Critical Care 888-493-0861\", \"availability\": \"Available\", \"related_info\": \"Marketed by WG Critical Care\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "44567-603-24",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "HQ Specialty Pharma",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by WG Critical Care",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "hq-specialty-pharma-dexmedetomidine-hydrochloride-injection-44567-603-24",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/hq-specialty-pharma-dexmedetomidine-hydrochloride-injection-44567-603-24/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22HQ%20Specialty%20Pharma%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"44567-603-24\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"WG Critical Care 888-493-0861\", \"availability\": \"Available\", \"related_info\": \"Marketed by WG Critical Care\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "73293-0002-2",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Huons Co., Ltd",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/20/2018",
      "update_date": "07/30/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "huons-co-ltd-bupivacaine-hydrochloride-injection-73293-0002-2",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/huons-co-ltd-bupivacaine-hydrochloride-injection-73293-0002-2/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Huons%20Co.,%20Ltd%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"73293-0002-2\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"+82-2-854-4700 or via email intbiz@huons.com\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "73293-0001-2",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Huons Co., Ltd. (South Korea)",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2018",
      "update_date": "07/30/2026",
      "days_in_shortage": "2971",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "huons-co-ltd-south-korea-lidocaine-hydrochloride-injection-73293-0001-2",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/huons-co-ltd-south-korea-lidocaine-hydrochloride-injection-73293-0001-2/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Huons%20Co.,%20Ltd.%20(South%20Korea)%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2018\", \"package_ndc\": \"73293-0001-2\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"intbiz@huons.com\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-0152-24",
      "generic_name": "Metronidazole Injection",
      "manufacturer_name": "InfoRLife SA",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Labeler: Hospira Inc.",
      "initial_posting_date": "01/13/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1692",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "inforlife-sa-metronidazole-injection-0409-0152-24",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/inforlife-sa-metronidazole-injection-0409-0152-24/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/13/2022\", \"package_ndc\": \"0409-0152-24\", \"generic_name\": \"Metronidazole Injection\", \"contact_info\": \"Sagent: 866-625-1618\", \"availability\": \"Limited Availability\", \"related_info\": \"Labeler: Hospira Inc.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-131-82",
      "generic_name": "Metronidazole Injection",
      "manufacturer_name": "InfoRLife SA",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: August 2026; Marketed by Sagent Pharmaceuticals",
      "initial_posting_date": "01/13/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1692",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "inforlife-sa-metronidazole-injection-25021-131-82",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/inforlife-sa-metronidazole-injection-25021-131-82/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/13/2022\", \"package_ndc\": \"25021-131-82\", \"generic_name\": \"Metronidazole Injection\", \"contact_info\": \"Sagent: 866-625-1618\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: August 2026; Marketed by Sagent Pharmaceuticals\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-652-82",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "InfoRLife SA",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Sagent Pharmaceuticals",
      "initial_posting_date": "03/27/2018",
      "update_date": "08/18/2026",
      "days_in_shortage": "3080",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "inforlife-sa-ropivacaine-hydrochloride-injection-25021-652-82",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/inforlife-sa-ropivacaine-hydrochloride-injection-25021-652-82/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/27/2018\", \"package_ndc\": \"25021-652-82\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"Sagent: 866-625-1618\", \"availability\": \"Available\", \"related_info\": \"Marketed by Sagent Pharmaceuticals\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-652-87",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "InfoRLife SA",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Sagent Pharmaceuticals",
      "initial_posting_date": "03/27/2018",
      "update_date": "08/18/2026",
      "days_in_shortage": "3080",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "inforlife-sa-ropivacaine-hydrochloride-injection-25021-652-87",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/inforlife-sa-ropivacaine-hydrochloride-injection-25021-652-87/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/27/2018\", \"package_ndc\": \"25021-652-87\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"Sagent: 866-625-1618\", \"availability\": \"Available\", \"related_info\": \"Marketed by Sagent Pharmaceuticals\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-671-66",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "InfoRLife SA",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals",
      "initial_posting_date": "03/27/2018",
      "update_date": "08/18/2026",
      "days_in_shortage": "3080",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "inforlife-sa-ropivacaine-hydrochloride-injection-25021-671-66",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/inforlife-sa-ropivacaine-hydrochloride-injection-25021-671-66/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/27/2018\", \"package_ndc\": \"25021-671-66\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"Sagent: 866-625-1618\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-671-67",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "InfoRLife SA",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals",
      "initial_posting_date": "03/27/2018",
      "update_date": "08/18/2026",
      "days_in_shortage": "3080",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "inforlife-sa-ropivacaine-hydrochloride-injection-25021-671-67",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/inforlife-sa-ropivacaine-hydrochloride-injection-25021-671-67/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/27/2018\", \"package_ndc\": \"25021-671-67\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"Sagent: 866-625-1618\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-671-82",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "InfoRLife SA",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Sagent Pharmaceuticals",
      "initial_posting_date": "03/27/2018",
      "update_date": "08/18/2026",
      "days_in_shortage": "3080",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "inforlife-sa-ropivacaine-hydrochloride-injection-25021-671-82",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/inforlife-sa-ropivacaine-hydrochloride-injection-25021-671-82/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/27/2018\", \"package_ndc\": \"25021-671-82\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"Sagent: 866-625-1618\", \"availability\": \"Available\", \"related_info\": \"Marketed by Sagent Pharmaceuticals\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-671-87",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "InfoRLife SA",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Sagent Pharmaceuticals",
      "initial_posting_date": "03/27/2018",
      "update_date": "08/18/2026",
      "days_in_shortage": "3080",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "inforlife-sa-ropivacaine-hydrochloride-injection-25021-671-87",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/inforlife-sa-ropivacaine-hydrochloride-injection-25021-671-87/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/27/2018\", \"package_ndc\": \"25021-671-87\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"Sagent: 866-625-1618\", \"availability\": \"Available\", \"related_info\": \"Marketed by Sagent Pharmaceuticals\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "50458-585-01",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Janssen Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/19/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "janssen-pharmaceuticals-methylphenidate-hydrochloride-tablet-extended-release-50458-585-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/janssen-pharmaceuticals-methylphenidate-hydrochloride-tablet-extended-release-50458-585-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Janssen%20Pharmaceuticals%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"50458-585-01\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "50458-586-01",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Janssen Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/19/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "janssen-pharmaceuticals-methylphenidate-hydrochloride-tablet-extended-release-50458-586-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/janssen-pharmaceuticals-methylphenidate-hydrochloride-tablet-extended-release-50458-586-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Janssen%20Pharmaceuticals%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"50458-586-01\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "50458-587-01",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Janssen Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/19/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "janssen-pharmaceuticals-methylphenidate-hydrochloride-tablet-extended-release-50458-587-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/janssen-pharmaceuticals-methylphenidate-hydrochloride-tablet-extended-release-50458-587-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Janssen%20Pharmaceuticals%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"50458-587-01\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "50458-588-01",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Janssen Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/19/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "janssen-pharmaceuticals-methylphenidate-hydrochloride-tablet-extended-release-50458-588-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/janssen-pharmaceuticals-methylphenidate-hydrochloride-tablet-extended-release-50458-588-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Janssen%20Pharmaceuticals%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"50458-588-01\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0781-3493-95",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Sandoz Inc.; Customer service: 800-525-8747",
      "initial_posting_date": "04/10/2020",
      "update_date": "07/30/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "jiangsu-hengrui-pharmaceuticals-co-ltd-dexmedetomidine-hydrochloride-injection-0781-3493-95",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/jiangsu-hengrui-pharmaceuticals-co-ltd-dexmedetomidine-hydrochloride-injection-0781-3493-95/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Jiangsu%20Hengrui%20Pharmaceuticals%20Co.,%20Ltd.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0781-3493-95\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"See Related Information section below for customer service information\", \"availability\": \"Available\", \"related_info\": \"Marketed by Sandoz Inc.; Customer service: 800-525-8747\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0781-3494-95",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Sandoz Inc.; Customer service: 800-525-8747",
      "initial_posting_date": "04/10/2020",
      "update_date": "07/30/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "jiangsu-hengrui-pharmaceuticals-co-ltd-dexmedetomidine-hydrochloride-injection-0781-3494-95",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/jiangsu-hengrui-pharmaceuticals-co-ltd-dexmedetomidine-hydrochloride-injection-0781-3494-95/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Jiangsu%20Hengrui%20Pharmaceuticals%20Co.,%20Ltd.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0781-3494-95\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"See Related Information section below for customer service information\", \"availability\": \"Available\", \"related_info\": \"Marketed by Sandoz Inc.; Customer service: 800-525-8747\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0781-3495-95",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Sandoz Inc.; Customer service: 800-525-8747",
      "initial_posting_date": "04/10/2020",
      "update_date": "07/30/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "jiangsu-hengrui-pharmaceuticals-co-ltd-dexmedetomidine-hydrochloride-injection-0781-3495-95",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/jiangsu-hengrui-pharmaceuticals-co-ltd-dexmedetomidine-hydrochloride-injection-0781-3495-95/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Jiangsu%20Hengrui%20Pharmaceuticals%20Co.,%20Ltd.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0781-3495-95\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"See Related Information section below for customer service information\", \"availability\": \"Available\", \"related_info\": \"Marketed by Sandoz Inc.; Customer service: 800-525-8747\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "83634-600-02",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Avenacy; Contact information: 877-283-6229",
      "initial_posting_date": "04/10/2020",
      "update_date": "07/30/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "jiangsu-hengrui-pharmaceuticals-co-us-agent-evenus-pharmaceutical-laboratories-i-dexmedetomidine-hydrochloride-injection-83634-600-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/jiangsu-hengrui-pharmaceuticals-co-us-agent-evenus-pharmaceutical-laboratories-i-dexmedetomidine-hydrochloride-injection-83634-600-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Jiangsu%20Hengrui%20Pharmaceuticals%20Co.%20(US%20Agent%20eVenus%20Pharmaceutical%20Laboratories,%20Inc.)%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"83634-600-02\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"See Related Information section below for customer service information\", \"availability\": \"Available\", \"related_info\": \"Distributed by Avenacy; Contact information: 877-283-6229\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71288-722-32",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Kindos Pharmaceuticals Co. Ltd.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Meitheal Pharmaceuticals is distributor/labeler",
      "initial_posting_date": "02/20/2018",
      "update_date": "05/05/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "kindos-pharmaceuticals-co-ltd-bupivacaine-hydrochloride-injection-71288-722-32",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/kindos-pharmaceuticals-co-ltd-bupivacaine-hydrochloride-injection-71288-722-32/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Kindos%20Pharmaceuticals%20Co.%20Ltd.%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"71288-722-32\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Bupivacaine%20Hydrochloride%20Injection&st=d\", \"contact_info\": \"844-824-8426\", \"availability\": \"Limited Availability\", \"related_info\": \"Meitheal Pharmaceuticals is distributor/labeler\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71288-723-52",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Kindos Pharmaceuticals Co. Ltd.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Meitheal Pharmaceuticals is distributor/labeler",
      "initial_posting_date": "02/20/2018",
      "update_date": "05/05/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "kindos-pharmaceuticals-co-ltd-bupivacaine-hydrochloride-injection-71288-723-52",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/kindos-pharmaceuticals-co-ltd-bupivacaine-hydrochloride-injection-71288-723-52/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Kindos%20Pharmaceuticals%20Co.%20Ltd.%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"71288-723-52\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Bupivacaine%20Hydrochloride%20Injection&st=d\", \"contact_info\": \"844-824-8426\", \"availability\": \"Limited Availability\", \"related_info\": \"Meitheal Pharmaceuticals is distributor/labeler\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71288-725-32",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Kindos Pharmaceuticals Co. Ltd.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Meitheal Pharmaceuticals is distributor/labeler",
      "initial_posting_date": "02/20/2018",
      "update_date": "05/05/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "kindos-pharmaceuticals-co-ltd-bupivacaine-hydrochloride-injection-71288-725-32",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/kindos-pharmaceuticals-co-ltd-bupivacaine-hydrochloride-injection-71288-725-32/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Kindos%20Pharmaceuticals%20Co.%20Ltd.%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"71288-725-32\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Bupivacaine%20Hydrochloride%20Injection&st=d\", \"contact_info\": \"844-824-8426\", \"availability\": \"Limited Availability\", \"related_info\": \"Meitheal Pharmaceuticals is distributor/labeler\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71288-726-52",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Kindos Pharmaceuticals Co. Ltd.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Meitheal Pharmaceuticals is distributor/labeler",
      "initial_posting_date": "02/20/2018",
      "update_date": "05/05/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "kindos-pharmaceuticals-co-ltd-bupivacaine-hydrochloride-injection-71288-726-52",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/kindos-pharmaceuticals-co-ltd-bupivacaine-hydrochloride-injection-71288-726-52/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Kindos%20Pharmaceuticals%20Co.%20Ltd.%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"71288-726-52\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Bupivacaine%20Hydrochloride%20Injection&st=d\", \"contact_info\": \"844-824-8426\", \"availability\": \"Limited Availability\", \"related_info\": \"Meitheal Pharmaceuticals is distributor/labeler\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71288-728-32",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Kindos Pharmaceuticals Co. Ltd.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Meitheal Pharmaceuticals is distributor/labeler",
      "initial_posting_date": "02/20/2018",
      "update_date": "05/05/2026",
      "days_in_shortage": "3115",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "kindos-pharmaceuticals-co-ltd-bupivacaine-hydrochloride-injection-71288-728-32",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/kindos-pharmaceuticals-co-ltd-bupivacaine-hydrochloride-injection-71288-728-32/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Kindos%20Pharmaceuticals%20Co.%20Ltd.%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"71288-728-32\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Bupivacaine%20Hydrochloride%20Injection&st=d\", \"contact_info\": \"844-824-8426\", \"availability\": \"Limited Availability\", \"related_info\": \"Meitheal Pharmaceuticals is distributor/labeler\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "84383-110-01",
      "generic_name": "Penicillin G Benzathine Injection",
      "manufacturer_name": "Laboratorios Atral",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1224",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "laboratorios-atral-penicillin-g-benzathine-injection-84383-110-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/laboratorios-atral-penicillin-g-benzathine-injection-84383-110-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Laboratorios%20Atral%22+AND+generic_name%3A%22Penicillin%20G%20Benzathine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/26/2023\", \"package_ndc\": \"84383-110-01\", \"generic_name\": \"Penicillin G Benzathine Injection\", \"related_info_link\": \"https://www.fda.gov/media/193578/download\", \"contact_info\": \"Mark Cuban Cost Plus Drug Company: 682-428-8081\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0527-0760-37",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0527-0760-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0527-0760-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0527-0760-37\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0527-0761-37",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0527-0761-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0527-0761-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0527-0761-37\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0527-0763-37",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0527-0763-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0527-0763-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0527-0763-37\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0527-0764-37",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0527-0764-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0527-0764-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0527-0764-37\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0527-0766-37",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0527-0766-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0527-0766-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0527-0766-37\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0527-1502-37",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0527-1502-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0527-1502-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0527-1502-37\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"company_name\": \"Lannett Company, Inc.\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0527-1505-37",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0527-1505-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0527-1505-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0527-1505-37\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"company_name\": \"Lannett Company, Inc.\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0527-4661-37",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-lisdexamfetamine-dimesylate-capsule-0527-4661-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-lisdexamfetamine-dimesylate-capsule-0527-4661-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0527-4661-37\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0527-4662-37",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-lisdexamfetamine-dimesylate-capsule-0527-4662-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-lisdexamfetamine-dimesylate-capsule-0527-4662-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0527-4662-37\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0527-4663-37",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-lisdexamfetamine-dimesylate-capsule-0527-4663-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-lisdexamfetamine-dimesylate-capsule-0527-4663-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0527-4663-37\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0527-4664-37",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-lisdexamfetamine-dimesylate-capsule-0527-4664-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-lisdexamfetamine-dimesylate-capsule-0527-4664-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0527-4664-37\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0527-4665-37",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-lisdexamfetamine-dimesylate-capsule-0527-4665-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-lisdexamfetamine-dimesylate-capsule-0527-4665-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0527-4665-37\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0527-4666-37",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "09/20/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1077",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-lisdexamfetamine-dimesylate-capsule-0527-4666-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-lisdexamfetamine-dimesylate-capsule-0527-4666-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"09/20/2023\", \"package_ndc\": \"0527-4666-37\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0527-4667-37",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-lisdexamfetamine-dimesylate-capsule-0527-4667-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-lisdexamfetamine-dimesylate-capsule-0527-4667-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0527-4667-37\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62175-310-37",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-methylphenidate-hydrochloride-tablet-extended-release-62175-310-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-methylphenidate-hydrochloride-tablet-extended-release-62175-310-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"62175-310-37\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62175-311-37",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-methylphenidate-hydrochloride-tablet-extended-release-62175-311-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-methylphenidate-hydrochloride-tablet-extended-release-62175-311-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"62175-311-37\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62175-312-37",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-methylphenidate-hydrochloride-tablet-extended-release-62175-312-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-methylphenidate-hydrochloride-tablet-extended-release-62175-312-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"62175-312-37\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62175-313-37",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Lannett Company, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "lannett-company-inc-methylphenidate-hydrochloride-tablet-extended-release-62175-313-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lannett-company-inc-methylphenidate-hydrochloride-tablet-extended-release-62175-313-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"62175-313-37\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"844-834-0530\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72336-032-01",
      "generic_name": "Isocarboxazid Tablet",
      "manufacturer_name": "Lifsa Drugs LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "04/16/2026",
      "update_date": "08/06/2026",
      "days_in_shortage": "138",
      "shortage_reason": "Other",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "lifsa-drugs-llc-isocarboxazid-tablet-72336-032-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lifsa-drugs-llc-isocarboxazid-tablet-72336-032-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lifsa%20Drugs%20LLC%22+AND+generic_name%3A%22Isocarboxazid%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/16/2026\", \"package_ndc\": \"72336-032-01\", \"generic_name\": \"Isocarboxazid Tablet\", \"contact_info\": \"833.627.0070\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "81298-7620-3",
      "generic_name": "Sodium Bicarbonate Injection",
      "manufacturer_name": "Long Grove Pharmaceuticals LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/01/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3471",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "long-grove-pharmaceuticals-llc-sodium-bicarbonate-injection-81298-7620-3",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/long-grove-pharmaceuticals-llc-sodium-bicarbonate-injection-81298-7620-3/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Long%20Grove%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2017\", \"package_ndc\": \"81298-7620-3\", \"generic_name\": \"Sodium Bicarbonate Injection\", \"contact_info\": \"833-268-5559\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68180-554-09",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Lupin Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "lupin-pharmaceuticals-inc-quinapril-hydrochloride-tablet-68180-554-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lupin-pharmaceuticals-inc-quinapril-hydrochloride-tablet-68180-554-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"68180-554-09\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"866-587-4617\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68180-556-09",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Lupin Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "lupin-pharmaceuticals-inc-quinapril-hydrochloride-tablet-68180-556-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lupin-pharmaceuticals-inc-quinapril-hydrochloride-tablet-68180-556-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"68180-556-09\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"866-587-4617\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68180-557-09",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Lupin Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "lupin-pharmaceuticals-inc-quinapril-hydrochloride-tablet-68180-557-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lupin-pharmaceuticals-inc-quinapril-hydrochloride-tablet-68180-557-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"68180-557-09\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"Lupin Pharmaceuticals, Inc.\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68180-558-09",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Lupin Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Requirements related to complying with good manufacturing practices",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "lupin-pharmaceuticals-inc-quinapril-hydrochloride-tablet-68180-558-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lupin-pharmaceuticals-inc-quinapril-hydrochloride-tablet-68180-558-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"68180-558-09\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"866-587-4617\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68180-658-06",
      "generic_name": "Rifampin Capsule",
      "manufacturer_name": "Lupin Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/22/2021",
      "update_date": "08/18/2026",
      "days_in_shortage": "1714",
      "dosage_form": "Capsule",
      "therapeutic_category": "Anti-Infective",
      "id": "lupin-pharmaceuticals-inc-rifampin-capsule-68180-658-06",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lupin-pharmaceuticals-inc-rifampin-capsule-68180-658-06/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2021\", \"package_ndc\": \"68180-658-06\", \"generic_name\": \"Rifampin Capsule\", \"contact_info\": \"866-587-4617\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68180-659-06",
      "generic_name": "Rifampin Capsule",
      "manufacturer_name": "Lupin Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/22/2021",
      "update_date": "08/18/2026",
      "days_in_shortage": "1714",
      "dosage_form": "Capsule",
      "therapeutic_category": "Anti-Infective",
      "id": "lupin-pharmaceuticals-inc-rifampin-capsule-68180-659-06",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lupin-pharmaceuticals-inc-rifampin-capsule-68180-659-06/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2021\", \"package_ndc\": \"68180-659-06\", \"generic_name\": \"Rifampin Capsule\", \"contact_info\": \"866-587-4617\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68180-659-07",
      "generic_name": "Rifampin Capsule",
      "manufacturer_name": "Lupin Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/22/2021",
      "update_date": "08/18/2026",
      "days_in_shortage": "1714",
      "dosage_form": "Capsule",
      "therapeutic_category": "Anti-Infective",
      "id": "lupin-pharmaceuticals-inc-rifampin-capsule-68180-659-07",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/lupin-pharmaceuticals-inc-rifampin-capsule-68180-659-07/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2021\", \"package_ndc\": \"68180-659-07\", \"generic_name\": \"Rifampin Capsule\", \"contact_info\": \"866-587-4617\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64253-400-91",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Medefil, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/01/2012",
      "update_date": "08/17/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "medefil-inc-atropine-sulfate-injection-64253-400-91",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/medefil-inc-atropine-sulfate-injection-64253-400-91/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medefil,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"64253-400-91\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"630-682-4600\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "64253-020-30",
      "generic_name": "Sterile Water Injection",
      "manufacturer_name": "Medefil, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/23/2021",
      "update_date": "08/17/2026",
      "days_in_shortage": "1743",
      "dosage_form": "Injection",
      "therapeutic_category": "Other",
      "id": "medefil-inc-sterile-water-injection-64253-020-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/medefil-inc-sterile-water-injection-64253-020-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medefil,%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/23/2021\", \"package_ndc\": \"64253-020-30\", \"generic_name\": \"Sterile Water Injection\", \"contact_info\": \"630-682-4600\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59137-570-01",
      "generic_name": "Triamcinolone Hexacetonide Injection",
      "manufacturer_name": "Medexus",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "05/04/2021",
      "update_date": "05/27/2026",
      "days_in_shortage": "1946",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "medexus-triamcinolone-hexacetonide-injection-59137-570-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/medexus-triamcinolone-hexacetonide-injection-59137-570-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medexus%22+AND+generic_name%3A%22Triamcinolone%20Hexacetonide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"05/04/2021\", \"package_ndc\": \"59137-570-01\", \"generic_name\": \"Triamcinolone Hexacetonide Injection\", \"related_info_link\": \"https://www.fda.gov/media/192735/download?attachment\", \"contact_info\": \"1-855-336-3322 Option 9\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "71288-115-30",
      "generic_name": "Azacitidine Injection",
      "manufacturer_name": "Meitheal Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/18/2020",
      "update_date": "08/27/2026",
      "days_in_shortage": "2083",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "meitheal-pharmaceuticals-inc-azacitidine-injection-71288-115-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/meitheal-pharmaceuticals-inc-azacitidine-injection-71288-115-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/18/2020\", \"package_ndc\": \"71288-115-30\", \"generic_name\": \"Azacitidine Injection\", \"contact_info\": \"844-824-8426\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71288-505-03",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Meitheal Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2021",
      "update_date": "08/27/2026",
      "days_in_shortage": "1970",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "meitheal-pharmaceuticals-inc-dexmedetomidine-hydrochloride-injection-71288-505-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/meitheal-pharmaceuticals-inc-dexmedetomidine-hydrochloride-injection-71288-505-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2021\", \"package_ndc\": \"71288-505-03\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-824-8426\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71288-203-05",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Meitheal Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/27/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "meitheal-pharmaceuticals-inc-furosemide-injection-71288-203-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/meitheal-pharmaceuticals-inc-furosemide-injection-71288-203-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"71288-203-05\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"844-824-8426\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71288-203-11",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Meitheal Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/27/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "meitheal-pharmaceuticals-inc-furosemide-injection-71288-203-11",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/meitheal-pharmaceuticals-inc-furosemide-injection-71288-203-11/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"71288-203-11\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"844-824-8426\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71288-205-03",
      "generic_name": "Furosemide Injection",
      "manufacturer_name": "Meitheal Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Check wholesalers for inventory",
      "initial_posting_date": "04/07/2020",
      "update_date": "08/27/2026",
      "days_in_shortage": "2338",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "meitheal-pharmaceuticals-inc-furosemide-injection-71288-205-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/meitheal-pharmaceuticals-inc-furosemide-injection-71288-205-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/07/2020\", \"package_ndc\": \"71288-205-03\", \"generic_name\": \"Furosemide Injection\", \"contact_info\": \"844-824-8426\", \"availability\": \"Available\", \"related_info\": \"Check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71288-563-84",
      "generic_name": "Liraglutide Injection",
      "manufacturer_name": "Meitheal Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/18/2023",
      "update_date": "08/27/2026",
      "days_in_shortage": "1141",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "meitheal-pharmaceuticals-inc-liraglutide-injection-71288-563-84",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/meitheal-pharmaceuticals-inc-liraglutide-injection-71288-563-84/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/18/2023\", \"package_ndc\": \"71288-563-84\", \"generic_name\": \"Liraglutide Injection\", \"contact_info\": \"844-824-8426\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71288-563-85",
      "generic_name": "Liraglutide Injection",
      "manufacturer_name": "Meitheal Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/18/2023",
      "update_date": "08/27/2026",
      "days_in_shortage": "1141",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "meitheal-pharmaceuticals-inc-liraglutide-injection-71288-563-85",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/meitheal-pharmaceuticals-inc-liraglutide-injection-71288-563-85/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/18/2023\", \"package_ndc\": \"71288-563-85\", \"generic_name\": \"Liraglutide Injection\", \"contact_info\": \"844-824-8426\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71288-700-06",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Meitheal Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/27/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "meitheal-pharmaceuticals-inc-rocuronium-bromide-injection-71288-700-06",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/meitheal-pharmaceuticals-inc-rocuronium-bromide-injection-71288-700-06/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"71288-700-06\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"844-824-8426\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71288-718-11",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Meitheal Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/27/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "meitheal-pharmaceuticals-inc-rocuronium-bromide-injection-71288-718-11",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/meitheal-pharmaceuticals-inc-rocuronium-bromide-injection-71288-718-11/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"71288-718-11\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"844-824-8426\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42571-132-52",
      "generic_name": "Cromolyn Sodium Concentrate",
      "manufacturer_name": "Micro Labs LTD",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/03/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1033",
      "dosage_form": "Concentrate",
      "therapeutic_category": "Pulmonary/Allergy",
      "id": "micro-labs-ltd-cromolyn-sodium-concentrate-42571-132-52",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/micro-labs-ltd-cromolyn-sodium-concentrate-42571-132-52/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Micro%20Labs%20LTD%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/03/2023\", \"package_ndc\": \"42571-132-52\", \"generic_name\": \"Cromolyn Sodium Concentrate\", \"contact_info\": \"(908) 484-7410\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71357-002-10",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Milla Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/03/2016",
      "update_date": "08/15/2026",
      "days_in_shortage": "3863",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "milla-pharmaceuticals-sodium-acetate-injection-71357-002-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/milla-pharmaceuticals-sodium-acetate-injection-71357-002-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Milla%20Pharmaceuticals%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/03/2016\", \"package_ndc\": \"71357-002-10\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"833-251-8463\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71357-007-10",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Milla Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2016",
      "update_date": "08/15/2026",
      "days_in_shortage": "3814",
      "dosage_form": "Injection",
      "therapeutic_category": "Total Parenteral Nutrition",
      "id": "milla-pharmaceuticals-sodium-acetate-injection-71357-007-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/milla-pharmaceuticals-sodium-acetate-injection-71357-007-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Milla%20Pharmaceuticals%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2016\", \"package_ndc\": \"71357-007-10\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"833-251-8463\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71357-008-10",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Milla Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2016",
      "update_date": "08/15/2026",
      "days_in_shortage": "3814",
      "dosage_form": "Injection",
      "therapeutic_category": "Total Parenteral Nutrition",
      "id": "milla-pharmaceuticals-sodium-acetate-injection-71357-008-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/milla-pharmaceuticals-sodium-acetate-injection-71357-008-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Milla%20Pharmaceuticals%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2016\", \"package_ndc\": \"71357-008-10\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"833-251-8463\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "71357-009-10",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Milla Pharmaceuticals",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "02/03/2016",
      "update_date": "08/15/2026",
      "days_in_shortage": "3863",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "milla-pharmaceuticals-sodium-acetate-injection-71357-009-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/milla-pharmaceuticals-sodium-acetate-injection-71357-009-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Milla%20Pharmaceuticals%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/03/2016\", \"package_ndc\": \"71357-009-10\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"833-251-8463\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72205-101-01",
      "generic_name": "Bumetanide Injection",
      "manufacturer_name": "MSN Laboratories Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by: Novadoz Pharmaceuticals LLC",
      "initial_posting_date": "12/13/2017",
      "update_date": "08/21/2026",
      "days_in_shortage": "3184",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "msn-laboratories-private-limited-bumetanide-injection-72205-101-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/msn-laboratories-private-limited-bumetanide-injection-72205-101-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22MSN%20Laboratories%20Private%20Limited%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/13/2017\", \"package_ndc\": \"72205-101-01\", \"generic_name\": \"Bumetanide Injection\", \"contact_info\": \"855-668-2369; customerservice@novadozpharma.com\", \"availability\": \"Available\", \"related_info\": \"Distributed by: Novadoz Pharmaceuticals LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "72205-101-07",
      "generic_name": "Bumetanide Injection",
      "manufacturer_name": "MSN Laboratories Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by: Novadoz Pharmaceuticals LLC",
      "initial_posting_date": "12/13/2017",
      "update_date": "08/21/2026",
      "days_in_shortage": "3184",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "msn-laboratories-private-limited-bumetanide-injection-72205-101-07",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/msn-laboratories-private-limited-bumetanide-injection-72205-101-07/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22MSN%20Laboratories%20Private%20Limited%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/13/2017\", \"package_ndc\": \"72205-101-07\", \"generic_name\": \"Bumetanide Injection\", \"contact_info\": \"855-668-2369; customerservice@novadozpharma.com\", \"availability\": \"Available\", \"related_info\": \"Distributed by: Novadoz Pharmaceuticals LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "72205-102-01",
      "generic_name": "Bumetanide Injection",
      "manufacturer_name": "MSN Laboratories Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by: Novadoz Pharmaceuticals LLC",
      "initial_posting_date": "12/13/2017",
      "update_date": "08/21/2026",
      "days_in_shortage": "3184",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "msn-laboratories-private-limited-bumetanide-injection-72205-102-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/msn-laboratories-private-limited-bumetanide-injection-72205-102-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22MSN%20Laboratories%20Private%20Limited%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/13/2017\", \"package_ndc\": \"72205-102-01\", \"generic_name\": \"Bumetanide Injection\", \"contact_info\": \"855-668-2369; customerservice@novadozpharma.com\", \"availability\": \"Available\", \"related_info\": \"Distributed by: Novadoz Pharmaceuticals LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "72205-102-07",
      "generic_name": "Bumetanide Injection",
      "manufacturer_name": "MSN Laboratories Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by: Novadoz Pharmaceuticals LLC",
      "initial_posting_date": "12/13/2017",
      "update_date": "08/21/2026",
      "days_in_shortage": "3184",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "msn-laboratories-private-limited-bumetanide-injection-72205-102-07",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/msn-laboratories-private-limited-bumetanide-injection-72205-102-07/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22MSN%20Laboratories%20Private%20Limited%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/13/2017\", \"package_ndc\": \"72205-102-07\", \"generic_name\": \"Bumetanide Injection\", \"contact_info\": \"855-668-2369; customerservice@novadozpharma.com\", \"availability\": \"Available\", \"related_info\": \"Distributed by: Novadoz Pharmaceuticals LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "83301-0080-2",
      "generic_name": "Bumetanide Injection",
      "manufacturer_name": "Mullan Pharmaceutical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/13/2017",
      "update_date": "08/11/2026",
      "days_in_shortage": "3184",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "mullan-pharmaceutical-inc-bumetanide-injection-83301-0080-2",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mullan-pharmaceutical-inc-bumetanide-injection-83301-0080-2/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mullan%20Pharmaceutical%20Inc.%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/13/2017\", \"package_ndc\": \"83301-0080-2\", \"generic_name\": \"Bumetanide Injection\", \"contact_info\": \"800-673-9839\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "83301-0081-2",
      "generic_name": "Bumetanide Injection",
      "manufacturer_name": "Mullan Pharmaceutical Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/13/2017",
      "update_date": "08/11/2026",
      "days_in_shortage": "3184",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "mullan-pharmaceutical-inc-bumetanide-injection-83301-0081-2",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mullan-pharmaceutical-inc-bumetanide-injection-83301-0081-2/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mullan%20Pharmaceutical%20Inc.%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/13/2017\", \"package_ndc\": \"83301-0081-2\", \"generic_name\": \"Bumetanide Injection\", \"contact_info\": \"800-673-9839\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "67457-420-10",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/20/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "mylan-institutional-a-viatris-company-dexamethasone-sodium-phosphate-injection-67457-420-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-dexamethasone-sodium-phosphate-injection-67457-420-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"67457-420-10\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "67457-421-30",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/20/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "mylan-institutional-a-viatris-company-dexamethasone-sodium-phosphate-injection-67457-421-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-dexamethasone-sodium-phosphate-injection-67457-421-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"67457-421-30\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "67457-422-54",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/20/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "mylan-institutional-a-viatris-company-dexamethasone-sodium-phosphate-injection-67457-422-54",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-dexamethasone-sodium-phosphate-injection-67457-422-54/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"67457-422-54\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "67457-423-12",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/08/2019",
      "update_date": "08/20/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "mylan-institutional-a-viatris-company-dexamethasone-sodium-phosphate-injection-67457-423-12",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-dexamethasone-sodium-phosphate-injection-67457-423-12/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"67457-423-12\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "67457-251-02",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/20/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "mylan-institutional-a-viatris-company-dexmedetomidine-hydrochloride-injection-67457-251-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-dexmedetomidine-hydrochloride-injection-67457-251-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"67457-251-02\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "67457-924-50",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/20/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "mylan-institutional-a-viatris-company-dexmedetomidine-hydrochloride-injection-67457-924-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-dexmedetomidine-hydrochloride-injection-67457-924-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"67457-924-50\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "67457-925-10",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/20/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "mylan-institutional-a-viatris-company-dexmedetomidine-hydrochloride-injection-67457-925-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-dexmedetomidine-hydrochloride-injection-67457-925-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"67457-925-10\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "67457-902-10",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/05/2022",
      "update_date": "08/20/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "mylan-institutional-a-viatris-company-etomidate-injection-67457-902-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-etomidate-injection-67457-902-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"67457-902-10\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "67457-903-20",
      "generic_name": "Etomidate Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/05/2022",
      "update_date": "08/20/2026",
      "days_in_shortage": "1427",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "mylan-institutional-a-viatris-company-etomidate-injection-67457-903-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-etomidate-injection-67457-903-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/05/2022\", \"package_ndc\": \"67457-903-20\", \"generic_name\": \"Etomidate Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72078-034-01",
      "generic_name": "Remifentanil Hydrochloride Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "06/28/2022",
      "update_date": "08/20/2026",
      "days_in_shortage": "1526",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "mylan-institutional-a-viatris-company-remifentanil-hydrochloride-injection-72078-034-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-remifentanil-hydrochloride-injection-72078-034-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/28/2022\", \"package_ndc\": \"72078-034-01\", \"generic_name\": \"Remifentanil Hydrochloride Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72078-035-02",
      "generic_name": "Remifentanil Hydrochloride Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "06/28/2022",
      "update_date": "08/20/2026",
      "days_in_shortage": "1526",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "mylan-institutional-a-viatris-company-remifentanil-hydrochloride-injection-72078-035-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-remifentanil-hydrochloride-injection-72078-035-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/28/2022\", \"package_ndc\": \"72078-035-02\", \"generic_name\": \"Remifentanil Hydrochloride Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72078-036-05",
      "generic_name": "Remifentanil Hydrochloride Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "06/28/2022",
      "update_date": "08/20/2026",
      "days_in_shortage": "1526",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "mylan-institutional-a-viatris-company-remifentanil-hydrochloride-injection-72078-036-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-remifentanil-hydrochloride-injection-72078-036-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/28/2022\", \"package_ndc\": \"72078-036-05\", \"generic_name\": \"Remifentanil Hydrochloride Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "67457-445-60",
      "generic_name": "Rifampin Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: Q4 2026",
      "initial_posting_date": "02/17/2021",
      "update_date": "08/20/2026",
      "days_in_shortage": "2022",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "mylan-institutional-a-viatris-company-rifampin-injection-67457-445-60",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-rifampin-injection-67457-445-60/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/17/2021\", \"package_ndc\": \"67457-445-60\", \"generic_name\": \"Rifampin Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: Q4 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "67457-228-05",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "mylan-institutional-a-viatris-company-rocuronium-bromide-injection-67457-228-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-rocuronium-bromide-injection-67457-228-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"67457-228-05\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "67457-228-10",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Mylan Institutional, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "mylan-institutional-a-viatris-company-rocuronium-bromide-injection-67457-228-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-institutional-a-viatris-company-rocuronium-bromide-injection-67457-228-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"67457-228-10\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0378-6854-77",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "mylan-pharmaceuticals-inc-a-viatris-company-lisdexamfetamine-dimesylate-capsule-0378-6854-77",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-pharmaceuticals-inc-a-viatris-company-lisdexamfetamine-dimesylate-capsule-0378-6854-77/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Pharmaceuticals%20Inc.,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0378-6854-77\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0378-6855-77",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "mylan-pharmaceuticals-inc-a-viatris-company-lisdexamfetamine-dimesylate-capsule-0378-6855-77",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-pharmaceuticals-inc-a-viatris-company-lisdexamfetamine-dimesylate-capsule-0378-6855-77/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Pharmaceuticals%20Inc.,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0378-6855-77\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0378-6856-77",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "mylan-pharmaceuticals-inc-a-viatris-company-lisdexamfetamine-dimesylate-capsule-0378-6856-77",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-pharmaceuticals-inc-a-viatris-company-lisdexamfetamine-dimesylate-capsule-0378-6856-77/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Pharmaceuticals%20Inc.,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0378-6856-77\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0378-6857-77",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "mylan-pharmaceuticals-inc-a-viatris-company-lisdexamfetamine-dimesylate-capsule-0378-6857-77",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-pharmaceuticals-inc-a-viatris-company-lisdexamfetamine-dimesylate-capsule-0378-6857-77/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Pharmaceuticals%20Inc.,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0378-6857-77\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0378-6858-77",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "mylan-pharmaceuticals-inc-a-viatris-company-lisdexamfetamine-dimesylate-capsule-0378-6858-77",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-pharmaceuticals-inc-a-viatris-company-lisdexamfetamine-dimesylate-capsule-0378-6858-77/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Pharmaceuticals%20Inc.,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0378-6858-77\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0378-6859-77",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "mylan-pharmaceuticals-inc-a-viatris-company-lisdexamfetamine-dimesylate-capsule-0378-6859-77",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-pharmaceuticals-inc-a-viatris-company-lisdexamfetamine-dimesylate-capsule-0378-6859-77/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Pharmaceuticals%20Inc.,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0378-6859-77\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0378-6860-77",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "mylan-pharmaceuticals-inc-a-viatris-company-lisdexamfetamine-dimesylate-capsule-0378-6860-77",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-pharmaceuticals-inc-a-viatris-company-lisdexamfetamine-dimesylate-capsule-0378-6860-77/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Pharmaceuticals%20Inc.,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0378-6860-77\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0037-0678-96",
      "generic_name": "Cromolyn Sodium Concentrate",
      "manufacturer_name": "Mylan Specialty, a Viatris Company",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/03/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1033",
      "dosage_form": "Concentrate",
      "therapeutic_category": "Pulmonary/Allergy",
      "id": "mylan-specialty-a-viatris-company-cromolyn-sodium-concentrate-0037-0678-96",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/mylan-specialty-a-viatris-company-cromolyn-sodium-concentrate-0037-0678-96/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Specialty,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/03/2023\", \"package_ndc\": \"0037-0678-96\", \"generic_name\": \"Cromolyn Sodium Concentrate\", \"contact_info\": \"(800) 796-9526\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0487-6105-01",
      "generic_name": "Sterile Water Injection",
      "manufacturer_name": "Nephron Pharmaceuticals Corporation",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Small amount of inventory available with 12/31/2026 dating",
      "initial_posting_date": "11/23/2021",
      "update_date": "08/04/2026",
      "days_in_shortage": "1743",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Other",
      "id": "nephron-pharmaceuticals-corporation-sterile-water-injection-0487-6105-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/nephron-pharmaceuticals-corporation-sterile-water-injection-0487-6105-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Nephron%20Pharmaceuticals%20Corporation%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/23/2021\", \"package_ndc\": \"0487-6105-01\", \"generic_name\": \"Sterile Water Injection\", \"contact_info\": \"800-443-4313\", \"availability\": \"Limited Availability\", \"related_info\": \"Small amount of inventory available with 12/31/2026 dating\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72205-132-91",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Novadoz Pharmaceuticals LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "novadoz-pharmaceuticals-llc-lisdexamfetamine-dimesylate-tablet-chewable-72205-132-91",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/novadoz-pharmaceuticals-llc-lisdexamfetamine-dimesylate-tablet-chewable-72205-132-91/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novadoz%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"72205-132-91\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"(855) 668-2369; customerservice@novadozpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72205-133-91",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Novadoz Pharmaceuticals LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "novadoz-pharmaceuticals-llc-lisdexamfetamine-dimesylate-tablet-chewable-72205-133-91",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/novadoz-pharmaceuticals-llc-lisdexamfetamine-dimesylate-tablet-chewable-72205-133-91/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novadoz%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"72205-133-91\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"(855) 668-2369; customerservice@novadozpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72205-134-91",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Novadoz Pharmaceuticals LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "novadoz-pharmaceuticals-llc-lisdexamfetamine-dimesylate-tablet-chewable-72205-134-91",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/novadoz-pharmaceuticals-llc-lisdexamfetamine-dimesylate-tablet-chewable-72205-134-91/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novadoz%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"72205-134-91\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"(855) 668-2369; customerservice@novadozpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72205-135-91",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Novadoz Pharmaceuticals LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "novadoz-pharmaceuticals-llc-lisdexamfetamine-dimesylate-tablet-chewable-72205-135-91",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/novadoz-pharmaceuticals-llc-lisdexamfetamine-dimesylate-tablet-chewable-72205-135-91/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novadoz%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"72205-135-91\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"(855) 668-2369; customerservice@novadozpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72205-136-91",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Novadoz Pharmaceuticals LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "novadoz-pharmaceuticals-llc-lisdexamfetamine-dimesylate-tablet-chewable-72205-136-91",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/novadoz-pharmaceuticals-llc-lisdexamfetamine-dimesylate-tablet-chewable-72205-136-91/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novadoz%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"72205-136-91\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"(855) 668-2369; customerservice@novadozpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72205-137-91",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Novadoz Pharmaceuticals LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "novadoz-pharmaceuticals-llc-lisdexamfetamine-dimesylate-tablet-chewable-72205-137-91",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/novadoz-pharmaceuticals-llc-lisdexamfetamine-dimesylate-tablet-chewable-72205-137-91/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novadoz%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"72205-137-91\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"(855) 668-2369; customerservice@novadozpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0574-2410-65",
      "generic_name": "Methylphenidate Film, Extended Release",
      "manufacturer_name": "Noven Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Available. Distributed by Padagis US LLC",
      "initial_posting_date": "02/28/2025",
      "update_date": "08/15/2026",
      "days_in_shortage": "550",
      "dosage_form": "Film, Extended Release",
      "therapeutic_category": "Psychiatry",
      "id": "noven-pharmaceuticals-inc-methylphenidate-film-extended-release-0574-2410-65",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/noven-pharmaceuticals-inc-methylphenidate-film-extended-release-0574-2410-65/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Noven%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Film,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/28/2025\", \"package_ndc\": \"0574-2410-65\", \"generic_name\": \"Methylphenidate Film, Extended Release\", \"contact_info\": \"800-455-8070\", \"availability\": \"Available\", \"related_info\": \"Available. Distributed by Padagis US LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0574-2415-65",
      "generic_name": "Methylphenidate Film, Extended Release",
      "manufacturer_name": "Noven Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Available. Distributed by Padagis US LLC",
      "initial_posting_date": "02/28/2025",
      "update_date": "08/15/2026",
      "days_in_shortage": "550",
      "dosage_form": "Film, Extended Release",
      "therapeutic_category": "Psychiatry",
      "id": "noven-pharmaceuticals-inc-methylphenidate-film-extended-release-0574-2415-65",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/noven-pharmaceuticals-inc-methylphenidate-film-extended-release-0574-2415-65/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Noven%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Film,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/28/2025\", \"package_ndc\": \"0574-2415-65\", \"generic_name\": \"Methylphenidate Film, Extended Release\", \"contact_info\": \"800-455-8070\", \"availability\": \"Available\", \"related_info\": \"Available. Distributed by Padagis US LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0574-2420-65",
      "generic_name": "Methylphenidate Film, Extended Release",
      "manufacturer_name": "Noven Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Available. Distributed by Padagis US LLC",
      "initial_posting_date": "02/28/2025",
      "update_date": "08/15/2026",
      "days_in_shortage": "550",
      "dosage_form": "Film, Extended Release",
      "therapeutic_category": "Psychiatry",
      "id": "noven-pharmaceuticals-inc-methylphenidate-film-extended-release-0574-2420-65",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/noven-pharmaceuticals-inc-methylphenidate-film-extended-release-0574-2420-65/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Noven%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Film,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/28/2025\", \"package_ndc\": \"0574-2420-65\", \"generic_name\": \"Methylphenidate Film, Extended Release\", \"contact_info\": \"800-455-8070\", \"availability\": \"Available\", \"related_info\": \"Available. Distributed by Padagis US LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0574-2430-65",
      "generic_name": "Methylphenidate Film, Extended Release",
      "manufacturer_name": "Noven Pharmaceuticals, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Available. Distributed by Padagis US LLC",
      "initial_posting_date": "02/28/2025",
      "update_date": "08/15/2026",
      "days_in_shortage": "550",
      "dosage_form": "Film, Extended Release",
      "therapeutic_category": "Psychiatry",
      "id": "noven-pharmaceuticals-inc-methylphenidate-film-extended-release-0574-2430-65",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/noven-pharmaceuticals-inc-methylphenidate-film-extended-release-0574-2430-65/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Noven%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Film,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/28/2025\", \"package_ndc\": \"0574-2430-65\", \"generic_name\": \"Methylphenidate Film, Extended Release\", \"contact_info\": \"800-455-8070\", \"availability\": \"Available\", \"related_info\": \"Available. Distributed by Padagis US LLC\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0169-2800-15",
      "generic_name": "Liraglutide Injection",
      "manufacturer_name": "Novo Nordisk, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Product will be available until discontinuation in January 2027",
      "initial_posting_date": "07/18/2023",
      "update_date": "08/25/2026",
      "days_in_shortage": "1141",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "novo-nordisk-inc-liraglutide-injection-0169-2800-15",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/novo-nordisk-inc-liraglutide-injection-0169-2800-15/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/18/2023\", \"package_ndc\": \"0169-2800-15\", \"generic_name\": \"Liraglutide Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Liraglutide+Injection&st=d\", \"contact_info\": \"833-493-4689\", \"availability\": \"Limited Availability\", \"related_info\": \"Product will be available until discontinuation in January 2027\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0169-4060-12",
      "generic_name": "Liraglutide Injection",
      "manufacturer_name": "Novo Nordisk, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated shortage duration: TBD",
      "initial_posting_date": "07/18/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1141",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "novo-nordisk-inc-liraglutide-injection-0169-4060-12",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/novo-nordisk-inc-liraglutide-injection-0169-4060-12/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/18/2023\", \"package_ndc\": \"0169-4060-12\", \"generic_name\": \"Liraglutide Injection\", \"contact_info\": \"833-493-4689\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated shortage duration: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0169-4060-13",
      "generic_name": "Liraglutide Injection",
      "manufacturer_name": "Novo Nordisk, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated shortage duration: TBD",
      "initial_posting_date": "07/18/2023",
      "update_date": "08/25/2026",
      "days_in_shortage": "1141",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "novo-nordisk-inc-liraglutide-injection-0169-4060-13",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/novo-nordisk-inc-liraglutide-injection-0169-4060-13/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/18/2023\", \"package_ndc\": \"0169-4060-13\", \"generic_name\": \"Liraglutide Injection\", \"contact_info\": \"833-493-4689\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated shortage duration: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0480-3667-20",
      "generic_name": "Liraglutide Injection",
      "manufacturer_name": "Novo Nordisk, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Teva",
      "initial_posting_date": "07/18/2023",
      "update_date": "08/25/2026",
      "days_in_shortage": "1141",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "novo-nordisk-inc-liraglutide-injection-0480-3667-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/novo-nordisk-inc-liraglutide-injection-0480-3667-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/18/2023\", \"package_ndc\": \"0480-3667-20\", \"generic_name\": \"Liraglutide Injection\", \"contact_info\": \"833-493-4689\", \"availability\": \"Available\", \"related_info\": \"Distributed by Teva\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0480-3667-22",
      "generic_name": "Liraglutide Injection",
      "manufacturer_name": "Novo Nordisk, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Teva",
      "initial_posting_date": "07/18/2023",
      "update_date": "08/25/2026",
      "days_in_shortage": "1141",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "novo-nordisk-inc-liraglutide-injection-0480-3667-22",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/novo-nordisk-inc-liraglutide-injection-0480-3667-22/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/18/2023\", \"package_ndc\": \"0480-3667-22\", \"generic_name\": \"Liraglutide Injection\", \"contact_info\": \"833-493-4689\", \"availability\": \"Available\", \"related_info\": \"Distributed by Teva\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72266-263-10",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "ONESOURCE SPECIALTY PTE LTD",
      "status": "Current",
      "availability": "Available",
      "related_info": "Distributed by Fosun Pharma USA Inc.",
      "initial_posting_date": "02/20/2018",
      "update_date": "08/18/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "onesource-specialty-pte-ltd-bupivacaine-hydrochloride-injection-72266-263-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/onesource-specialty-pte-ltd-bupivacaine-hydrochloride-injection-72266-263-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22ONESOURCE%20SPECIALTY%20PTE%20LTD%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"72266-263-10\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"888-217-8103\", \"availability\": \"Available\", \"related_info\": \"Distributed by Fosun Pharma USA Inc.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72516-011-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Oryza Pharmaceuticals Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated availability April 2027",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/04/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "oryza-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-72516-011-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/oryza-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-72516-011-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Oryza%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"72516-011-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"855-257-0292\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated availability April 2027\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72516-012-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Oryza Pharmaceuticals Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated availability April 2027",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/04/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "oryza-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-72516-012-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/oryza-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-72516-012-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Oryza%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"72516-012-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"855-257-0292\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated availability April 2027\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72516-013-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Oryza Pharmaceuticals Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated availability April 2027",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/04/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "oryza-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-72516-013-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/oryza-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-72516-013-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Oryza%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"72516-013-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"855-257-0292\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated availability April 2027\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72516-014-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Oryza Pharmaceuticals Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated availability April 2027",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/04/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "oryza-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-72516-014-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/oryza-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-72516-014-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Oryza%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"72516-014-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"855-257-0292\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated availability April 2027\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72516-016-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Oryza Pharmaceuticals Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated availability April 2027",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/04/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "oryza-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-72516-016-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/oryza-pharmaceuticals-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-72516-016-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Oryza%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"72516-016-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"855-257-0292\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated availability April 2027\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-4178-03",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2093",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "otsuka-icu-medical-llc-amino-acid-injection-0990-4178-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-amino-acid-injection-0990-4178-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0990-4178-03\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-4179-05",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2093",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "otsuka-icu-medical-llc-amino-acid-injection-0990-4179-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-amino-acid-injection-0990-4179-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0990-4179-05\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7171-17",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2093",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "otsuka-icu-medical-llc-amino-acid-injection-0990-7171-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-amino-acid-injection-0990-7171-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0990-7171-17\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7172-17",
      "generic_name": "Amino Acid Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "12/08/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2093",
      "dosage_form": "Injection",
      "therapeutic_category": "Gastroenterology",
      "id": "otsuka-icu-medical-llc-amino-acid-injection-0990-7172-17",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-amino-acid-injection-0990-7172-17/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/08/2020\", \"package_ndc\": \"0990-7172-17\", \"generic_name\": \"Amino Acid Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7922-02",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7922-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7922-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0990-7922-02\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7922-03",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7922-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7922-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0990-7922-03\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7922-09",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7922-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7922-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0990-7922-09\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7922-55",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7922-55",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7922-55/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0990-7922-55\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7922-61",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7922-61",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7922-61/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0990-7922-61\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7923-13",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7923-13",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7923-13/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0990-7923-13\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7923-20",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7923-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7923-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0990-7923-20\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7923-23",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7923-23",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7923-23/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0990-7923-23\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7923-36",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7923-36",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7923-36/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0990-7923-36\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7923-37",
      "generic_name": "Dextrose Monohydrate 5% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "02/14/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1660",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7923-37",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-5-injection-0990-7923-37/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/14/2022\", \"package_ndc\": \"0990-7923-37\", \"generic_name\": \"Dextrose Monohydrate 5% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7930-02",
      "generic_name": "Dextrose Monohydrate 10% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "03/01/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1645",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-10-injection-0990-7930-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-10-injection-0990-7930-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"0990-7930-02\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7930-03",
      "generic_name": "Dextrose Monohydrate 10% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "03/01/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1645",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-10-injection-0990-7930-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-10-injection-0990-7930-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"0990-7930-03\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7930-09",
      "generic_name": "Dextrose Monohydrate 10% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "03/01/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1645",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-10-injection-0990-7930-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-10-injection-0990-7930-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"0990-7930-09\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7938-19",
      "generic_name": "Dextrose Monohydrate 10% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Product discontinued. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "03/01/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1645",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-10-injection-0990-7938-19",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-10-injection-0990-7938-19/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/01/2022\", \"package_ndc\": \"0990-7938-19\", \"generic_name\": \"Dextrose Monohydrate 10% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Unavailable\", \"related_info\": \"Product discontinued. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7120-07",
      "generic_name": "Dextrose Monohydrate 70% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "10/11/2024",
      "update_date": "08/17/2026",
      "days_in_shortage": "690",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-70-injection-0990-7120-07",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-70-injection-0990-7120-07/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/11/2024\", \"package_ndc\": \"0990-7120-07\", \"generic_name\": \"Dextrose Monohydrate 70% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7918-19",
      "generic_name": "Dextrose Monohydrate 70% Injection",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "10/11/2024",
      "update_date": "08/17/2026",
      "days_in_shortage": "690",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "otsuka-icu-medical-llc-dextrose-monohydrate-70-injection-0990-7918-19",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-dextrose-monohydrate-70-injection-0990-7918-19/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/11/2024\", \"package_ndc\": \"0990-7918-19\", \"generic_name\": \"Dextrose Monohydrate 70% Injection\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Available\", \"related_info\": \"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-6139-03",
      "generic_name": "Sterile Water Irrigant",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Irrigant",
      "therapeutic_category": "Gastroenterology",
      "id": "otsuka-icu-medical-llc-sterile-water-irrigant-0990-6139-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-sterile-water-irrigant-0990-6139-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"0990-6139-03\", \"generic_name\": \"Sterile Water Irrigant\", \"related_info_link\": \"https://www.fda.gov/media/182619/download?attachment\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Unavailable\", \"related_info\": \"Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-6139-22",
      "generic_name": "Sterile Water Irrigant",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Irrigant",
      "therapeutic_category": "Gastroenterology",
      "id": "otsuka-icu-medical-llc-sterile-water-irrigant-0990-6139-22",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-sterile-water-irrigant-0990-6139-22/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"0990-6139-22\", \"generic_name\": \"Sterile Water Irrigant\", \"related_info_link\": \"https://www.fda.gov/media/182619/download?attachment\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Unavailable\", \"related_info\": \"Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7139-09",
      "generic_name": "Sterile Water Irrigant",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Irrigant",
      "therapeutic_category": "Gastroenterology",
      "id": "otsuka-icu-medical-llc-sterile-water-irrigant-0990-7139-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-sterile-water-irrigant-0990-7139-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"0990-7139-09\", \"generic_name\": \"Sterile Water Irrigant\", \"related_info_link\": \"https://www.fda.gov/media/182619/download?attachment\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Unavailable\", \"related_info\": \"Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0990-7139-36",
      "generic_name": "Sterile Water Irrigant",
      "manufacturer_name": "Otsuka ICU Medical LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Irrigant",
      "therapeutic_category": "Gastroenterology",
      "id": "otsuka-icu-medical-llc-sterile-water-irrigant-0990-7139-36",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/otsuka-icu-medical-llc-sterile-water-irrigant-0990-7139-36/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"0990-7139-36\", \"generic_name\": \"Sterile Water Irrigant\", \"related_info_link\": \"https://www.fda.gov/media/182619/download?attachment\", \"contact_info\": \"1-866-829-9025 or ProductAvailability@icumed.com\", \"availability\": \"Unavailable\", \"related_info\": \"Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0574-4022-35",
      "generic_name": "Bacitracin Ophthalmic Ointment",
      "manufacturer_name": "Padagis US LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Shortage is estimated for 24 months",
      "initial_posting_date": "03/03/2025",
      "update_date": "06/01/2026",
      "days_in_shortage": "547",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Ophthalmic Ointment",
      "therapeutic_category": "Anti-Infective",
      "id": "padagis-us-llc-bacitracin-ophthalmic-ointment-0574-4022-35",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/padagis-us-llc-bacitracin-ophthalmic-ointment-0574-4022-35/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Padagis%20US%20LLC%22+AND+generic_name%3A%22Bacitracin%20Ophthalmic%20Ointment%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/03/2025\", \"package_ndc\": \"0574-4022-35\", \"generic_name\": \"Bacitracin Ophthalmic Ointment\", \"contact_info\": \"866-634-9120\", \"availability\": \"Unavailable\", \"related_info\": \"Shortage is estimated for 24 months\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42023-146-25",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Par Health, USA LLC",
      "status": "Current",
      "availability": "Available",
      "related_info": "Please check wholesalers for inventory",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/18/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "par-health-usa-llc-dexmedetomidine-hydrochloride-injection-42023-146-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/par-health-usa-llc-dexmedetomidine-hydrochloride-injection-42023-146-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Par%20Health,%20USA%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"42023-146-25\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"800-828-9393\", \"availability\": \"Available\", \"related_info\": \"Please check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42023-186-20",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Par Health, USA LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD; Please check wholesalers for inventory",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/18/2026",
      "days_in_shortage": "2335",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "par-health-usa-llc-dexmedetomidine-hydrochloride-injection-42023-186-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/par-health-usa-llc-dexmedetomidine-hydrochloride-injection-42023-186-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Par%20Health,%20USA%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"42023-186-20\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"800-828-9393\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD; Please check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42023-187-10",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Par Health, USA LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD; Please check wholesalers for inventory",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/18/2026",
      "days_in_shortage": "2335",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "par-health-usa-llc-dexmedetomidine-hydrochloride-injection-42023-187-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/par-health-usa-llc-dexmedetomidine-hydrochloride-injection-42023-187-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Par%20Health,%20USA%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"42023-187-10\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"800-828-9393\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD; Please check wholesalers for inventory\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42023-240-01",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Par Health, USA LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "06/16/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1538",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "par-health-usa-llc-methylprednisolone-acetate-injection-42023-240-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/par-health-usa-llc-methylprednisolone-acetate-injection-42023-240-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Par%20Health,%20USA%20LLC%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/16/2022\", \"package_ndc\": \"42023-240-01\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"800-828-9393\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0009-0775-26",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1260",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "pfizer-inc-clindamycin-phosphate-injection-0009-0775-26",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-clindamycin-phosphate-injection-0009-0775-26/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0009-0775-26\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d\", \"contact_info\": \"800-533-4535\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0009-0870-26",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery and Estimated Recovery: December 2028",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1260",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "pfizer-inc-clindamycin-phosphate-injection-0009-0870-26",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-clindamycin-phosphate-injection-0009-0870-26/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0009-0870-26\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d\", \"contact_info\": \"800-533-4535\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2028\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0009-0902-18",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1260",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "pfizer-inc-clindamycin-phosphate-injection-0009-0902-18",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-clindamycin-phosphate-injection-0009-0902-18/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0009-0902-18\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d\", \"contact_info\": \"800-533-4535\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "related_info",
          "value": "Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0009-0902-18\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d\", \"contact_info\": \"800-533-4535\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay\"",
          "as_of": "2026-09-10"
        },
        {
          "field": "shortage_reason",
          "value": "Other",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0009-0902-18\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d\", \"contact_info\": \"800-533-4535\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay\"",
          "as_of": "2026-09-10"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0009-3051-02",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1260",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "pfizer-inc-clindamycin-phosphate-injection-0009-3051-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-clindamycin-phosphate-injection-0009-3051-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0009-3051-02\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d\", \"contact_info\": \"800-533-4535\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0009-4073-04",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1260",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "pfizer-inc-clindamycin-phosphate-injection-0009-4073-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-clindamycin-phosphate-injection-0009-4073-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0009-4073-04\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d\", \"contact_info\": \"800-533-4535\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0009-5095-06",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1260",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "pfizer-inc-clindamycin-phosphate-injection-0009-5095-06",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-clindamycin-phosphate-injection-0009-5095-06/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0009-5095-06\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d\", \"contact_info\": \"800-533-4535\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-0155-02",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-0155-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-0155-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0409-0155-02\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1174-10",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-1174-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-1174-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0409-1174-10\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1434-01",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-1434-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-1434-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0409-1434-01\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1454-20",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-1454-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-1454-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0409-1454-20\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1596-10",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-1596-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-1596-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0409-1596-10\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1638-02",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-1638-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-1638-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0409-1638-02\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1660-20",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-1660-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-1660-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0409-1660-20\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-1660-50",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-1660-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-1660-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0409-1660-50\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-2815-01",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-2815-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-2815-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0409-2815-01\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-3301-10",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-3301-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-3301-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0409-3301-10\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-4596-20",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-4596-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-4596-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0409-4596-20\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-7838-24",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-7838-24",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-7838-24/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0409-7838-24\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-7853-24",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-7853-24",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-7853-24/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0409-7853-24\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0409-7875-12",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "08/24/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-7875-12",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-dexmedetomidine-hydrochloride-injection-0409-7875-12/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"0409-7875-12\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0009-0274-01",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1721",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "pfizer-inc-methylprednisolone-acetate-injection-0009-0274-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0274-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"0009-0274-01\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0009-0280-02",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1721",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "pfizer-inc-methylprednisolone-acetate-injection-0009-0280-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0280-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"0009-0280-02\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0009-0280-03",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1721",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "pfizer-inc-methylprednisolone-acetate-injection-0009-0280-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0280-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"0009-0280-03\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0009-0280-51",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1721",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "pfizer-inc-methylprednisolone-acetate-injection-0009-0280-51",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0280-51/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"0009-0280-51\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0009-0280-52",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1721",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "pfizer-inc-methylprednisolone-acetate-injection-0009-0280-52",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0280-52/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"0009-0280-52\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0009-0306-02",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1721",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "pfizer-inc-methylprednisolone-acetate-injection-0009-0306-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0306-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"0009-0306-02\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0009-0306-12",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1721",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "pfizer-inc-methylprednisolone-acetate-injection-0009-0306-12",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0306-12/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"0009-0306-12\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0009-3073-01",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1721",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "pfizer-inc-methylprednisolone-acetate-injection-0009-3073-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3073-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"0009-3073-01\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0009-3073-03",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1721",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "pfizer-inc-methylprednisolone-acetate-injection-0009-3073-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3073-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"0009-3073-03\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0009-3073-22",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: September 2026; Estimated Recovery: December 2026",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1721",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "pfizer-inc-methylprednisolone-acetate-injection-0009-3073-22",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3073-22/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"0009-3073-22\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: September 2026; Estimated Recovery: December 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0009-3073-23",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1721",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "pfizer-inc-methylprednisolone-acetate-injection-0009-3073-23",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3073-23/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"0009-3073-23\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0009-3475-01",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1721",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "pfizer-inc-methylprednisolone-acetate-injection-0009-3475-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3475-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"0009-3475-01\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0009-3475-03",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/24/2026",
      "days_in_shortage": "1721",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "pfizer-inc-methylprednisolone-acetate-injection-0009-3475-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3475-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"0009-3475-03\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"844-646-4398\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "60793-700-10",
      "generic_name": "Penicillin G Benzathine Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Next Delivery: October 2027; Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "04/26/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1224",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "pfizer-inc-penicillin-g-benzathine-injection-60793-700-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-penicillin-g-benzathine-injection-60793-700-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Penicillin%20G%20Benzathine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/26/2023\", \"package_ndc\": \"60793-700-10\", \"generic_name\": \"Penicillin G Benzathine Injection\", \"related_info_link\": \"https://www.fda.gov/media/190713/download\", \"contact_info\": \"800-533-4535\", \"availability\": \"Unavailable\", \"related_info\": \"Next Delivery: October 2027; Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "60793-701-10",
      "generic_name": "Penicillin G Benzathine Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "04/26/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1224",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "pfizer-inc-penicillin-g-benzathine-injection-60793-701-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-penicillin-g-benzathine-injection-60793-701-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Penicillin%20G%20Benzathine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/26/2023\", \"package_ndc\": \"60793-701-10\", \"generic_name\": \"Penicillin G Benzathine Injection\", \"related_info_link\": \"https://www.fda.gov/media/190713/download\", \"contact_info\": \"800-533-4535\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "60793-702-10",
      "generic_name": "Penicillin G Benzathine Injection",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay",
      "initial_posting_date": "04/26/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1224",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "pfizer-inc-penicillin-g-benzathine-injection-60793-702-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-penicillin-g-benzathine-injection-60793-702-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Penicillin%20G%20Benzathine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/26/2023\", \"package_ndc\": \"60793-702-10\", \"generic_name\": \"Penicillin G Benzathine Injection\", \"related_info_link\": \"https://www.fda.gov/media/190713/download\", \"contact_info\": \"800-533-4535\", \"availability\": \"Limited Availability\", \"related_info\": \"Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0071-0527-23",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "pfizer-inc-quinapril-hydrochloride-tablet-0071-0527-23",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-quinapril-hydrochloride-tablet-0071-0527-23/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"0071-0527-23\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"800-533-4535\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0071-0530-23",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "pfizer-inc-quinapril-hydrochloride-tablet-0071-0530-23",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-quinapril-hydrochloride-tablet-0071-0530-23/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"0071-0530-23\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"800-533-4535\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0071-0532-23",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "pfizer-inc-quinapril-hydrochloride-tablet-0071-0532-23",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-quinapril-hydrochloride-tablet-0071-0532-23/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"0071-0532-23\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"800-533-4535\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0071-0535-23",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "pfizer-inc-quinapril-hydrochloride-tablet-0071-0535-23",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-quinapril-hydrochloride-tablet-0071-0535-23/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"0071-0535-23\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"800-533-4535\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0071-0220-23",
      "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "pfizer-inc-quinapril-hydrochlorothiazide-tablet-0071-0220-23",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-quinapril-hydrochlorothiazide-tablet-0071-0220-23/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"0071-0220-23\", \"generic_name\": \"Quinapril/Hydrochlorothiazide Tablet\", \"contact_info\": \"800-533-4535\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0071-0222-23",
      "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "pfizer-inc-quinapril-hydrochlorothiazide-tablet-0071-0222-23",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-quinapril-hydrochlorothiazide-tablet-0071-0222-23/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"0071-0222-23\", \"generic_name\": \"Quinapril/Hydrochlorothiazide Tablet\", \"contact_info\": \"800-533-4535\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0071-0223-23",
      "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
      "manufacturer_name": "Pfizer Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "01/19/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "pfizer-inc-quinapril-hydrochlorothiazide-tablet-0071-0223-23",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-quinapril-hydrochlorothiazide-tablet-0071-0223-23/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"0071-0223-23\", \"generic_name\": \"Quinapril/Hydrochlorothiazide Tablet\", \"contact_info\": \"800-533-4535\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "66794-160-02",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Piramal Critical Care Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "On allocation",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/04/2026",
      "days_in_shortage": "3227",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "piramal-critical-care-inc-morphine-sulfate-injection-66794-160-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/piramal-critical-care-inc-morphine-sulfate-injection-66794-160-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Piramal%20Critical%20Care%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"66794-160-02\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"800-414-1901\", \"availability\": \"Limited Availability\", \"related_info\": \"On allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "66794-162-02",
      "generic_name": "Morphine Sulfate Injection",
      "manufacturer_name": "Piramal Critical Care Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/31/2017",
      "update_date": "08/04/2026",
      "days_in_shortage": "3227",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "piramal-critical-care-inc-morphine-sulfate-injection-66794-162-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/piramal-critical-care-inc-morphine-sulfate-injection-66794-162-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Piramal%20Critical%20Care%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/31/2017\", \"package_ndc\": \"66794-162-02\", \"generic_name\": \"Morphine Sulfate Injection\", \"contact_info\": \"800-414-1901\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "66794-228-41",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Piramal Critical Care Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "On allocation",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/04/2026",
      "days_in_shortage": "1294",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "piramal-critical-care-inc-rocuronium-bromide-injection-66794-228-41",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/piramal-critical-care-inc-rocuronium-bromide-injection-66794-228-41/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Piramal%20Critical%20Care%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"66794-228-41\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"800-414-1901\", \"availability\": \"Limited Availability\", \"related_info\": \"On allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "66794-229-41",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Piramal Critical Care Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "On allocation",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/04/2026",
      "days_in_shortage": "1294",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "piramal-critical-care-inc-rocuronium-bromide-injection-66794-229-41",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/piramal-critical-care-inc-rocuronium-bromide-injection-66794-229-41/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Piramal%20Critical%20Care%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"66794-229-41\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"800-414-1901\", \"availability\": \"Limited Availability\", \"related_info\": \"On allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-406-10",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Prinston Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Solco Healthcare",
      "initial_posting_date": "03/10/2023",
      "update_date": "07/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "prinston-pharmaceutical-inc-clonazepam-tablet-43547-406-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/prinston-pharmaceutical-inc-clonazepam-tablet-43547-406-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Prinston%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"43547-406-10\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"For orders, Solco Healthcare 866-931-9829\", \"availability\": \"Available\", \"related_info\": \"Marketed by Solco Healthcare\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-406-11",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Prinston Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Solco Healthcare",
      "initial_posting_date": "03/10/2023",
      "update_date": "07/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "prinston-pharmaceutical-inc-clonazepam-tablet-43547-406-11",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/prinston-pharmaceutical-inc-clonazepam-tablet-43547-406-11/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Prinston%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"43547-406-11\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"For orders, Solco Healthcare 866-931-9829\", \"availability\": \"Available\", \"related_info\": \"Marketed by Solco Healthcare\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-406-50",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Prinston Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Solco Healthcare",
      "initial_posting_date": "03/10/2023",
      "update_date": "07/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "prinston-pharmaceutical-inc-clonazepam-tablet-43547-406-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/prinston-pharmaceutical-inc-clonazepam-tablet-43547-406-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Prinston%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"43547-406-50\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"For orders, Solco Healthcare 866-931-9829\", \"availability\": \"Available\", \"related_info\": \"Marketed by Solco Healthcare\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-407-10",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Prinston Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Solco Healthcare",
      "initial_posting_date": "03/10/2023",
      "update_date": "07/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "prinston-pharmaceutical-inc-clonazepam-tablet-43547-407-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/prinston-pharmaceutical-inc-clonazepam-tablet-43547-407-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Prinston%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"43547-407-10\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"For orders, Solco Healthcare 866-931-9829\", \"availability\": \"Available\", \"related_info\": \"Marketed by Solco Healthcare\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-407-11",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Prinston Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Solco Healthcare",
      "initial_posting_date": "03/10/2023",
      "update_date": "07/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "prinston-pharmaceutical-inc-clonazepam-tablet-43547-407-11",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/prinston-pharmaceutical-inc-clonazepam-tablet-43547-407-11/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Prinston%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"43547-407-11\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"For orders, Solco Healthcare 866-931-9829\", \"availability\": \"Available\", \"related_info\": \"Marketed by Solco Healthcare\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-407-50",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Prinston Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Solco Healthcare",
      "initial_posting_date": "03/10/2023",
      "update_date": "07/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "prinston-pharmaceutical-inc-clonazepam-tablet-43547-407-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/prinston-pharmaceutical-inc-clonazepam-tablet-43547-407-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Prinston%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"43547-407-50\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"For orders, Solco Healthcare 866-931-9829\", \"availability\": \"Available\", \"related_info\": \"Marketed by Solco Healthcare\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-408-10",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Prinston Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Solco Healthcare",
      "initial_posting_date": "03/10/2023",
      "update_date": "07/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "prinston-pharmaceutical-inc-clonazepam-tablet-43547-408-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/prinston-pharmaceutical-inc-clonazepam-tablet-43547-408-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Prinston%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"43547-408-10\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"For orders, Solco Healthcare 866-931-9829\", \"availability\": \"Available\", \"related_info\": \"Marketed by Solco Healthcare\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-408-50",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Prinston Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Solco Healthcare",
      "initial_posting_date": "03/10/2023",
      "update_date": "07/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "prinston-pharmaceutical-inc-clonazepam-tablet-43547-408-50",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/prinston-pharmaceutical-inc-clonazepam-tablet-43547-408-50/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Prinston%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"43547-408-50\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"For orders, Solco Healthcare 866-931-9829\", \"availability\": \"Available\", \"related_info\": \"Marketed by Solco Healthcare\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42858-161-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Rhodes Pharmaceuticals L.P.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/24/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "rhodes-pharmaceuticals-l-p-lisdexamfetamine-dimesylate-capsule-42858-161-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rhodes-pharmaceuticals-l-p-lisdexamfetamine-dimesylate-capsule-42858-161-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rhodes%20Pharmaceuticals%20L.P.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"42858-161-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"888-827-0616\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42858-162-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Rhodes Pharmaceuticals L.P.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/24/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "rhodes-pharmaceuticals-l-p-lisdexamfetamine-dimesylate-capsule-42858-162-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rhodes-pharmaceuticals-l-p-lisdexamfetamine-dimesylate-capsule-42858-162-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rhodes%20Pharmaceuticals%20L.P.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"42858-162-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"888-827-0616\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42858-163-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Rhodes Pharmaceuticals L.P.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/24/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "rhodes-pharmaceuticals-l-p-lisdexamfetamine-dimesylate-capsule-42858-163-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rhodes-pharmaceuticals-l-p-lisdexamfetamine-dimesylate-capsule-42858-163-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rhodes%20Pharmaceuticals%20L.P.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"42858-163-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"888-827-0616\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42858-164-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Rhodes Pharmaceuticals L.P.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/24/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "rhodes-pharmaceuticals-l-p-lisdexamfetamine-dimesylate-capsule-42858-164-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rhodes-pharmaceuticals-l-p-lisdexamfetamine-dimesylate-capsule-42858-164-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rhodes%20Pharmaceuticals%20L.P.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"42858-164-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"888-827-0616\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42858-165-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Rhodes Pharmaceuticals L.P.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/24/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "rhodes-pharmaceuticals-l-p-lisdexamfetamine-dimesylate-capsule-42858-165-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rhodes-pharmaceuticals-l-p-lisdexamfetamine-dimesylate-capsule-42858-165-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rhodes%20Pharmaceuticals%20L.P.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"42858-165-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"888-827-0616\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42858-166-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Rhodes Pharmaceuticals L.P.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/24/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "rhodes-pharmaceuticals-l-p-lisdexamfetamine-dimesylate-capsule-42858-166-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rhodes-pharmaceuticals-l-p-lisdexamfetamine-dimesylate-capsule-42858-166-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rhodes%20Pharmaceuticals%20L.P.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"42858-166-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"888-827-0616\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "42858-167-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Rhodes Pharmaceuticals L.P.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "01/11/2024",
      "update_date": "06/24/2026",
      "days_in_shortage": "964",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "rhodes-pharmaceuticals-l-p-lisdexamfetamine-dimesylate-capsule-42858-167-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rhodes-pharmaceuticals-l-p-lisdexamfetamine-dimesylate-capsule-42858-167-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rhodes%20Pharmaceuticals%20L.P.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/11/2024\", \"package_ndc\": \"42858-167-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"888-827-0616\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "16571-600-96",
      "generic_name": "Cromolyn Sodium Concentrate",
      "manufacturer_name": "Rising Pharma Holdings, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/03/2023",
      "update_date": "08/24/2026",
      "days_in_shortage": "1033",
      "dosage_form": "Concentrate",
      "therapeutic_category": "Pulmonary/Allergy",
      "id": "rising-pharma-holdings-inc-cromolyn-sodium-concentrate-16571-600-96",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rising-pharma-holdings-inc-cromolyn-sodium-concentrate-16571-600-96/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rising%20Pharma%20Holdings,%20Inc.%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/03/2023\", \"package_ndc\": \"16571-600-96\", \"generic_name\": \"Cromolyn Sodium Concentrate\", \"contact_info\": \"(201) 961-9000 or contact@risingpharma.com\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0378-4415-01",
      "generic_name": "Flurazepam Hydrochloride Capsule",
      "manufacturer_name": "Rising Pharma Holdings, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.",
      "initial_posting_date": "08/03/2022",
      "update_date": "08/24/2026",
      "days_in_shortage": "1490",
      "shortage_reason": "Regulatory delay",
      "dosage_form": "Capsule",
      "therapeutic_category": "Neurology",
      "id": "rising-pharma-holdings-inc-flurazepam-hydrochloride-capsule-0378-4415-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rising-pharma-holdings-inc-flurazepam-hydrochloride-capsule-0378-4415-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rising%20Pharma%20Holdings,%20Inc.%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"08/03/2022\", \"package_ndc\": \"0378-4415-01\", \"generic_name\": \"Flurazepam Hydrochloride Capsule\", \"contact_info\": \"1-844-874-7464\", \"availability\": \"Unavailable\", \"related_info\": \"Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0378-4430-01",
      "generic_name": "Flurazepam Hydrochloride Capsule",
      "manufacturer_name": "Rising Pharma Holdings, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.",
      "initial_posting_date": "08/03/2022",
      "update_date": "08/24/2026",
      "days_in_shortage": "1490",
      "shortage_reason": "Regulatory delay",
      "dosage_form": "Capsule",
      "therapeutic_category": "Neurology",
      "id": "rising-pharma-holdings-inc-flurazepam-hydrochloride-capsule-0378-4430-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rising-pharma-holdings-inc-flurazepam-hydrochloride-capsule-0378-4430-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rising%20Pharma%20Holdings,%20Inc.%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"08/03/2022\", \"package_ndc\": \"0378-4430-01\", \"generic_name\": \"Flurazepam Hydrochloride Capsule\", \"contact_info\": \"1-844-874-7464\", \"availability\": \"Unavailable\", \"related_info\": \"Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72888-152-00",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Rubicon Research Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Advagen Pharma Ltd.",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "rubicon-research-private-limited-clonazepam-tablet-72888-152-00",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rubicon-research-private-limited-clonazepam-tablet-72888-152-00/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"72888-152-00\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"sales@advagenpharma.com\", \"availability\": \"Available\", \"related_info\": \"Marketed by Advagen Pharma Ltd.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72888-152-01",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Rubicon Research Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Advagen Pharma Ltd.",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "rubicon-research-private-limited-clonazepam-tablet-72888-152-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rubicon-research-private-limited-clonazepam-tablet-72888-152-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"72888-152-01\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"sales@advagenpharma.com\", \"availability\": \"Available\", \"related_info\": \"Marketed by Advagen Pharma Ltd.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72888-152-05",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Rubicon Research Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Advagen Pharma Ltd.",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "rubicon-research-private-limited-clonazepam-tablet-72888-152-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rubicon-research-private-limited-clonazepam-tablet-72888-152-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"72888-152-05\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"sales@advagenpharma.com\", \"availability\": \"Available\", \"related_info\": \"Marketed by Advagen Pharma Ltd.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72888-152-30",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Rubicon Research Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Advagen Pharma Ltd.",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "rubicon-research-private-limited-clonazepam-tablet-72888-152-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rubicon-research-private-limited-clonazepam-tablet-72888-152-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"72888-152-30\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"sales@advagenpharma.com\", \"availability\": \"Available\", \"related_info\": \"Marketed by Advagen Pharma Ltd.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72888-153-00",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Rubicon Research Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Advagen Pharma Ltd.",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "rubicon-research-private-limited-clonazepam-tablet-72888-153-00",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rubicon-research-private-limited-clonazepam-tablet-72888-153-00/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"72888-153-00\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"sales@advagenpharma.com\", \"availability\": \"Available\", \"related_info\": \"Marketed by Advagen Pharma Ltd.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72888-153-01",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Rubicon Research Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Advagen Pharma Ltd.",
      "initial_posting_date": "03/27/2023",
      "update_date": "06/01/2026",
      "days_in_shortage": "1254",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "rubicon-research-private-limited-clonazepam-tablet-72888-153-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rubicon-research-private-limited-clonazepam-tablet-72888-153-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/27/2023\", \"package_ndc\": \"72888-153-01\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"sales@advagenpharma.com\", \"availability\": \"Available\", \"related_info\": \"Marketed by Advagen Pharma Ltd.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72888-153-05",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Rubicon Research Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Advagen Pharma Ltd.",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "rubicon-research-private-limited-clonazepam-tablet-72888-153-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rubicon-research-private-limited-clonazepam-tablet-72888-153-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"72888-153-05\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"sales@advagenpharma.com\", \"availability\": \"Available\", \"related_info\": \"Marketed by Advagen Pharma Ltd.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72888-153-30",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Rubicon Research Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Advagen Pharma Ltd.",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "rubicon-research-private-limited-clonazepam-tablet-72888-153-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rubicon-research-private-limited-clonazepam-tablet-72888-153-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"72888-153-30\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"sales@advagenpharma.com\", \"availability\": \"Available\", \"related_info\": \"Marketed by Advagen Pharma Ltd.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72888-154-01",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Rubicon Research Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Advagen Pharma Ltd.",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "rubicon-research-private-limited-clonazepam-tablet-72888-154-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rubicon-research-private-limited-clonazepam-tablet-72888-154-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"72888-154-01\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"sales@advagenpharma.com\", \"availability\": \"Available\", \"related_info\": \"Marketed by Advagen Pharma Ltd.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72888-154-05",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Rubicon Research Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Advagen Pharma Ltd.",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "rubicon-research-private-limited-clonazepam-tablet-72888-154-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rubicon-research-private-limited-clonazepam-tablet-72888-154-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"72888-154-05\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"sales@advagenpharma.com\", \"availability\": \"Available\", \"related_info\": \"Marketed by Advagen Pharma Ltd.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72888-154-30",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Rubicon Research Private Limited",
      "status": "Current",
      "availability": "Available",
      "related_info": "Marketed by Advagen Pharma Ltd.",
      "initial_posting_date": "03/10/2023",
      "update_date": "06/01/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "rubicon-research-private-limited-clonazepam-tablet-72888-154-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/rubicon-research-private-limited-clonazepam-tablet-72888-154-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"72888-154-30\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"sales@advagenpharma.com\", \"availability\": \"Available\", \"related_info\": \"Marketed by Advagen Pharma Ltd.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-321-04",
      "generic_name": "Bumetanide Injection",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/31/2018",
      "update_date": "08/18/2026",
      "days_in_shortage": "3135",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "sagent-pharmaceuticals-bumetanide-injection-25021-321-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sagent-pharmaceuticals-bumetanide-injection-25021-321-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/31/2018\", \"package_ndc\": \"25021-321-04\", \"generic_name\": \"Bumetanide Injection\", \"contact_info\": \"866-625-1618\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-321-10",
      "generic_name": "Bumetanide Injection",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/31/2018",
      "update_date": "08/18/2026",
      "days_in_shortage": "3135",
      "dosage_form": "Injection",
      "therapeutic_category": "Cardiovascular",
      "id": "sagent-pharmaceuticals-bumetanide-injection-25021-321-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sagent-pharmaceuticals-bumetanide-injection-25021-321-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/31/2018\", \"package_ndc\": \"25021-321-10\", \"generic_name\": \"Bumetanide Injection\", \"contact_info\": \"866-625-1618\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-115-02",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Selling through remaining short-dated inventory (Dec 2026), API not available, Exiting product line",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1260",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "sagent-pharmaceuticals-clindamycin-phosphate-injection-25021-115-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sagent-pharmaceuticals-clindamycin-phosphate-injection-25021-115-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"25021-115-02\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"contact_info\": \"866-625-1618\", \"availability\": \"Limited Availability\", \"related_info\": \"Selling through remaining short-dated inventory (Dec 2026), API not available, Exiting product line\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-115-04",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1260",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "sagent-pharmaceuticals-clindamycin-phosphate-injection-25021-115-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sagent-pharmaceuticals-clindamycin-phosphate-injection-25021-115-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"25021-115-04\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"contact_info\": \"866-625-1618\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-115-06",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Selling through remaining short-dated inventory (Dec 2026), API not available, Exiting product line",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1260",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "sagent-pharmaceuticals-clindamycin-phosphate-injection-25021-115-06",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sagent-pharmaceuticals-clindamycin-phosphate-injection-25021-115-06/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"25021-115-06\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"contact_info\": \"866-625-1618\", \"availability\": \"Limited Availability\", \"related_info\": \"Selling through remaining short-dated inventory (Dec 2026), API not available, Exiting product line\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-700-01",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: late September 2026",
      "initial_posting_date": "03/26/2018",
      "update_date": "08/18/2026",
      "days_in_shortage": "3081",
      "shortage_reason": "Delay in shipping of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "sagent-pharmaceuticals-ketorolac-tromethamine-injection-25021-700-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sagent-pharmaceuticals-ketorolac-tromethamine-injection-25021-700-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/26/2018\", \"package_ndc\": \"25021-700-01\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"866-625-1618\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: late September 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-701-01",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/26/2018",
      "update_date": "08/18/2026",
      "days_in_shortage": "3081",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "sagent-pharmaceuticals-ketorolac-tromethamine-injection-25021-701-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sagent-pharmaceuticals-ketorolac-tromethamine-injection-25021-701-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/26/2018\", \"package_ndc\": \"25021-701-01\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"866-625-1618\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-701-02",
      "generic_name": "Ketorolac Tromethamine Injection",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/26/2018",
      "update_date": "08/18/2026",
      "days_in_shortage": "3081",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "sagent-pharmaceuticals-ketorolac-tromethamine-injection-25021-701-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sagent-pharmaceuticals-ketorolac-tromethamine-injection-25021-701-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/26/2018\", \"package_ndc\": \"25021-701-02\", \"generic_name\": \"Ketorolac Tromethamine Injection\", \"contact_info\": \"866-625-1618\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-820-05",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: November 2026",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/18/2026",
      "days_in_shortage": "1721",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "sagent-pharmaceuticals-methylprednisolone-acetate-injection-25021-820-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sagent-pharmaceuticals-methylprednisolone-acetate-injection-25021-820-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"25021-820-05\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"866-625-1618\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: November 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-820-10",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: November 2026",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/18/2026",
      "days_in_shortage": "1721",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "sagent-pharmaceuticals-methylprednisolone-acetate-injection-25021-820-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sagent-pharmaceuticals-methylprednisolone-acetate-injection-25021-820-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"25021-820-10\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"866-625-1618\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: November 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-821-05",
      "generic_name": "Methylprednisolone Acetate Injection",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: November 2026, Product on hand is 8-12 months of dating prior to expiry",
      "initial_posting_date": "12/15/2021",
      "update_date": "08/18/2026",
      "days_in_shortage": "1721",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "sagent-pharmaceuticals-methylprednisolone-acetate-injection-25021-821-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sagent-pharmaceuticals-methylprednisolone-acetate-injection-25021-821-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/15/2021\", \"package_ndc\": \"25021-821-05\", \"generic_name\": \"Methylprednisolone Acetate Injection\", \"contact_info\": \"866-625-1618\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: November 2026, Product on hand is 8-12 months of dating prior to expiry\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "25021-687-05",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "sagent-pharmaceuticals-rocuronium-bromide-injection-25021-687-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sagent-pharmaceuticals-rocuronium-bromide-injection-25021-687-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"25021-687-05\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"866-625-1618\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0185-0842-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Sandoz Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-0842-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-0842-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0185-0842-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-525-8747\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0185-0853-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Sandoz Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-0853-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-0853-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0185-0853-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-525-8747\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0185-2098-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Sandoz Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-2098-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-2098-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0185-2098-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-525-8747\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0185-2099-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Sandoz Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/18/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-2099-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-2099-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0185-2099-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-525-8747\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0781-3288-09",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Sandoz Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1260",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "sandoz-inc-clindamycin-phosphate-injection-0781-3288-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-clindamycin-phosphate-injection-0781-3288-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0781-3288-09\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"contact_info\": \"800-525-8747\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0781-3289-09",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Sandoz Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1260",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "sandoz-inc-clindamycin-phosphate-injection-0781-3289-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-clindamycin-phosphate-injection-0781-3289-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0781-3289-09\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"contact_info\": \"800-525-8747\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0781-3290-09",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Sandoz Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1260",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "sandoz-inc-clindamycin-phosphate-injection-0781-3290-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-clindamycin-phosphate-injection-0781-3290-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"0781-3290-09\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"contact_info\": \"800-525-8747\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72572-074-24",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Sandoz Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Civica Label",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1260",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "sandoz-inc-clindamycin-phosphate-injection-72572-074-24",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-clindamycin-phosphate-injection-72572-074-24/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"72572-074-24\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"contact_info\": \"800-525-8747\", \"availability\": \"Available\", \"related_info\": \"Civica Label\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "72572-076-24",
      "generic_name": "Clindamycin Phosphate Injection",
      "manufacturer_name": "Sandoz Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Civica Label",
      "initial_posting_date": "03/21/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1260",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "sandoz-inc-clindamycin-phosphate-injection-72572-076-24",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-clindamycin-phosphate-injection-72572-076-24/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/21/2023\", \"package_ndc\": \"72572-076-24\", \"generic_name\": \"Clindamycin Phosphate Injection\", \"contact_info\": \"800-525-8747\", \"availability\": \"Available\", \"related_info\": \"Civica Label\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0781-3220-92",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Sandoz Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "sandoz-inc-rocuronium-bromide-injection-0781-3220-92",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-rocuronium-bromide-injection-0781-3220-92/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"0781-3220-92\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"800-525-8747\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0781-3220-95",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "Sandoz Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "sandoz-inc-rocuronium-bromide-injection-0781-3220-95",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-rocuronium-bromide-injection-0781-3220-95/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"0781-3220-95\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"800-525-8747\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0068-0597-01",
      "generic_name": "Rifampin Injection",
      "manufacturer_name": "Sanofi-Aventis U.S. LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "initial_posting_date": "02/17/2021",
      "update_date": "06/22/2026",
      "days_in_shortage": "2022",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Anti-Infective",
      "id": "sanofi-aventis-u-s-llc-rifampin-injection-0068-0597-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sanofi-aventis-u-s-llc-rifampin-injection-0068-0597-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sanofi-Aventis%20U.S.%20LLC%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/17/2021\", \"package_ndc\": \"0068-0597-01\", \"generic_name\": \"Rifampin Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Rifampin%20Injection&st=d\", \"contact_info\": \"800-633-1610\", \"availability\": \"Unavailable\", \"related_info\": \"Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-602-10",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Solco Healthcare US, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "On allocation",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/29/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "solco-healthcare-us-llc-lisdexamfetamine-dimesylate-capsule-43547-602-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/solco-healthcare-us-llc-lisdexamfetamine-dimesylate-capsule-43547-602-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"43547-602-10\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"866-931-9829\", \"availability\": \"Limited Availability\", \"related_info\": \"On allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-603-10",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Solco Healthcare US, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "On allocation",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/29/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "solco-healthcare-us-llc-lisdexamfetamine-dimesylate-capsule-43547-603-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/solco-healthcare-us-llc-lisdexamfetamine-dimesylate-capsule-43547-603-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"43547-603-10\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"866-931-9829\", \"availability\": \"Limited Availability\", \"related_info\": \"On allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-604-10",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Solco Healthcare US, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "On allocation",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/29/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "solco-healthcare-us-llc-lisdexamfetamine-dimesylate-capsule-43547-604-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/solco-healthcare-us-llc-lisdexamfetamine-dimesylate-capsule-43547-604-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"43547-604-10\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"866-931-9829\", \"availability\": \"Limited Availability\", \"related_info\": \"On allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-605-10",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Solco Healthcare US, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "On allocation",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/29/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "solco-healthcare-us-llc-lisdexamfetamine-dimesylate-capsule-43547-605-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/solco-healthcare-us-llc-lisdexamfetamine-dimesylate-capsule-43547-605-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"43547-605-10\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"866-931-9829\", \"availability\": \"Limited Availability\", \"related_info\": \"On allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-606-10",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Solco Healthcare US, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "On allocation",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/29/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "solco-healthcare-us-llc-lisdexamfetamine-dimesylate-capsule-43547-606-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/solco-healthcare-us-llc-lisdexamfetamine-dimesylate-capsule-43547-606-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"43547-606-10\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"866-931-9829\", \"availability\": \"Limited Availability\", \"related_info\": \"On allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-607-10",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Solco Healthcare US, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "On allocation",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/29/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "solco-healthcare-us-llc-lisdexamfetamine-dimesylate-capsule-43547-607-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/solco-healthcare-us-llc-lisdexamfetamine-dimesylate-capsule-43547-607-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"43547-607-10\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"866-931-9829\", \"availability\": \"Limited Availability\", \"related_info\": \"On allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-608-10",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Solco Healthcare US, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "On allocation",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/29/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "solco-healthcare-us-llc-lisdexamfetamine-dimesylate-capsule-43547-608-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/solco-healthcare-us-llc-lisdexamfetamine-dimesylate-capsule-43547-608-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"43547-608-10\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"866-931-9829\", \"availability\": \"Limited Availability\", \"related_info\": \"On allocation\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-410-09",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Solco Healthcare US, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Not available. Long-term backorder for all NDCs. No estimated release date at this time.",
      "initial_posting_date": "01/19/2023",
      "update_date": "06/29/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "solco-healthcare-us-llc-quinapril-hydrochloride-tablet-43547-410-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/solco-healthcare-us-llc-quinapril-hydrochloride-tablet-43547-410-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"43547-410-09\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"866-931-9829\", \"availability\": \"Unavailable\", \"related_info\": \"Not available. Long-term backorder for all NDCs. No estimated release date at this time.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-411-09",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Solco Healthcare US, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Not available. Long-term backorder for all NDCs. No estimated release date at this time.",
      "initial_posting_date": "01/19/2023",
      "update_date": "06/29/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "solco-healthcare-us-llc-quinapril-hydrochloride-tablet-43547-411-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/solco-healthcare-us-llc-quinapril-hydrochloride-tablet-43547-411-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"43547-411-09\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"866-931-9829\", \"availability\": \"Unavailable\", \"related_info\": \"Not available. Long-term backorder for all NDCs. No estimated release date at this time.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-412-09",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Solco Healthcare US, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Not available. Long-term backorder for all NDCs. No estimated release date at this time.",
      "initial_posting_date": "01/19/2023",
      "update_date": "06/29/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "solco-healthcare-us-llc-quinapril-hydrochloride-tablet-43547-412-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/solco-healthcare-us-llc-quinapril-hydrochloride-tablet-43547-412-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"43547-412-09\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"866-931-9829\", \"availability\": \"Unavailable\", \"related_info\": \"Not available. Long-term backorder for all NDCs. No estimated release date at this time.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "43547-413-09",
      "generic_name": "Quinapril Hydrochloride Tablet",
      "manufacturer_name": "Solco Healthcare US, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Not available. Long-term backorder for all NDCs. No estimated release date at this time.",
      "initial_posting_date": "01/19/2023",
      "update_date": "06/29/2026",
      "days_in_shortage": "1321",
      "shortage_reason": "Shortage of an active ingredient",
      "dosage_form": "Tablet",
      "therapeutic_category": "Cardiovascular",
      "id": "solco-healthcare-us-llc-quinapril-hydrochloride-tablet-43547-413-09",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/solco-healthcare-us-llc-quinapril-hydrochloride-tablet-43547-413-09/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/19/2023\", \"package_ndc\": \"43547-413-09\", \"generic_name\": \"Quinapril Hydrochloride Tablet\", \"contact_info\": \"866-931-9829\", \"availability\": \"Unavailable\", \"related_info\": \"Not available. Long-term backorder for all NDCs. No estimated release date at this time.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-481-10",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/01/2012",
      "update_date": "07/20/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-atropine-sulfate-injection-70069-481-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-atropine-sulfate-injection-70069-481-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"70069-481-10\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-631-25",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/01/2012",
      "update_date": "07/20/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-atropine-sulfate-injection-70069-631-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-atropine-sulfate-injection-70069-631-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"70069-631-25\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-641-25",
      "generic_name": "Atropine Sulfate Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "01/01/2012",
      "update_date": "07/20/2026",
      "days_in_shortage": "5357",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-atropine-sulfate-injection-70069-641-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-atropine-sulfate-injection-70069-641-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"01/01/2012\", \"package_ndc\": \"70069-641-25\", \"generic_name\": \"Atropine Sulfate Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-752-01",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-bupivacaine-hydrochloride-injection-70069-752-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-bupivacaine-hydrochloride-injection-70069-752-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"70069-752-01\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-752-10",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-bupivacaine-hydrochloride-injection-70069-752-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-bupivacaine-hydrochloride-injection-70069-752-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"70069-752-10\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-752-25",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-bupivacaine-hydrochloride-injection-70069-752-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-bupivacaine-hydrochloride-injection-70069-752-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"70069-752-25\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-753-01",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-bupivacaine-hydrochloride-injection-70069-753-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-bupivacaine-hydrochloride-injection-70069-753-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"70069-753-01\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-753-10",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-bupivacaine-hydrochloride-injection-70069-753-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-bupivacaine-hydrochloride-injection-70069-753-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"70069-753-10\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-753-25",
      "generic_name": "Bupivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/20/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3115",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-bupivacaine-hydrochloride-injection-70069-753-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-bupivacaine-hydrochloride-injection-70069-753-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/20/2018\", \"package_ndc\": \"70069-753-25\", \"generic_name\": \"Bupivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-021-25",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/08/2019",
      "update_date": "07/20/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "somerset-therapeutics-llc-dexamethasone-sodium-phosphate-injection-70069-021-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-dexamethasone-sodium-phosphate-injection-70069-021-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"70069-021-25\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"732-554-1019\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-025-10",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/08/2019",
      "update_date": "07/20/2026",
      "days_in_shortage": "2762",
      "dosage_form": "Injection",
      "therapeutic_category": "Dermatology",
      "id": "somerset-therapeutics-llc-dexamethasone-sodium-phosphate-injection-70069-025-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-dexamethasone-sodium-phosphate-injection-70069-025-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/08/2019\", \"package_ndc\": \"70069-025-10\", \"generic_name\": \"Dexamethasone Sodium Phosphate Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-758-04",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "07/20/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-dexmedetomidine-hydrochloride-injection-70069-758-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-dexmedetomidine-hydrochloride-injection-70069-758-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"70069-758-04\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-759-04",
      "generic_name": "Dexmedetomidine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "04/10/2020",
      "update_date": "07/20/2026",
      "days_in_shortage": "2335",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-dexmedetomidine-hydrochloride-injection-70069-759-04",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-dexmedetomidine-hydrochloride-injection-70069-759-04/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/10/2020\", \"package_ndc\": \"70069-759-04\", \"generic_name\": \"Dexmedetomidine Hydrochloride Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-061-10",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-061-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-061-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"70069-061-10\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1019\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-061-25",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-061-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-061-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"70069-061-25\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1019\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-062-10",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-062-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-062-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"70069-062-10\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1019\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-062-25",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-062-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-062-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"70069-062-25\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1019\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-063-25",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-063-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-063-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"70069-063-25\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-064-01",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-064-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-064-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"70069-064-01\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1019\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-064-10",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-064-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-064-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"70069-064-10\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1019\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-064-25",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-064-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-064-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"70069-064-25\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1019\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-067-10",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-067-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-067-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"70069-067-10\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-067-25",
      "generic_name": "Ropivacaine Hydrochloride Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/23/2018",
      "update_date": "07/20/2026",
      "days_in_shortage": "3084",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-067-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-ropivacaine-hydrochloride-injection-70069-067-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/23/2018\", \"package_ndc\": \"70069-067-25\", \"generic_name\": \"Ropivacaine Hydrochloride Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-047-25",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/03/2016",
      "update_date": "07/20/2026",
      "days_in_shortage": "3863",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "somerset-therapeutics-llc-sodium-acetate-injection-70069-047-25",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-sodium-acetate-injection-70069-047-25/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/03/2016\", \"package_ndc\": \"70069-047-25\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "70069-048-20",
      "generic_name": "Sodium Acetate Injection",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/03/2016",
      "update_date": "07/20/2026",
      "days_in_shortage": "3863",
      "dosage_form": "Injection",
      "therapeutic_category": "Endocrinology/Metabolism",
      "id": "somerset-therapeutics-llc-sodium-acetate-injection-70069-048-20",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/somerset-therapeutics-llc-sodium-acetate-injection-70069-048-20/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/03/2016\", \"package_ndc\": \"70069-048-20\", \"generic_name\": \"Sodium Acetate Injection\", \"contact_info\": \"732-554-1037\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0406-8884-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "SpecGx LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/20/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "specgx-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0406-8884-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/specgx-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0406-8884-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0406-8884-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-325-8888\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0406-8885-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "SpecGx LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/20/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "specgx-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0406-8885-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/specgx-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0406-8885-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0406-8885-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-325-8888\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0406-8891-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "SpecGx LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/20/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "specgx-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0406-8891-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/specgx-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0406-8891-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0406-8891-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-325-8888\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0406-8892-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "SpecGx LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/20/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "specgx-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0406-8892-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/specgx-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0406-8892-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0406-8892-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-325-8888\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0406-8893-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "SpecGx LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/20/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "specgx-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0406-8893-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/specgx-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0406-8893-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0406-8893-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-325-8888\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0406-8894-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "SpecGx LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/20/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "specgx-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0406-8894-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/specgx-llc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0406-8894-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0406-8894-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-325-8888\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0406-5111-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "SpecGx LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "specgx-llc-lisdexamfetamine-dimesylate-capsule-0406-5111-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/specgx-llc-lisdexamfetamine-dimesylate-capsule-0406-5111-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0406-5111-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-325-8888\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0406-5112-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "SpecGx LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "specgx-llc-lisdexamfetamine-dimesylate-capsule-0406-5112-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/specgx-llc-lisdexamfetamine-dimesylate-capsule-0406-5112-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0406-5112-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-325-8888\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0406-5113-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "SpecGx LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "specgx-llc-lisdexamfetamine-dimesylate-capsule-0406-5113-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/specgx-llc-lisdexamfetamine-dimesylate-capsule-0406-5113-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0406-5113-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-325-8888\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0406-5114-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "SpecGx LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "specgx-llc-lisdexamfetamine-dimesylate-capsule-0406-5114-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/specgx-llc-lisdexamfetamine-dimesylate-capsule-0406-5114-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0406-5114-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-325-8888\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0406-5115-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "SpecGx LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "specgx-llc-lisdexamfetamine-dimesylate-capsule-0406-5115-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/specgx-llc-lisdexamfetamine-dimesylate-capsule-0406-5115-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0406-5115-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-325-8888\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0406-5116-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "SpecGx LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "specgx-llc-lisdexamfetamine-dimesylate-capsule-0406-5116-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/specgx-llc-lisdexamfetamine-dimesylate-capsule-0406-5116-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0406-5116-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-325-8888\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0406-5117-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "SpecGx LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/20/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "specgx-llc-lisdexamfetamine-dimesylate-capsule-0406-5117-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/specgx-llc-lisdexamfetamine-dimesylate-capsule-0406-5117-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0406-5117-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-325-8888\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "65282-1605-1",
      "generic_name": "Lidocaine Hydrochloride Injection",
      "manufacturer_name": "Spectra Medical Devices, LLC",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "06/14/2018",
      "update_date": "05/15/2026",
      "days_in_shortage": "3001",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "spectra-medical-devices-llc-lidocaine-hydrochloride-injection-65282-1605-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/spectra-medical-devices-llc-lidocaine-hydrochloride-injection-65282-1605-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Spectra%20Medical%20Devices,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/14/2018\", \"package_ndc\": \"65282-1605-1\", \"generic_name\": \"Lidocaine Hydrochloride Injection\", \"contact_info\": \"978-657-0889 ext. 5231\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "21586-011-02",
      "generic_name": "Cefotaxime Sodium Powder, for Solution",
      "manufacturer_name": "SteriMax, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/17/2015",
      "update_date": "06/15/2026",
      "days_in_shortage": "4214",
      "dosage_form": "Powder, For Solution",
      "therapeutic_category": "Anti-Infective",
      "id": "sterimax-inc-cefotaxime-sodium-powder-for-solution-21586-011-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sterimax-inc-cefotaxime-sodium-powder-for-solution-21586-011-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SteriMax,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/17/2015\", \"package_ndc\": \"21586-011-02\", \"generic_name\": \"Cefotaxime Sodium Powder, for Solution\", \"related_info_link\": \"https://www.fda.gov/media/193116/download?attachment\", \"contact_info\": \"800-881-3550\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "21586-012-02",
      "generic_name": "Cefotaxime Sodium Powder, for Solution",
      "manufacturer_name": "SteriMax, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "02/17/2015",
      "update_date": "06/15/2026",
      "days_in_shortage": "4214",
      "dosage_form": "Powder, For Solution",
      "therapeutic_category": "Anti-Infective",
      "id": "sterimax-inc-cefotaxime-sodium-powder-for-solution-21586-012-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sterimax-inc-cefotaxime-sodium-powder-for-solution-21586-012-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SteriMax,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/17/2015\", \"package_ndc\": \"21586-012-02\", \"generic_name\": \"Cefotaxime Sodium Powder, for Solution\", \"related_info_link\": \"https://www.fda.gov/media/193116/download?attachment\", \"contact_info\": \"800-881-3550\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "21586-211-02",
      "generic_name": "Ifosfamide Injection",
      "manufacturer_name": "SteriMax, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "To place an order, please contact GlobalRX at info@globalrx.com or (919) 245-8418",
      "initial_posting_date": "06/12/2026",
      "update_date": "09/08/2026",
      "days_in_shortage": "90",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "sterimax-inc-ifosfamide-injection-21586-211-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sterimax-inc-ifosfamide-injection-21586-211-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SteriMax,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"06/12/2026\", \"package_ndc\": \"21586-211-02\", \"generic_name\": \"Ifosfamide Injection\", \"related_info_link\": \"https://www.fda.gov/media/194567/download\", \"contact_info\": \"877-373-4657\", \"availability\": \"Available\", \"related_info\": \"To place an order, please contact GlobalRX at info@globalrx.com or (919) 245-8418\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-046-88",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Other",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-capsule-57664-046-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-capsule-57664-046-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"57664-046-88\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-818-4555\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-048-88",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Other",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-capsule-57664-048-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-capsule-57664-048-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"57664-048-88\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-818-4555\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-049-88",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Other",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-capsule-57664-049-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-capsule-57664-049-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"57664-049-88\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-818-4555\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-050-88",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Other",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-capsule-57664-050-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-capsule-57664-050-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"57664-050-88\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-818-4555\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-051-88",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Other",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-capsule-57664-051-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-capsule-57664-051-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"57664-051-88\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-818-4555\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-052-88",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1145",
      "shortage_reason": "Other",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-capsule-57664-052-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-capsule-57664-052-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"57664-052-88\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-818-4555\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-083-88",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-tablet-chewable-57664-083-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-tablet-chewable-57664-083-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"57664-083-88\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"800-818-4555\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-084-88",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-tablet-chewable-57664-084-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-tablet-chewable-57664-084-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"57664-084-88\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"800-818-4555\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-085-88",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-tablet-chewable-57664-085-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-tablet-chewable-57664-085-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"57664-085-88\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"800-818-4555\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-086-88",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-tablet-chewable-57664-086-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-tablet-chewable-57664-086-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"57664-086-88\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"800-818-4555\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-087-88",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-tablet-chewable-57664-087-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-tablet-chewable-57664-087-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"57664-087-88\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"800-818-4555\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-088-88",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-tablet-chewable-57664-088-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-lisdexamfetamine-dimesylate-tablet-chewable-57664-088-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"57664-088-88\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"800-818-4555\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-606-88",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Currently not marketed",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1133",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-methylphenidate-hydrochloride-tablet-extended-release-57664-606-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-methylphenidate-hydrochloride-tablet-extended-release-57664-606-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"57664-606-88\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-818-4555\", \"availability\": \"Unavailable\", \"related_info\": \"Currently not marketed\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-607-88",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Currently not marketed",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1133",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-methylphenidate-hydrochloride-tablet-extended-release-57664-607-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-methylphenidate-hydrochloride-tablet-extended-release-57664-607-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"57664-607-88\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-818-4555\", \"availability\": \"Unavailable\", \"related_info\": \"Currently not marketed\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-608-88",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Currently not marketed",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1133",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-methylphenidate-hydrochloride-tablet-extended-release-57664-608-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-methylphenidate-hydrochloride-tablet-extended-release-57664-608-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"57664-608-88\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-818-4555\", \"availability\": \"Unavailable\", \"related_info\": \"Currently not marketed\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57664-609-88",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Currently not marketed",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "1133",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sun-pharmaceutical-industries-inc-methylphenidate-hydrochloride-tablet-extended-release-57664-609-88",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-methylphenidate-hydrochloride-tablet-extended-release-57664-609-88/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"57664-609-88\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-818-4555\", \"availability\": \"Unavailable\", \"related_info\": \"Currently not marketed\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "45567-0060-1",
      "generic_name": "Technetium TC-99M Pyrophosphate Kit Injection",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "12/27/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "979",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Medical Imaging",
      "id": "sun-pharmaceutical-industries-inc-technetium-tc-99m-pyrophosphate-kit-injection-45567-0060-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-technetium-tc-99m-pyrophosphate-kit-injection-45567-0060-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Technetium%20TC-99M%20Pyrophosphate%20Kit%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/27/2023\", \"package_ndc\": \"45567-0060-1\", \"generic_name\": \"Technetium TC-99M Pyrophosphate Kit Injection\", \"contact_info\": \"800-818-4555\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "45567-0060-2",
      "generic_name": "Technetium TC-99M Pyrophosphate Kit Injection",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "12/27/2023",
      "update_date": "08/05/2026",
      "days_in_shortage": "979",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Medical Imaging",
      "id": "sun-pharmaceutical-industries-inc-technetium-tc-99m-pyrophosphate-kit-injection-45567-0060-2",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sun-pharmaceutical-industries-inc-technetium-tc-99m-pyrophosphate-kit-injection-45567-0060-2/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Technetium%20TC-99M%20Pyrophosphate%20Kit%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/27/2023\", \"package_ndc\": \"45567-0060-2\", \"generic_name\": \"Technetium TC-99M Pyrophosphate Kit Injection\", \"contact_info\": \"800-818-4555\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "11534-190-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Sunrise Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/16/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sunrise-pharmaceutical-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-11534-190-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sunrise-pharmaceutical-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-11534-190-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sunrise%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"11534-190-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"732-382-6085 Monday to Friday 9 am to 3:45 pm\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "11534-191-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Sunrise Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/16/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sunrise-pharmaceutical-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-11534-191-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sunrise-pharmaceutical-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-11534-191-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sunrise%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"11534-191-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"732-382-6085 Monday to Friday 9 am to 3:45 pm\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "11534-192-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Sunrise Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/16/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sunrise-pharmaceutical-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-11534-192-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sunrise-pharmaceutical-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-11534-192-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sunrise%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"11534-192-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"732-382-6085 Monday to Friday 9 am to 3:45 pm\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "11534-193-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Sunrise Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/16/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sunrise-pharmaceutical-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-11534-193-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sunrise-pharmaceutical-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-11534-193-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sunrise%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"11534-193-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"732-382-6085 Monday to Friday 9 am to 3:45 pm\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "11534-194-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Sunrise Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/16/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sunrise-pharmaceutical-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-11534-194-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sunrise-pharmaceutical-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-11534-194-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sunrise%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"11534-194-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"732-382-6085 Monday to Friday 9 am to 3:45 pm\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "11534-195-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Sunrise Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/16/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sunrise-pharmaceutical-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-11534-195-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sunrise-pharmaceutical-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-11534-195-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sunrise%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"11534-195-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"732-382-6085 Monday to Friday 9 am to 3:45 pm\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "11534-196-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Sunrise Pharmaceutical, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/16/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "sunrise-pharmaceutical-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-11534-196-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/sunrise-pharmaceutical-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-11534-196-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sunrise%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"11534-196-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"732-382-6085 Monday to Friday 9 am to 3:45 pm\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59417-101-10",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Takeda Pharmaceuticals USA Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-59417-101-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-59417-101-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"59417-101-10\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"877-TAKEDA-7 (1-877-825-3327)\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59417-102-10",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Takeda Pharmaceuticals USA Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-59417-102-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-59417-102-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"59417-102-10\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"877-TAKEDA-7 (1-877-825-3327)\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59417-103-10",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Takeda Pharmaceuticals USA Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-59417-103-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-59417-103-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"59417-103-10\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"877-TAKEDA-7 (1-877-825-3327)\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59417-104-10",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Takeda Pharmaceuticals USA Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-59417-104-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-59417-104-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"59417-104-10\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"877-TAKEDA-7 (1-877-825-3327)\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59417-105-10",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Takeda Pharmaceuticals USA Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-59417-105-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-59417-105-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"59417-105-10\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"877-TAKEDA-7 (1-877-825-3327)\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59417-106-10",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Takeda Pharmaceuticals USA Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-59417-106-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-59417-106-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"59417-106-10\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"877-TAKEDA-7 (1-877-825-3327)\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59417-107-10",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Takeda Pharmaceuticals USA Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-59417-107-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-59417-107-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"59417-107-10\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"877-TAKEDA-7 (1-877-825-3327)\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59417-115-01",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Takeda Pharmaceuticals USA Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-tablet-chewable-59417-115-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-tablet-chewable-59417-115-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"59417-115-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"877-TAKEDA-7 (1-877-825-3327)\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59417-116-01",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Takeda Pharmaceuticals USA Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-tablet-chewable-59417-116-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-tablet-chewable-59417-116-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"59417-116-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"877-TAKEDA-7 (1-877-825-3327)\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59417-117-01",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Takeda Pharmaceuticals USA Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-tablet-chewable-59417-117-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-tablet-chewable-59417-117-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"59417-117-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"877-TAKEDA-7 (1-877-825-3327)\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59417-118-01",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Takeda Pharmaceuticals USA Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-tablet-chewable-59417-118-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-tablet-chewable-59417-118-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"59417-118-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"877-TAKEDA-7 (1-877-825-3327)\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59417-119-01",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Takeda Pharmaceuticals USA Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-tablet-chewable-59417-119-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-tablet-chewable-59417-119-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"59417-119-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"877-TAKEDA-7 (1-877-825-3327)\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "59417-120-01",
      "generic_name": "Lisdexamfetamine Dimesylate Tablet, Chewable",
      "manufacturer_name": "Takeda Pharmaceuticals USA Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Tablet, Chewable",
      "therapeutic_category": "Psychiatry",
      "id": "takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-tablet-chewable-59417-120-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/takeda-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-tablet-chewable-59417-120-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"59417-120-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Tablet, Chewable\", \"contact_info\": \"877-TAKEDA-7 (1-877-825-3327)\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0555-0775-02",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0555-0775-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0555-0775-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0555-0775-02\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0555-0776-02",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0555-0776-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0555-0776-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0555-0776-02\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0555-0777-02",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0555-0777-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0555-0777-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0555-0777-02\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "related_info",
          "value": "Estimated recovery: September 2026",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0555-0777-02\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: September 2026\"",
          "as_of": "2026-09-03"
        },
        {
          "field": "shortage_reason",
          "value": "Other",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0555-0777-02\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: September 2026\"",
          "as_of": "2026-09-03"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0555-0971-02",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0555-0971-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0555-0971-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0555-0971-02\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0555-0972-02",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0555-0972-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0555-0972-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0555-0972-02\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0555-0973-02",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0555-0973-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0555-0973-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0555-0973-02\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "also_reported": [
        {
          "field": "related_info",
          "value": "Estimated recovery: TBD",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0555-0973-02\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
          "as_of": "2026-09-03"
        },
        {
          "field": "shortage_reason",
          "value": "Other",
          "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
          "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0555-0973-02\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
          "as_of": "2026-09-03"
        }
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0555-0974-02",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0555-0974-02",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0555-0974-02/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"0555-0974-02\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57844-105-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-57844-105-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-57844-105-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"57844-105-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57844-110-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-57844-110-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-57844-110-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"57844-110-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57844-112-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "shortage_reason": "Other",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-57844-112-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-57844-112-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"57844-112-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "57844-115-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-57844-115-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-57844-115-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"57844-115-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57844-117-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-57844-117-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-57844-117-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"57844-117-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57844-120-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-57844-120-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-57844-120-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"57844-120-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "57844-130-01",
      "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "10/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1420",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-57844-130-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-57844-130-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"10/12/2022\", \"package_ndc\": \"57844-130-01\", \"generic_name\": \"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68001-313-56",
      "generic_name": "Azacitidine Injection",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "12/22/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2079",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "teva-pharmaceuticals-usa-inc-azacitidine-injection-68001-313-56",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-azacitidine-injection-68001-313-56/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"12/22/2020\", \"package_ndc\": \"68001-313-56\", \"generic_name\": \"Azacitidine Injection\", \"contact_info\": \"800-545-8800\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0703-4239-01",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: December 2028",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "teva-pharmaceuticals-usa-inc-carboplatin-injection-0703-4239-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-carboplatin-injection-0703-4239-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"0703-4239-01\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"800-545-8800\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: December 2028\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0703-4244-01",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "teva-pharmaceuticals-usa-inc-carboplatin-injection-0703-4244-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-carboplatin-injection-0703-4244-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"0703-4244-01\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"800-545-8800\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0703-4246-01",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: September 2026",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "teva-pharmaceuticals-usa-inc-carboplatin-injection-0703-4246-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-carboplatin-injection-0703-4246-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"0703-4246-01\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"800-545-8800\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: September 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0703-4248-01",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: February 2027",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "teva-pharmaceuticals-usa-inc-carboplatin-injection-0703-4248-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-carboplatin-injection-0703-4248-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"0703-4248-01\", \"generic_name\": \"Carboplatin Injection\", \"contact_info\": \"800-545-8800\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: February 2027\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0093-0832-01",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-0832-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-0832-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"0093-0832-01\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0093-0832-05",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-0832-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-0832-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"0093-0832-05\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0093-3212-01",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated supply: August 2026",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "shortage_reason": "Other",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3212-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3212-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"0093-3212-01\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated supply: August 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0093-3212-05",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3212-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3212-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"0093-3212-05\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0093-3213-01",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3213-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3213-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"0093-3213-01\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0093-3213-05",
      "generic_name": "Clonazepam Tablet",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "03/10/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1271",
      "dosage_form": "Tablet",
      "therapeutic_category": "Neurology",
      "id": "teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3213-05",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3213-05/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/10/2023\", \"package_ndc\": \"0093-3213-05\", \"generic_name\": \"Clonazepam Tablet\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0703-0018-01",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/01/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3226",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "teva-pharmaceuticals-usa-inc-hydromorphone-hydrochloride-injection-0703-0018-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-hydromorphone-hydrochloride-injection-0703-0018-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2017\", \"package_ndc\": \"0703-0018-01\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0703-0110-03",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/01/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3226",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "teva-pharmaceuticals-usa-inc-hydromorphone-hydrochloride-injection-0703-0110-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-hydromorphone-hydrochloride-injection-0703-0110-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2017\", \"package_ndc\": \"0703-0110-03\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0703-0113-03",
      "generic_name": "Hydromorphone Hydrochloride Injection",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/01/2017",
      "update_date": "08/17/2026",
      "days_in_shortage": "3226",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "teva-pharmaceuticals-usa-inc-hydromorphone-hydrochloride-injection-0703-0113-03",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-hydromorphone-hydrochloride-injection-0703-0113-03/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/01/2017\", \"package_ndc\": \"0703-0113-03\", \"generic_name\": \"Hydromorphone Hydrochloride Injection\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0591-2888-30",
      "generic_name": "Hydroxocobalamin Injection",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: September 2026",
      "initial_posting_date": "11/04/2024",
      "update_date": "08/04/2026",
      "days_in_shortage": "666",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Other",
      "id": "teva-pharmaceuticals-usa-inc-hydroxocobalamin-injection-0591-2888-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-hydroxocobalamin-injection-0591-2888-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydroxocobalamin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/04/2024\", \"package_ndc\": \"0591-2888-30\", \"generic_name\": \"Hydroxocobalamin Injection\", \"contact_info\": \"800-545-8800\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: September 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0480-3564-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0480-3564-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0480-3564-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0480-3564-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0480-3565-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0480-3565-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0480-3565-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0480-3565-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0480-3566-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0480-3566-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0480-3566-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0480-3566-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0480-3567-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0480-3567-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0480-3567-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0480-3567-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0480-3568-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0480-3568-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0480-3568-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0480-3568-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0480-3569-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0480-3569-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0480-3569-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0480-3569-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0480-3570-01",
      "generic_name": "Lisdexamfetamine Dimesylate Capsule",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/14/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1145",
      "dosage_form": "Capsule",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0480-3570-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0480-3570-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/14/2023\", \"package_ndc\": \"0480-3570-01\", \"generic_name\": \"Lisdexamfetamine Dimesylate Capsule\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0703-3671-01",
      "generic_name": "Methotrexate Sodium Injection",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "03/13/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1268",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "teva-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0703-3671-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0703-3671-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"0703-3671-01\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"800-545-8800\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0703-3675-01",
      "generic_name": "Methotrexate Sodium Injection",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: December 2026",
      "initial_posting_date": "03/13/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1268",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "teva-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0703-3675-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0703-3675-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"0703-3675-01\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"800-545-8800\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: December 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "0703-3678-01",
      "generic_name": "Methotrexate Sodium Injection",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: October 2026",
      "initial_posting_date": "03/13/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1268",
      "shortage_reason": "Other",
      "dosage_form": "Injection",
      "therapeutic_category": "Rheumatology",
      "id": "teva-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0703-3678-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0703-3678-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"03/13/2023\", \"package_ndc\": \"0703-3678-01\", \"generic_name\": \"Methotrexate Sodium Injection\", \"contact_info\": \"800-545-8800\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: October 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "62037-725-01",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: September 2026",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "shortage_reason": "Other",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-methylphenidate-hydrochloride-tablet-extended-release-62037-725-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-methylphenidate-hydrochloride-tablet-extended-release-62037-725-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"62037-725-01\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-545-8800\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: September 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62037-726-01",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: September 2026",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "shortage_reason": "Other",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-methylphenidate-hydrochloride-tablet-extended-release-62037-726-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-methylphenidate-hydrochloride-tablet-extended-release-62037-726-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"62037-726-01\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-545-8800\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: September 2026\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "62037-727-01",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "shortage_reason": "Other",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-methylphenidate-hydrochloride-tablet-extended-release-62037-727-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-methylphenidate-hydrochloride-tablet-extended-release-62037-727-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"62037-727-01\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-545-8800\", \"availability\": \"Limited Availability\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ],
      "disagreements": []
    },
    {
      "package_ndc": "62037-734-01",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "teva-pharmaceuticals-usa-inc-methylphenidate-hydrochloride-tablet-extended-release-62037-734-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-methylphenidate-hydrochloride-tablet-extended-release-62037-734-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"62037-734-01\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-545-8800\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "0703-4636-01",
      "generic_name": "Streptozocin Powder, For Solution",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "07/12/2022",
      "update_date": "08/17/2026",
      "days_in_shortage": "1512",
      "shortage_reason": "Other",
      "dosage_form": "Powder, For Solution",
      "therapeutic_category": "Oncology",
      "id": "teva-pharmaceuticals-usa-inc-streptozocin-powder-for-solution-0703-4636-01",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-streptozocin-powder-for-solution-0703-4636-01/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Streptozocin%20Powder,%20For%20Solution%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/12/2022\", \"package_ndc\": \"0703-4636-01\", \"generic_name\": \"Streptozocin Powder, For Solution\", \"contact_info\": \"800-545-8800\", \"availability\": \"Unavailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "60505-6282-1",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Teyro Labs",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "teyro-labs-carboplatin-injection-60505-6282-1",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teyro-labs-carboplatin-injection-60505-6282-1/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teyro%20Labs%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"60505-6282-1\", \"generic_name\": \"Carboplatin Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Carboplatin%20Injection&st=d\", \"contact_info\": \"Apotex Inc.: 800-706-5575\", \"availability\": \"Unavailable\", \"related_info\": \"Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "60505-6282-3",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Teyro Labs",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "teyro-labs-carboplatin-injection-60505-6282-3",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teyro-labs-carboplatin-injection-60505-6282-3/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teyro%20Labs%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"60505-6282-3\", \"generic_name\": \"Carboplatin Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Carboplatin%20Injection&st=d\", \"contact_info\": \"Apotex Inc.: 800-706-5575\", \"availability\": \"Unavailable\", \"related_info\": \"Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "60505-6282-6",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Teyro Labs",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "teyro-labs-carboplatin-injection-60505-6282-6",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teyro-labs-carboplatin-injection-60505-6282-6/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teyro%20Labs%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"60505-6282-6\", \"generic_name\": \"Carboplatin Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Carboplatin%20Injection&st=d\", \"contact_info\": \"Apotex Inc.: 800-706-5575\", \"availability\": \"Unavailable\", \"related_info\": \"Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "60505-6282-7",
      "generic_name": "Carboplatin Injection",
      "manufacturer_name": "Teyro Labs",
      "status": "Current",
      "availability": "Unavailable",
      "related_info": "Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug",
      "initial_posting_date": "04/28/2023",
      "update_date": "08/18/2026",
      "days_in_shortage": "1222",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Oncology",
      "id": "teyro-labs-carboplatin-injection-60505-6282-7",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/teyro-labs-carboplatin-injection-60505-6282-7/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teyro%20Labs%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/28/2023\", \"package_ndc\": \"60505-6282-7\", \"generic_name\": \"Carboplatin Injection\", \"related_info_link\": \"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Carboplatin%20Injection&st=d\", \"contact_info\": \"Apotex Inc.: 800-706-5575\", \"availability\": \"Unavailable\", \"related_info\": \"Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "13811-700-30",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Trigen Laboratories, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Allocation to current contracted customers",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "trigen-laboratories-llc-methylphenidate-hydrochloride-tablet-extended-release-13811-700-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/trigen-laboratories-llc-methylphenidate-hydrochloride-tablet-extended-release-13811-700-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Trigen%20Laboratories,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"13811-700-30\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Limited Availability\", \"related_info\": \"Allocation to current contracted customers\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "13811-706-10",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Trigen Laboratories, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Allocation to current contracted customers",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "trigen-laboratories-llc-methylphenidate-hydrochloride-tablet-extended-release-13811-706-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/trigen-laboratories-llc-methylphenidate-hydrochloride-tablet-extended-release-13811-706-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Trigen%20Laboratories,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"13811-706-10\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Limited Availability\", \"related_info\": \"Allocation to current contracted customers\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "13811-707-10",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Trigen Laboratories, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Allocation to current contracted customers",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "trigen-laboratories-llc-methylphenidate-hydrochloride-tablet-extended-release-13811-707-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/trigen-laboratories-llc-methylphenidate-hydrochloride-tablet-extended-release-13811-707-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Trigen%20Laboratories,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"13811-707-10\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Limited Availability\", \"related_info\": \"Allocation to current contracted customers\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "13811-708-10",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Trigen Laboratories, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Allocation to current contracted customers",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "trigen-laboratories-llc-methylphenidate-hydrochloride-tablet-extended-release-13811-708-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/trigen-laboratories-llc-methylphenidate-hydrochloride-tablet-extended-release-13811-708-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Trigen%20Laboratories,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"13811-708-10\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Limited Availability\", \"related_info\": \"Allocation to current contracted customers\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "13811-709-10",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Trigen Laboratories, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Allocation to current contracted customers",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "trigen-laboratories-llc-methylphenidate-hydrochloride-tablet-extended-release-13811-709-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/trigen-laboratories-llc-methylphenidate-hydrochloride-tablet-extended-release-13811-709-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Trigen%20Laboratories,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"13811-709-10\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Limited Availability\", \"related_info\": \"Allocation to current contracted customers\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "13811-710-30",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Trigen Laboratories, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Allocation to current contracted customers",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "trigen-laboratories-llc-methylphenidate-hydrochloride-tablet-extended-release-13811-710-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/trigen-laboratories-llc-methylphenidate-hydrochloride-tablet-extended-release-13811-710-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Trigen%20Laboratories,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"13811-710-30\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Limited Availability\", \"related_info\": \"Allocation to current contracted customers\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "13811-711-30",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Trigen Laboratories, LLC",
      "status": "Current",
      "availability": "Limited Availability",
      "related_info": "Allocation to current contracted customers",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "trigen-laboratories-llc-methylphenidate-hydrochloride-tablet-extended-release-13811-711-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/trigen-laboratories-llc-methylphenidate-hydrochloride-tablet-extended-release-13811-711-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Trigen%20Laboratories,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"13811-711-30\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Limited Availability\", \"related_info\": \"Allocation to current contracted customers\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68025-084-30",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-084-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-084-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"68025-084-30\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68025-088-30",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-088-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-088-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"68025-088-30\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68025-089-30",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-089-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-089-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"68025-089-30\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68025-095-10",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-095-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-095-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"68025-095-10\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68025-095-30",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-095-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-095-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"68025-095-30\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68025-096-10",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-096-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-096-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"68025-096-10\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68025-096-30",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-096-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-096-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"68025-096-30\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68025-097-10",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-097-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-097-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"68025-097-10\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68025-097-30",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-097-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-097-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"68025-097-30\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68025-098-10",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-098-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-098-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"68025-098-10\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "68025-098-30",
      "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "07/26/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1133",
      "dosage_form": "Tablet",
      "therapeutic_category": "Psychiatry",
      "id": "vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-098-30",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/vertical-pharmaceuticals-llc-methylphenidate-hydrochloride-tablet-extended-release-68025-098-30/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"07/26/2023\", \"package_ndc\": \"68025-098-30\", \"generic_name\": \"Methylphenidate Hydrochloride Tablet, Extended Release\", \"contact_info\": \"800-541-4802\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "44567-610-10",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "WG Critical Care",
      "status": "Current",
      "availability": "Available",
      "related_info": "Please check wholesalers and distributors for inventory.",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2343",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "wg-critical-care-midazolam-hydrochloride-injection-44567-610-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/wg-critical-care-midazolam-hydrochloride-injection-44567-610-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22WG%20Critical%20Care%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"44567-610-10\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"888-493-0861\", \"availability\": \"Available\", \"related_info\": \"Please check wholesalers and distributors for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "44567-611-10",
      "generic_name": "Midazolam Hydrochloride Injection",
      "manufacturer_name": "WG Critical Care",
      "status": "Current",
      "availability": "Available",
      "related_info": "Please check wholesalers and distributors for inventory.",
      "initial_posting_date": "04/02/2020",
      "update_date": "08/17/2026",
      "days_in_shortage": "2343",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "wg-critical-care-midazolam-hydrochloride-injection-44567-611-10",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/wg-critical-care-midazolam-hydrochloride-injection-44567-611-10/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22WG%20Critical%20Care%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"04/02/2020\", \"package_ndc\": \"44567-611-10\", \"generic_name\": \"Midazolam Hydrochloride Injection\", \"contact_info\": \"888-493-0861\", \"availability\": \"Available\", \"related_info\": \"Please check wholesalers and distributors for inventory.\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "39822-5525-3",
      "generic_name": "Promethazine Hydrochloride Injection",
      "manufacturer_name": "XGen Pharmaceuticals DJB, Inc.",
      "status": "Current",
      "availability": "Available",
      "initial_posting_date": "11/21/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1015",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "xgen-pharmaceuticals-djb-inc-promethazine-hydrochloride-injection-39822-5525-3",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/xgen-pharmaceuticals-djb-inc-promethazine-hydrochloride-injection-39822-5525-3/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22XGen%20Pharmaceuticals%20DJB,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/21/2023\", \"package_ndc\": \"39822-5525-3\", \"generic_name\": \"Promethazine Hydrochloride Injection\", \"contact_info\": \"866-390-4411\", \"availability\": \"Available\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "39822-5550-6",
      "generic_name": "Promethazine Hydrochloride Injection",
      "manufacturer_name": "XGen Pharmaceuticals DJB, Inc.",
      "status": "Current",
      "availability": "Unvailable",
      "related_info": "Estimated recovery: TBD",
      "initial_posting_date": "11/21/2023",
      "update_date": "06/23/2026",
      "days_in_shortage": "1015",
      "shortage_reason": "Demand increase for the drug",
      "dosage_form": "Injection",
      "therapeutic_category": "Analgesia/Addiction",
      "id": "xgen-pharmaceuticals-djb-inc-promethazine-hydrochloride-injection-39822-5550-6",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/xgen-pharmaceuticals-djb-inc-promethazine-hydrochloride-injection-39822-5550-6/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22XGen%20Pharmaceuticals%20DJB,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"11/21/2023\", \"package_ndc\": \"39822-5550-6\", \"generic_name\": \"Promethazine Hydrochloride Injection\", \"contact_info\": \"866-390-4411\", \"availability\": \"Unvailable\", \"related_info\": \"Estimated recovery: TBD\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "shortage_reason",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "39822-4200-2",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "XGen Pharmaceuticals DJB, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Tamarang is the application holder and X-Gen is the distributor/labeler",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "xgen-pharmaceuticals-djb-inc-rocuronium-bromide-injection-39822-4200-2",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/xgen-pharmaceuticals-djb-inc-rocuronium-bromide-injection-39822-4200-2/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22XGen%20Pharmaceuticals%20DJB,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"39822-4200-2\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"866-390-4411\", \"availability\": \"Available\", \"related_info\": \"Tamarang is the application holder and X-Gen is the distributor/labeler\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    },
    {
      "package_ndc": "39822-4200-6",
      "generic_name": "Rocuronium Bromide Injection",
      "manufacturer_name": "XGen Pharmaceuticals DJB, Inc.",
      "status": "Current",
      "availability": "Available",
      "related_info": "Tamarang is the application holder and X-Gen is the distributor/labeler",
      "initial_posting_date": "02/15/2023",
      "update_date": "08/17/2026",
      "days_in_shortage": "1294",
      "dosage_form": "Injection",
      "therapeutic_category": "Anesthesia",
      "id": "xgen-pharmaceuticals-djb-inc-rocuronium-bromide-injection-39822-4200-6",
      "url": "https://referencesource.org/drug-shortage-duration-tracker/xgen-pharmaceuticals-djb-inc-rocuronium-bromide-injection-39822-4200-6/",
      "source": "https://api.fda.gov/drug/shortages.json?search=company_name%3A%22XGen%20Pharmaceuticals%20DJB,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000",
      "source_quote": "\"initial_posting_date\": \"02/15/2023\", \"package_ndc\": \"39822-4200-6\", \"generic_name\": \"Rocuronium Bromide Injection\", \"contact_info\": \"866-390-4411\", \"availability\": \"Available\", \"related_info\": \"Tamarang is the application holder and X-Gen is the distributor/labeler\"",
      "verified_fields": [
        "availability",
        "dosage_form",
        "generic_name",
        "initial_posting_date",
        "manufacturer_name",
        "package_ndc",
        "related_info",
        "status",
        "therapeutic_category",
        "update_date"
      ],
      "derived_fields": [
        "days_in_shortage"
      ]
    }
  ]
}